Processing 00000000.tx.1: MINIREVIEW Genetic approaches to the molecular understanding of type 2diabetes Mark I. 

Phrase: "MINIREVIEW Genetic approaches to the molecular understanding of type 2diabetes Mark I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0449445:Approaches [Spatial Concept]
   736   C1292724:Approaches [Functional Concept]
Processing 00000000.tx.2: McCarthy1 and Philippe Froguel2,3 1Imperial College Faculty of Medicine and Medical Research Council Clinical Sciences Centre, Imperial College, London W12 0NN; 

Phrase: "McCarthy1"

Phrase: "and"

Phrase: "Philippe Froguel2,"

Phrase: "3 1Imperial College Faculty of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0015535:Faculty [Professional or Occupational Group]

Phrase: "and"

Phrase: "Medical Research Council Clinical Sciences Centre,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   895   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   895   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   876   C0683939:research center [Manufactured Object,Organization]
   839   C2347782:Clinical Center [Organization]
   799   C0205099:Center [Spatial Concept]
   709   C0025118:medical sciences [Biomedical Occupation or Discipline]

Phrase: "Imperial College,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0557806:College [Manufactured Object]

Phrase: "London W12 0NN"

Phrase: ";"
Processing 00000000.tx.3: 2Queen Mary School of Medicine and Dentistry, London EC1M 6BQ, United Kingdom; 

Phrase: "2Queen Mary School of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "and"

Phrase: "Dentistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011438:Dentistry [Biomedical Occupation or Discipline]

Phrase: "London EC1M 6BQ,"

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: ";"
Processing 00000000.tx.4: and 3Centre National de la Recherche Scientifique-8090 Institut de Biology, Institut Pasteur de Lille, 59000Lille, France  ABSTRACT TOP ABSTRACT INTRODUCTION FROM GENES TO PHYSIOLOGY FROM PHYSIOLOGY TO GENES INTEGRATING PHYSIOLOGY AND... 

Phrase: "and"

Phrase: "3Centre National de la Recherche Scientifique-8090 Institut de Biology,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0005532:Biology [Biomedical Occupation or Discipline]
   718 E C0205460:Biologic [Qualitative Concept]
   718 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Institut Pasteur de Lille,"

Phrase: "59000Lille,"

Phrase: "France  ABSTRACT TOP ABSTRACT INTRODUCTION FROM GENES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1293116:Introduction [Health Care Activity]
   748   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "TO PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "FROM PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "TO GENES INTEGRATING PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0031842:Physiology [Biomedical Occupation or Discipline]
   827   C0031843:physiology [Physiologic Function]
   755 E C0205463:Physiologic [Functional Concept]

Phrase: "AND..."
Processing 00000000.tx.5: REFERENCES The appreciation that individual susceptibility to type 2diabetes (T2D) and related components of the dysmetabolic syndrome has a strong inherited component provides a coherent framework within which to develop a molecular understanding of the pathogenesis of T2D. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The appreciation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346843:Appreciation [Conceptual Entity]

Phrase: "that individual susceptibility to type 2diabetes (T2D)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012655:Susceptibility [Clinical Attribute]
   753   C0220898:Susceptibility [Organism Attribute]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "and"

Phrase: "related components of the dysmetabolic syndrome"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0449432:Components [Manufactured Object]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "has"

Phrase: "a strong inherited component"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a coherent framework within which to"

Phrase: "develop"

Phrase: "a molecular understanding of the pathogenesis of T2D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0162340:Understanding [Mental Process]
Processing 00000000.tx.6: This review focuses on the main approaches currently adopted by researchers seeking to identify the inherited basis of T2D and the present state of our knowledge. 

Phrase: "This review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "focuses on the main approaches currently"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205225:Main [Qualitative Concept]
   753   C0205234:Focus [Spatial Concept]
   753   C0449445:Approaches [Spatial Concept]
   753   C0521116:Currently [Temporal Concept]
   753   C1285542:focus [Functional Concept]
   753   C1292724:Approaches [Functional Concept]
   753   C1542147:Main [Qualitative Concept]

Phrase: "adopted by researchers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035173:Researchers [Professional or Occupational Group]
   790   C0425382:Adopted [Finding]

Phrase: "seeking"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the inherited basis of T2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]

Phrase: "and"

Phrase: "the present state of our knowledge."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]
Processing 00000000.tx.7: One central theme that emerges is that progress in defining the genetic basis of the common, multifactorial forms of T2D is hindered by etiological heterogeneity: T2D is likely to represent the final common pathway of diverse interacting primary disturbances. 

Phrase: "One central theme"

Phrase: "that"

Phrase: "emerges"

Phrase: "is"

Phrase: "that progress in defining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1272688:progress [Functional Concept]
   770   C1280477:Progress [Functional Concept]

Phrase: "the genetic basis of the common, multifactorial forms of T2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1527178:Basis [Functional Concept]
   738   C1874451:Basis [Pharmacologic Substance]

Phrase: "is"

Phrase: "hindered by etiological heterogeneity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019409:Heterogeneity [Qualitative Concept]

Phrase: ":"

Phrase: "T2D"

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the final common pathway of diverse interacting primary disturbances."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1704259:Pathway [Molecular Function]
   742   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.8: Such heterogeneity equally compromises efforts to understand the basis for T2D by use of other approaches, such as cellular biochemistry and classical physiology. 

Phrase: "Such heterogeneity equally"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "compromises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945640:compromise [Finding]

Phrase: "efforts to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015264:Effort [Organism Function]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the basis for T2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1527178:Basis [Functional Concept]
   760   C1874451:Basis [Pharmacologic Substance]

Phrase: "by use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of other approaches,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449445:Approaches [Spatial Concept]
  1000   C1292724:Approaches [Functional Concept]

Phrase: "such as cellular biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "classical physiology."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0031842:Physiology [Biomedical Occupation or Discipline]
   861   C0031843:physiology [Physiologic Function]
   789 E C0205463:Physiologic [Functional Concept]
Processing 00000000.tx.9: Analyses that seek to ally sophisticated physiological characterization with measures of genomic variation are likely to provide powerful tools for redressing the loss of power associated with such heterogeneity. linkage; 

Phrase: "Analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "that"

Phrase: "seek"

Phrase: "to ally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1098293:Ally [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "sophisticated"

Phrase: "physiological characterization with measures of genomic variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "powerful tools for redressing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   780   C0336794:Power tool [Manufactured Object]
   737   C0336791:Tool [Manufactured Object]
   737   C2827396:Tool [Manufactured Object]

Phrase: "the loss of power"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1881451:LOSS OF POWER [Event]
   909   C2984804:LOSS OF POWER [Functional Concept]
   770   C1517945:Loss [Quantitative Concept]

Phrase: "associated with such heterogeneity. linkage"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0019409:Heterogeneity [Qualitative Concept]
   760   C0023745:linkage [Molecular Function]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: ";"
Processing 00000000.tx.10: linkage disequilibrium; 

Phrase: "linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.11: susceptibility genes; 

Phrase: "susceptibility genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0919453:Susceptibility Gene [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.12: positional cloning  INTRODUCTION TOP ABSTRACT INTRODUCTION FROM GENES TO PHYSIOLOGY FROM PHYSIOLOGY TO GENES INTEGRATING PHYSIOLOGY AND... 

Phrase: "positional cloning  INTRODUCTION TOP ABSTRACT INTRODUCTION FROM GENES"

Phrase: "TO PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "FROM PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "TO GENES INTEGRATING PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0031842:Physiology [Biomedical Occupation or Discipline]
   827   C0031843:physiology [Physiologic Function]
   755 E C0205463:Physiologic [Functional Concept]

Phrase: "AND..."
Processing 00000000.tx.13: REFERENCES AROUND ONE IN TEN people alive today suffers from type 2diabetes (T2D) or is destined to develop it before he dies (109). 

Phrase: "REFERENCES AROUND ONE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1514811:Reference [Idea or Concept]
   756   C1706462:Reference [Conceptual Entity]

Phrase: "IN TEN people alive today"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0310367:Today [Antibiotic,Organic Chemical]
   812   C0750526:Today [Temporal Concept]

Phrase: "suffers from type 2diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332307:Type [Qualitative Concept]
   770   C0683278:suffer [Mental or Behavioral Dysfunction]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "(T2D"

Phrase: ")"

Phrase: "or"

Phrase: "is"

Phrase: "destined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "develop"

Phrase: "it before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "he dies"

Phrase: "(109"

Phrase: ")."
Processing 00000000.tx.14: T2D and associated components of the dysmetabolic syndrome already represent dominant causes of morbidity and mortality in societies worldwide, yet recent estimates predict a doubling in T2D prevalence by 2025(109). 

Phrase: "T2D"

Phrase: "and"

Phrase: "associated components of the dysmetabolic syndrome already"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0449432:Components [Manufactured Object]
   714 E C1705248:Component [Conceptual Entity]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "dominant causes of morbidity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0015127:causes [Functional Concept]
   770   C1314792:Causes [Functional Concept]
   737 E C1524003:Cause [Conceptual Entity]

Phrase: "and"

Phrase: "mortality in societies worldwide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026565:Mortality [Quantitative Concept]
   770   C0026566:mortality [Quantitative Concept]

Phrase: "yet recent estimates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0750572:estimates [Quantitative Concept]

Phrase: "predict"

Phrase: "a doubling in T2D prevalence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205173:doubling [Functional Concept]
   753   C1705764:Doubling [Activity]

Phrase: "by 2025"

Phrase: "(109"

Phrase: ")."
Processing 00000000.tx.15: Large intervention studies and clinical trials, notably the UK Prospective Diabetes Study (98) and the Diabetes Prevention Program (94, 109), have convincingly demonstrated the capacity of preventive and therapeutic strategies to reduce hyperglycemia and indicate that such maneuvers have a positive effect on disease progression and the development of complications. 

Phrase: "Large intervention studies"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0021810:Intervention Studies [Research Activity]
   848 E C3274035:Interventional Study [Research Activity]
       E   INTERVENTIONAL
   827   C0886296:intervention [Health Care Activity]
   827   C0947630:studies [Laboratory Procedure]
   827   C1273869:Intervention [Health Care Activity]
   827   C1948041:Intervention [Therapeutic or Preventive Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "clinical trials,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0008976:Clinical Trials [Research Activity]
           Trial
  1000   C1096775:clinical trials [Intellectual Product]
   861   C0205210:Clinical [Qualitative Concept]

Phrase: "notably"

Phrase: "the UK Prospective Diabetes Study"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C0033522:prospective study [Research Activity]
   875   C1709709:Prospective Study [Research Activity]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0023981:prospective [Research Activity]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]

Phrase: "(98"

Phrase: ")"

Phrase: "and"

Phrase: "the Diabetes Prevention Program"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0679717:prevention program [Intellectual Product]
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]
   734   C1659987:diabetes prevention [Educational Activity]

Phrase: "(94,"

Phrase: "109"

Phrase: ")"

Phrase: ","

Phrase: "have"

Phrase: "convincingly"

Phrase: "demonstrated"

Phrase: "the capacity of preventive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1516240:Capacity [Quantitative Concept]

Phrase: "and"

Phrase: "therapeutic strategies to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679199:strategies [Mental Process]

Phrase: "reduce"

Phrase: "hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "indicate"

Phrase: "that"

Phrase: "such maneuvers"

Phrase: "have"

Phrase: "a positive effect on disease progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "the development of complications."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]
Processing 00000000.tx.16: However, the benefits of these interventions seem hard to sustain in the long term (97). 

Phrase: "However,"

Phrase: "the benefits of these interventions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0814225:Benefits [Quantitative Concept]

Phrase: "seem"

Phrase: "hard to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018599:Hard [Qualitative Concept]

Phrase: "sustain in the long term"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0443252:Long-term [Temporal Concept]
   760   C0205166:Long [Qualitative Concept]
   760   C0443318:sustain [Functional Concept]
   760   C1515273:Term [Temporal Concept]
   760   C1705313:Term [Idea or Concept]
   760   C1706317:Long [Qualitative Concept]
   760   C2732140:Sustain [Organic Chemical,Pharmacologic Substance]
   760   C2826302:TERM [Intellectual Product]

Phrase: "(97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.17: New therapeutic and preventive treatments are urgently required, and these are most likely to arise out of rational drug discovery based on a thorough molecular understanding of the fundamental processes determining disease pathogenesis (71). 

Phrase: "New therapeutic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   861   C0302350:Therapeutic [Functional Concept]

Phrase: "and"

Phrase: "preventive treatments"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   966   C0199176:Preventive treatment [Therapeutic or Preventive Procedure]
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   861   C0445202:preventive [Functional Concept]
   861   C1456501:Preventive [Qualitative Concept]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]

Phrase: "are"

Phrase: "urgently"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "these"

Phrase: "are"

Phrase: "most likely to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0750501:most likely [Idea or Concept]
   827   C0205393:Most [Quantitative Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]
   755 E C0033204:Likelihood [Quantitative Concept]

Phrase: "arise out of rational drug discovery"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0920472:Drug Discovery [Research Activity]
   753   C0013227:Drug [Pharmacologic Substance]
   753   C0439787:Out [Spatial Concept]
   753   C0849355:Out [Qualitative Concept]
   753   C1254351:Drug [Pharmacologic Substance]
   753   C1880355:Discovery [Activity]

Phrase: "based on a thorough molecular understanding of the fundamental processes"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   739   C0162340:Understanding [Mental Process]
   739   C1521991:Molecular [Qualitative Concept]
   739   C1527178:Based [Functional Concept]
   739   C1705938:Based [Idea or Concept]
   706 E C0002055:base [Inorganic Chemical]
   706 E C0178499:Base [Chemical Viewed Functionally]
   706   C1184743:Process [Body Part, Organ, or Organ Component]
   706   C1522240:Process [Phenomenon or Process]
   706 E C1880279:Base [Biomedical or Dental Material]

Phrase: "determining"

Phrase: "disease pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0543483:pathogenesis [Functional Concept]
   861   C0699748:Pathogenesis [Pathologic Function]

Phrase: "(71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.18: The recognition that susceptibility to T2D (and related conditions within the dysmetabolic syndrome) has a strong inherited component (41) provides a mechanism for developing such a molecular understanding of the pathogenesis of T2D. 

Phrase: "The recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0524637:Recognition [Mental Process]

Phrase: "that susceptibility to T2D"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "("

Phrase: "and"

Phrase: "related conditions within the dysmetabolic syndrome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0012634:condition [Disease or Syndrome]
   719   C0348080:Condition [Qualitative Concept]
   719   C1705253:Condition [Conceptual Entity]

Phrase: ")"

Phrase: "has"

Phrase: "a strong inherited component"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "(41"

Phrase: ")"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a mechanism for developing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "such a molecular understanding of the pathogenesis of T2D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0162340:Understanding [Mental Process]
Processing 00000000.tx.19: Compared with other approaches to the dissection of pathophysiological mechanisms, gene discovery efforts have the merit of establishing chains of causality, since physiological changes result from genomic variation, and never the reverse.  

Phrase: "Compared with other approaches"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449445:Approaches [Spatial Concept]
   770   C1292724:Approaches [Functional Concept]
   770   C1707455:Compared [Activity]

Phrase: "to the dissection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012737:Dissection [Therapeutic or Preventive Procedure]

Phrase: "of pathophysiological mechanisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "gene discovery efforts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0015264:Effort [Organism Function]
   734   C2717881:Gene Discovery [Molecular Biology Research Technique]

Phrase: "have"

Phrase: "the merit of establishing chains of causality,"

Phrase: "since"

Phrase: "physiological changes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0205463:Physiological [Functional Concept]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]
   789 E C0031842:Physiology [Biomedical Occupation or Discipline]
   789 E C0031843:physiology [Physiologic Function]

Phrase: "result from genomic variation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0017428:Genomic [Gene or Genome]
   770   C0205419:Variation [Qualitative Concept]
   770   C0887950:genomic [Biomedical Occupation or Discipline]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "and"

Phrase: "never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003901:Never [Temporal Concept]

Phrase: "the reverse."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.20: FROM GENES TO PHYSIOLOGY TOP ABSTRACT INTRODUCTION FROM GENES TO PHYSIOLOGY FROM PHYSIOLOGY TO GENES INTEGRATING PHYSIOLOGY AND... 

Phrase: "FROM GENES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "TO PHYSIOLOGY TOP ABSTRACT INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1293116:Introduction [Health Care Activity]
   812   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "FROM GENES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "TO PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "FROM PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "TO GENES INTEGRATING PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0031842:Physiology [Biomedical Occupation or Discipline]
   827   C0031843:physiology [Physiologic Function]
   755 E C0205463:Physiologic [Functional Concept]

Phrase: "AND..."
Processing 00000000.tx.21: REFERENCES One of the classical routes to the genetic dissection of any inherited trait has been to adopt a positional approach, that is, to attempt to map susceptibility loci purely on the basis of chromosomal location (59). 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "One of the classical routes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "to the genetic dissection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012737:Dissection [Therapeutic or Preventive Procedure]

Phrase: "of any inherited trait"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599883:Trait [Organism Attribute]

Phrase: "has"

Phrase: "been"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "adopt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "a positional approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "that"

Phrase: "is"

Phrase: ","

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "attempt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "map"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024779:Map [Manufactured Object]
  1000   C1706473:Map [Conceptual Entity]

Phrase: "susceptibility loci purely on the basis of chromosomal location"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1708726:Locus [Gene or Genome]

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.22: The substrates for such approaches are typically sets of families segregating the trait of interest, and the tools are linkage and linkage disequilibrium (LD) analysis. 

Phrase: "The substrates for such approaches"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1710236:Substrate [Manufactured Object]

Phrase: "are"

Phrase: "typically"

Phrase: "sets of families"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0015576:Families [Family Group]
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1704727:Family [Conceptual Entity]
   790   C1705195:Set [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "segregating"

Phrase: "the trait of interest,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0599883:Trait [Organism Attribute]

Phrase: "and"

Phrase: "the tools"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0336791:Tool [Manufactured Object]
   966   C2827396:Tool [Manufactured Object]

Phrase: "are"

Phrase: "linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]

Phrase: "and"

Phrase: "linkage disequilibrium (LD) analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0796345:linkage analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0023746:Linkage Disequilibrium [Quantitative Concept]
Processing 00000000.tx.23: At the heart of both of these methods is the expectation that genes with similar chromosomal positions will only rarely be separated during meiotic recombination. 

Phrase: "At the heart"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018787:Heart [Body Part, Organ, or Organ Component]
  1000   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "of both"

Phrase: "of these methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "is"

Phrase: "the expectation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679138:Expectation [Idea or Concept]

Phrase: "that genes with similar chromosomal positions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0887940:Gene Positions [Molecular Function]
   753   C0017337:Genes [Gene or Genome]

Phrase: "will"

Phrase: "only rarely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C0522498:Rarely [Qualitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "be"

Phrase: "separated during meiotic recombination."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1155792:Meiotic Recombination [Cell Function]
   770   C0026207:Miotic [Pharmacologic Substance]
   770   C0034865:Recombination [Genetic Function]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
Processing 00000000.tx.24: The analysis of transmission patterns through successive generations (observed in families or inferred in populations) therefore allows researchers to localize susceptibility variants by detecting chromosomal markers that show significant cosegregation with disease (68). 

Phrase: "The analysis of transmission patterns"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "through successive generations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0079411:Generations [Temporal Concept]
   827 E C3146294:Generation [Activity]
   761 E C1414672:Genesis [Gene or Genome]
   761 E C2984892:Genesis [Gene or Genome]

Phrase: "("

Phrase: "observed in families"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0015576:Families [Family Group]
   790   C1441672:Observed [Functional Concept]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "or"

Phrase: "inferred in populations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0032659:Population [Quantitative Concept]
   790   C0679201:Inferred [Mental Process]
   790   C1257890:Population [Population Group]
   790   C3245504:inferred [Idea or Concept]

Phrase: ")"

Phrase: "therefore"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "researchers to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035173:Researchers [Professional or Occupational Group]

Phrase: "localize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:localize [Spatial Concept]

Phrase: "susceptibility variants by detecting chromosomal markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:variants [Qualitative Concept]

Phrase: "that"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "significant cosegregation with disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986591:Cosegregation [Functional Concept]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.25: When successful, such "reverse genetics" approaches allow susceptibility genes to be identified in the absence of prior assumptions about their biological function (50). 

Phrase: "When"

Phrase: "successful,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1272703:Successful [Qualitative Concept]
   928 E C0597535:Success [Social Behavior]

Phrase: "such ""reverse genetics"" approaches"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0449445:Approaches [Spatial Concept]
   827   C1292724:Approaches [Functional Concept]
   734   C1657306:Reverse Genetics [Research Activity]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "susceptibility genes to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0919453:Susceptibility Gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "be"

Phrase: "identified in the absence of prior assumptions"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0205396:Identified [Qualitative Concept]
   748   C0332152:Prior [Temporal Concept]
   748   C0332197:absence [Quantitative Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C2826257:PRIOR [Event]

Phrase: "about their biological function"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0031845:Biological function, NOS [Physiologic Function]
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0031843:function [Physiologic Function]
   861   C0205460:biological [Qualitative Concept]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.26: The value of such approaches is obvious when, as with T2D, the principal pathogenetic mechanisms are not known. 

Phrase: "The value of such"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1522609:Value [Quantitative Concept]

Phrase: "approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449445:Approach [Spatial Concept]
  1000   C1292724:Approaches [Functional Concept]

Phrase: "is"

Phrase: "obvious"

Phrase: "when"

Phrase: ","

Phrase: "as with T2D,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "the principal pathogenetic mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.27: Positional cloning in maturity onset diabetes of the young. 

Phrase: "Positional cloning in maturity onset diabetes of the young."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1656250:positional cloning [Research Activity]
   742   C0009015:Cloning [Research Activity]
   716   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   716   C2984262:Maturity onset diabetes of the young [Functional Concept]
Processing 00000000.tx.28: The past decade has seen substantial strides in our understanding of the basis of monogenic [maturity onset diabetes of the young (MODY)] and syndromic [e.g., maternally inherited diabetes with deafness (55), myotonic dystrophy (84)] forms of diabetes, often gained through positional cloning approaches. 

Phrase: "The past decade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2981279:Decade [Quantitative Concept]

Phrase: "has"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "substantial strides in our understanding of the basis of monogenic"

Phrase: "[maturity onset diabetes of the young (MODY)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
  1000   C2984262:Maturity onset diabetes of the young [Functional Concept]
   833   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C0449989:Maturity [Qualitative Concept]
   753   C0700597:Maturity [Temporal Concept]

Phrase: "]"

Phrase: "and"

Phrase: "syndromic"

Phrase: "["

Phrase: "e.g."

Phrase: ","

Phrase: "maternally inherited diabetes with deafness"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "myotonic dystrophy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0027126:Myotonic Dystrophy [Disease or Syndrome]
  1000   C0410226:Myotonic Dystrophy [Disease or Syndrome]
   861   C0333606:Dystrophy [Pathologic Function]
   789 E C0333607:Dystrophic [Functional Concept]

Phrase: "(84"

Phrase: ")"

Phrase: "]"

Phrase: "forms of diabetes,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1522492:Form [Functional Concept]

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "gained through positional cloning approaches."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C1656250:positional cloning [Research Activity]
   760   C0009015:Cloning [Research Activity]
   760   C0240795:POSITIONAL [Finding]
   760   C0449445:Approaches [Spatial Concept]
   760   C1292724:Approaches [Functional Concept]
   726 E C0009013:Clone [Cell]
   726   C1517378:Gain [Quantitative Concept]
   726 E C1522642:Clone [Tissue]
Processing 00000000.tx.29: MODY is a strongly familial form of non-insulin-dependent diabetes displaying clear autosomal dominant inheritance, which usually develops during childhood, adolescence, or young adulthood. 

Phrase: "MODY"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
  1000   C2984262:Maturity onset diabetes of the young [Functional Concept]
   833   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C0449989:Maturity [Qualitative Concept]
   753   C0700597:Maturity [Temporal Concept]

Phrase: "is"

Phrase: "a strongly familial form of non-insulin-dependent diabetes displaying"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1832428:Familial form [Finding]
   739   C0348078:Form [Qualitative Concept]
   739   C0376315:Form [Manufactured Object]
   739   C1522492:Form [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "autosomal dominant inheritance,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0443147:Autosomal dominant inheritance [Intellectual Product]
           Autosomal dominant
   913   C0678944:autosomal inheritance [Genetic Function]
   901   C0678942:dominant inheritance [Genetic Function]
   827   C0242538:Inheritance [Quantitative Concept]
   827   C0728826:Inheritance [Functional Concept]
   827   C1527180:Dominant [Functional Concept]

Phrase: "which usually"

Phrase: "develops during childhood,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0231335:Childhood [Temporal Concept]

Phrase: "adolescence,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001578:Adolescence [Age Group]
   928 E C0205653:Adolescent [Age Group]

Phrase: "or"

Phrase: "young adulthood."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680085:young adulthood [Age Group]
   861   C0700597:Adulthood [Temporal Concept]
Processing 00000000.tx.30: The predominant physiological feature is a defect in insulin secretion (33). 

Phrase: "The predominant physiological feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "is"

Phrase: "a defect in insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.31: Through a combination of positional cloning and candidate gene efforts, six MODY genes (MODY1-6) have been identified. 

Phrase: "Through a combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "of positional cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1656250:positional cloning [Research Activity]
   861   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "candidate gene efforts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0015264:Effort [Organism Function]
   734   C1332838:Candidate Gene [Gene or Genome]

Phrase: "six MODY genes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   909   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   909   C2984262:Maturity onset diabetes of the young [Functional Concept]
   800   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0332162:Onset [Qualitative Concept]
   744   C0449989:Maturity [Qualitative Concept]
   744   C0700597:Maturity [Temporal Concept]

Phrase: "(MODY1-6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1852093:MODY1 [Disease or Syndrome]

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.32: These genes encode the enzyme glucokinase (GCK/MODY2) (34) and the transcription factors, hepatocyte nuclear factor-4 (HNF-4/MODY1) (107), hepatocyte nuclear factor-1 (HNF-1/MODY3) (99, 100, 108), insulin promoter factor-1 (IPF-1/MODY4) (88, 89), HNF-1 (HNF-1/MODY5) (49), and neuroD1/2 (MODY6) (65). 

Phrase: "These genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "the enzyme glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: "(GCK/MODY2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0342277:MODY2 [Disease or Syndrome]
   861   C1841962:MODY2 [Disease or Syndrome]

Phrase: ")"

Phrase: "(34"

Phrase: ")"

Phrase: "and"

Phrase: "the transcription factors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "hepatocyte nuclear factor-4"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "(HNF-4/MODY1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1852093:MODY1 [Disease or Syndrome]

Phrase: ")"

Phrase: "(107"

Phrase: ")"

Phrase: ","

Phrase: "hepatocyte nuclear factor-1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   923   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "(HNF-1/MODY3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1838100:MODY3 [Disease or Syndrome]
   827   C3273648:MODY3 [Gene or Genome]

Phrase: ")"

Phrase: "(99,"

Phrase: "100,"

Phrase: "108"

Phrase: ")"

Phrase: ","

Phrase: "insulin promoter factor-1"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0248419:insulin promoter factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826562:INSULIN PROMOTER FACTOR 1 [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C2827422:Factor [Conceptual Entity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IPF-1/MODY4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1826562:MODY4 [Gene or Genome]
           INSULIN PROMOTER FACTOR 1
   804   C1833382:MODY4 [Disease or Syndrome]
   771   C0248419:insulin promoter factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "(88,"

Phrase: "89"

Phrase: ")"

Phrase: ","

Phrase: "HNF-1"

Phrase: "(HNF-1/MODY5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0431693:MODY5 [Congenital Abnormality,Disease or Syndrome]
   827   C1420636:MODY5 [Gene or Genome]
   827   C2348633:MODY5 [Gene or Genome]
   827   C3540897:MODY5 [Disease or Syndrome]

Phrase: ")"

Phrase: "(49"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "neuroD1/2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0297513:NeuroD1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1417683:NEUROD1 [Gene or Genome]

Phrase: "(MODY6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1417683:MODY6 [Gene or Genome]
  1000   C1853371:MODY6 [Disease or Syndrome]
  1000   C3273872:MODY6 [Gene or Genome]

Phrase: ")"

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.33: Mutations in GCK and HNF-1 predominate, with other MODY subtypes rare in all populations so far examined. 

Phrase: "Mutations in GCK"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "HNF-1"

Phrase: "predominate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332251:Predominate [Qualitative Concept]

Phrase: ","

Phrase: "with other MODY subtypes"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   901   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   901   C2984262:Maturity onset diabetes of the young [Functional Concept]
   829   C0332162:With onset [Qualitative Concept]
           Onset
   827   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   791   C0011847:Diabetes [Disease or Syndrome]
   791   C0011849:Diabetes [Disease or Syndrome]
   791   C0332239:Young [Temporal Concept]
   791   C0332287:With [Qualitative Concept]
   791   C0449560:subtypes [Classification]
   791   C0449989:Maturity [Qualitative Concept]
   791   C0700597:Maturity [Temporal Concept]
   791   C1705690:With [Intellectual Product]
   720 E C0205286:Mature [Temporal Concept]

Phrase: "rare in all populations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0521114:Rare [Temporal Concept]
   770   C0522498:Rare [Qualitative Concept]
   770   C1514917:RARE [Gene or Genome]

Phrase: "so"

Phrase: "far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205108:far [Spatial Concept]

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.34: Additional MODY genes (so-called MODY-X) undoubtedly exist, since there remains a minority of families (between 16and 45%) in which MODY does not cosegregate with markers tightly linked to the known loci (20). 

Phrase: "Additional MODY genes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   909   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   909   C2984262:Maturity onset diabetes of the young [Functional Concept]
   800   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0332162:Onset [Qualitative Concept]
   744   C0449989:Maturity [Qualitative Concept]
   744   C0700597:Maturity [Temporal Concept]

Phrase: "(so-called MODY-X) undoubtedly"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   862   C2984262:Maturity onset diabetes of the young [Functional Concept]
   782   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   739   C0011847:Diabetes [Disease or Syndrome]
   739   C0011849:Diabetes [Disease or Syndrome]
   739   C0332162:Onset [Qualitative Concept]
   739   C0449989:Maturity [Qualitative Concept]
   739   C0700597:Maturity [Temporal Concept]

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: ","

Phrase: "since"

Phrase: "there"

Phrase: "remains"

Phrase: "a minority of families"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0026192:Minority [Population Group]

Phrase: "("

Phrase: "between 16and 45%"

Phrase: ")"

Phrase: "in which MODY"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   923   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   923   C2984262:Maturity onset diabetes of the young [Functional Concept]
   835   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   793   C0011847:Diabetes [Disease or Syndrome]
   793   C0011849:Diabetes [Disease or Syndrome]
   793   C0150312:In [Quantitative Concept]
   793   C0332162:Onset [Qualitative Concept]
   793   C0332239:Young [Temporal Concept]
   793   C0332285:In [Spatial Concept]
   793   C0449989:Maturity [Qualitative Concept]
   793   C0700597:Maturity [Temporal Concept]
   721 E C0205286:Mature [Temporal Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cosegregate with markers tightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0005516:Marker [Clinical Attribute]

Phrase: "linked to the known loci"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205309:Known [Qualitative Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   726   C1708726:Locus [Gene or Genome]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.35: The major value of these successful gene discovery efforts has lain in the impetus they have provided to understanding of -cell development and function. 

Phrase: "The major value of these successful gene discovery efforts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1522609:Value [Quantitative Concept]

Phrase: "has"

Phrase: "lain in the impetus"

Phrase: "they"

Phrase: "have"

Phrase: "provided to understanding of -cell development"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0815089:cell development [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0162340:Understanding [Mental Process]
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1527148:Development [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C1999230:Provided [Activity]

Phrase: "and"

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.36: GCK (MODY2) phosphorylates glucose to glucose 6-phosphate in pancreatic -cells and hepatocytes and plays a major role in the regulation and integration of glucose metabolism (66). 

Phrase: "GCK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1415014:GCK [Gene or Genome]
  1000   C1417019:GCK [Gene or Genome]

Phrase: "(MODY2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0342277:MODY2 [Disease or Syndrome]
  1000   C1841962:MODY2 [Disease or Syndrome]

Phrase: ")"

Phrase: "phosphorylates"

Phrase: "glucose to glucose 6-phosphate"

Phrase: "in pancreatic -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a major role in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "integration of glucose metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1158478:Integration [Genetic Function]
   770   C1705422:Integration [Machine Activity]

Phrase: "(66"

Phrase: ")."
Processing 00000000.tx.37: The physiological characteristics of subjects with GCK mutations have clearly confirmed GCK as the -cell glucose sensor, and >100 GCK mutations have been observed in MODY to date (31, 34). 

Phrase: "The physiological characteristics of subjects"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0681884:subject characteristics [Research Activity]
   781   C1519021:Subject Characteristics [Organism Attribute]
   781   C1706465:Subject Characteristics [Idea or Concept]
   760   C1521970:Characteristics [Qualitative Concept]

Phrase: "with GCK mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "clearly confirmed GCK as the -cell glucose sensor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1415014:GCK [Gene or Genome]
   744   C1417019:GCK [Gene or Genome]

Phrase: "and >"

Phrase: "100 GCK mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "observed in MODY"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   909   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   909   C2984262:Maturity onset diabetes of the young [Functional Concept]
   800   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0332162:Onset [Qualitative Concept]
   744   C0332239:Young [Temporal Concept]
   744   C0449989:Maturity [Qualitative Concept]
   744   C0700597:Maturity [Temporal Concept]
   744   C1441672:Observed [Functional Concept]

Phrase: "to date"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.38: The kinetic properties of recombinant GCK proteins have shown that the relative enzymatic activity of mutant proteins is impaired (40), resulting in decreased glycolytic flux (91). 

Phrase: "The kinetic properties of recombinant GCK proteins"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0871161:properties [Qualitative Concept]
   748   C1292721:properties [Functional Concept]
   714 E C1882134:Property [Conceptual Entity]
   714 E C2347695:Property [Entity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the relative enzymatic activity of mutant proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C2267219:Enzymatic Activity [Molecular Function]
   757   C1537044:protein activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "resulting in decreased glycolytic flux"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C0332294:Resulting in [Functional Concept]
   770   C1371662:Decreased Glycolysis [Organ or Tissue Function]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C0678226:resulting [Functional Concept]
   760   C2348693:Flux [Natural Phenomenon or Process]
   726 E C0547047:Decrease [Quantitative Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "(91"

Phrase: ")."
Processing 00000000.tx.39: This defect translates in vivo as a glucose-sensing defect leading to an increase in the blood glucose threshold that triggers insulin secretion (101) and a right shift in the dose-response curve of glucose-induced insulin secretion (17). 

Phrase: "This defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1457869:Defect [Functional Concept]
  1000   C1861101:DEFECT [Disease or Syndrome]

Phrase: "translates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040710:translate [Occupational Activity]

Phrase: "in vivo as a glucose-sensing defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "leading to an increase"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0332152:Leading [Temporal Concept]
   770   C0442805:Increase [Functional Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the blood glucose threshold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449864:Threshold [Qualitative Concept]
   734   C0005802:Blood Glucose [Carbohydrate]

Phrase: "that"

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(101"

Phrase: ")"

Phrase: "and"

Phrase: "a right shift in the dose-response curve"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0427514:Right shift [Finding]
   744   C0333051:Shift [Functional Concept]
   744   C2347509:Shift [Phenomenon or Process]

Phrase: "of glucose-induced insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.40: An insulin-secretory defect in the absence of insulin resistance is also a feature of diabetic and nondiabetic carriers of MODY3 (HNF-1) mutations (18). 

Phrase: "An insulin-secretory defect in the absence of insulin resistance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1457869:Defect [Functional Concept]
   739   C1861101:DEFECT [Disease or Syndrome]

Phrase: "is"

Phrase: "also"

Phrase: "a feature of diabetic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1521970:Feature [Qualitative Concept]
   770   C1706388:Feature [Conceptual Entity]
   770   C2346469:Feature [Qualitative Concept]
   770   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "nondiabetic carriers of MODY3"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0007294:carriers [Finding]
   737 E C0560175:Carrier [Finding]
   737 E C1706209:Carrier [Medical Device]
   737 E C3273162:Carrier [Intellectual Product]

Phrase: "(HNF-1"

Phrase: ")"

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.41: Over 120different mutations have been reported within coding and promoter regions of this gene (99, 100, 108). 

Phrase: "Over 120different mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "reported within coding"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0009219:Coding [Occupational Activity]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "promoter regions of this gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0033413:Promoter Regions [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   797   C0314621:Promoter gene [Gene or Genome]
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "(99,"

Phrase: "100,"

Phrase: "108"

Phrase: ")."
Processing 00000000.tx.42: In contrast, only a few kindred with HNF-4 (MODY1)-associated diabetes have been described (62, 107). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a few kindred with HNF-4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0598429:kindred [Qualitative Concept]

Phrase: "(MODY1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1852093:MODY1 [Disease or Syndrome]

Phrase: ")-"

Phrase: "associated diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(62,"

Phrase: "107"

Phrase: ")."
Processing 00000000.tx.43: HNF-4 is a member of the steroid/thyroid hormone receptor superfamily and acts within the same transcriptional network as HNF-1. 

Phrase: "HNF-4"

Phrase: "is"

Phrase: "a member of the steroid/thyroid hormone receptor superfamily"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0680022:member [Population Group]
   742   C2698041:Member [Professional or Occupational Group]

Phrase: "and"

Phrase: "acts within the same transcriptional network"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1720950:Transcriptional Network [Molecular Function]
   753   C0040649:Transcriptional [Genetic Function]
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C0445247:Same [Qualitative Concept]
   753   C1513822:Network [Professional or Occupational Group]
   753   C1705739:Network [Manufactured Object]
   753   C1882071:Network [Conceptual Entity]

Phrase: "as HNF-1."
Processing 00000000.tx.44: Whereas HNF-4 controls the expression of HNF-1 in embryonic endoderm, liver, and pancreatic cells, the tables are turned in pancreatic and intestinal cells. 

Phrase: "Whereas"

Phrase: "HNF-4"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the expression of HNF-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in embryonic endoderm,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C2331344:Embryonic endoderm [Embryonic Structure]
   861   C0014144:Endoderm [Embryonic Structure]
   789 E C0521461:Endodermal [Body Location or Region]

Phrase: "liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "pancreatic cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the tables"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0039224:tables [Manufactured Object]
  1000   C1706074:Tables [Intellectual Product]
   966 E C1706073:Table [Medical Device]

Phrase: "are"

Phrase: "turned in pancreatic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   790   C0541749:turned [Finding]
   756 E C1709743:Turn [Spatial Concept]

Phrase: "and"

Phrase: "intestinal cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0814997:Intestinal cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.45: This cellular specificity is explained by an alternate promoter of HNF-4 (known as P2), the importance of which has been independently proved by human and mouse genetic studies (11, 96). 

Phrase: "This cellular specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "is"

Phrase: "explained by an alternate promoter of HNF-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0332270:alternate [Functional Concept]
   744   C1523987:Alternate [Conceptual Entity]

Phrase: "("

Phrase: "known as P2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205309:Known [Qualitative Concept]
   790   C1384585:P2 [Immunologic Factor]
   790   C1419693:P2 [Gene or Genome]
   790   C1539372:p2 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "the importance of which"

Phrase: "has"

Phrase: "been"

Phrase: "independently"

Phrase: "proved by human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0086418:Human [Human]

Phrase: "and"

Phrase: "mouse genetic studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   884   C2827447:Genetic Study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "(11,"

Phrase: "96"

Phrase: ")."
Processing 00000000.tx.46: A nucleotide substitution within the IPF-1-binding site of P2, which segregates with diabetes in a large MODY family, has been shown to cause a threefold reduction in transcriptional activity (96). 

Phrase: "A nucleotide substitution within the IPF-1-binding site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1555721:Substitution [Idea or Concept]
   738   C1706204:Substitution [Activity]

Phrase: "of P2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "which"

Phrase: "segregates with diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]

Phrase: "in a large MODY family,"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   884   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   884   C2984262:Maturity onset diabetes of the young [Functional Concept]
   868   C0424972:Large family [Family Group]
   821   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0015576:Family [Family Group]
   790   C0150312:In [Quantitative Concept]
   790   C0332162:Onset [Qualitative Concept]
   790   C0332239:Young [Temporal Concept]
   790   C0332285:In [Spatial Concept]
   790   C0449989:Maturity [Qualitative Concept]
   790   C0549177:Large [Quantitative Concept]
   790   C0700597:Maturity [Temporal Concept]
   790   C1704727:Family [Conceptual Entity]
   718 E C0205286:Mature [Temporal Concept]
   718 E C0241888:Familial [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a threefold reduction in transcriptional activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C2267000:Reduction Activity [Molecular Function]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(96"

Phrase: ")."
Processing 00000000.tx.47: Reports of mutations in HNF-1 (MODY5) were initially restricted to a few families with early-onset diabetes (49). 

Phrase: "Reports of mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0684224:Reports [Intellectual Product]
   790   C0700287:reports [Health Care Activity]
   756 E C3273238:Report [Intellectual Product]

Phrase: "in HNF-1"

Phrase: "(MODY5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0431693:MODY5 [Congenital Abnormality,Disease or Syndrome]
  1000   C1420636:MODY5 [Gene or Genome]
  1000   C2348633:MODY5 [Gene or Genome]
  1000   C3540897:MODY5 [Disease or Syndrome]

Phrase: ")"

Phrase: "were"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "restricted to a few families"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0015576:Families [Family Group]
   760   C0443288:Restricted [Functional Concept]
   760   C1704727:Family [Conceptual Entity]

Phrase: "with early-onset diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1833334:Early-onset [Finding]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C1279919:Early [Temporal Concept]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.48: However, it has recently become clear that nondiabetic cystic renal disease is a feature of most HNF-1 mutations and that many subjects with HNF-1 mutations present through the renal clinic. 

Phrase: "However,"

Phrase: "it"

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "become"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that nondiabetic cystic renal disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   923   C1691228:Cystic renal disease [Disease or Syndrome]
   875   C0334054:Cystic disease, NOS [Disease or Syndrome]
   861   C0022658:Renal disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0022646:Renal [Body Part, Organ, or Organ Component]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "a feature of most HNF-1 mutations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1521970:Feature [Qualitative Concept]
   748   C1706388:Feature [Conceptual Entity]
   748   C2346469:Feature [Qualitative Concept]
   748   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "many subjects with HNF-1 mutations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "present through the renal clinic."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0022646:Renal [Body Part, Organ, or Organ Component]
   760   C0150312:Present [Quantitative Concept]
   760   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0449450:Present [Idea or Concept]
Processing 00000000.tx.49: This has led to the description of the previously unrecognized clinical syndrome of renal cysts and diabetes (RCAD) (10). 

Phrase: "This"

Phrase: "has"

Phrase: "led to the description of the previously unrecognized clinical syndrome"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0221444:clinical syndrome [Classification]
   739   C0039082:Syndrome [Disease or Syndrome]
   739   C0205210:Clinical [Qualitative Concept]
   739   C0678257:Description [Idea or Concept]
   739   C1708698:LED [Manufactured Object]
   706 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   706 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   706 E C1522538:Lead [Functional Concept]
   706 E C2348269:Lead [Element, Ion, or Isotope]
   706 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "of renal cysts and diabetes (RCAD)"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   875   C0017980:Renal diabetes [Disease or Syndrome]
   840   C0268800:Renal cysts [Congenital Abnormality]
   823 E C0022679:Renal cyst [Disease or Syndrome]
   823 E C1546765:Cyst, Renal [Intellectual Product]
   804   C0010709:Cysts [Disease or Syndrome]
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   804   C0022646:Renal [Body Part, Organ, or Organ Component]
   804   C0332285:Of [Spatial Concept]
   771 E C0686883:Cyst [Eukaryote]
   721 E C0205207:Cystic [Qualitative Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.50: Three discrete renal histologies have been described: oligomeganephronia, cystic dysplasia, and familial hypoplastic glomerulocystic kidney disease (9). 

Phrase: "Three discrete renal histologies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0019638:histologies [Biomedical Occupation or Discipline]
   779 E C0205462:histology [Functional Concept]
   779 E C0344441:Histology [Laboratory Procedure]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: ":"

Phrase: "oligomeganephronia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1841998:Oligomeganephronia [Finding]

Phrase: "cystic dysplasia,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0205207:Cystic [Qualitative Concept]
   861   C0334044:Dysplasia [Pathologic Function]
   789 E C0010709:Cyst [Disease or Syndrome]
   789 E C0686883:Cyst [Eukaryote]

Phrase: "and"

Phrase: "familial hypoplastic glomerulocystic kidney disease"
Meta Candidates (Total=17; Excluded=6; Pruned=0; Remaining=11)
   937   C0431693:Glomerulocystic kidney, familial hypoplastic [Congenital Abnormality,Disease or Syndrome]
   897   C0277558:Familial disease [Disease or Syndrome]
   862 E C0344339:family disease [Finding]
   853   C0266295:Hypoplastic kidney [Congenital Abnormality]
   840   C0022658:Kidney disease [Disease or Syndrome]
   829   C0027706:Nephritis, Familial [Disease or Syndrome]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0022646:Kidney [Body Part, Organ, or Organ Component]
   804   C0227665:kidney [Body Part, Organ, or Organ Component]
   804   C0543481:Hypoplastic [Functional Concept]
   804   C1278978:Kidney [Body Part, Organ, or Organ Component]
   804   C1514845:KIDNEY [Tissue]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   733 E C0243069:HYPOPLASIAS [Pathologic Function]
   711 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.51: Approximately 50% of HNF-1 subjects will develop nonnephropathic end-stage renal failure before the age of 45. 

Phrase: "Approximately 50% of HNF-1 subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0332232:Approximately [Qualitative Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "will"

Phrase: "develop"

Phrase: "nonnephropathic end-stage renal failure before the age of 45."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0022661:Renal Failure, End-Stage [Disease or Syndrome]
   806   C2316810:End Stage Renal Failure [Disease or Syndrome,Finding]
   760   C0035078:Renal Failure [Disease or Syndrome]
   760   C1963154:Renal failure [Finding]
   739   C0022646:Renal [Body Part, Organ, or Organ Component]
   739   C0231174:Failure [Functional Concept]
   739   C0680095:failure [Individual Behavior]
Processing 00000000.tx.52: A deletion in the gene for the homeodomain transcription factor IPF-1 (or IDX-1, STF-1, PDX-1) was found to cosegregate with early-onset diabetes in a large consanguineous kindred (89). 

Phrase: "A deletion in the gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0017260:Gene Deletion [Genetic Function]
   797   C1442161:Gene Deletion [Cell or Molecular Dysfunction]
           Deletion
   760   C1511760:Deletion [Genetic Function]
   760   C1880274:Deletion [Activity]

Phrase: "for the homeodomain transcription factor IPF-1"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   884   C0209278:Transcription Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1420631:TRANSCRIPTION FACTOR 1 [Gene or Genome]
   877   C0248419:insulin promoter factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   877   C1826562:INSULIN PROMOTER FACTOR 1 [Gene or Genome]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "or"

Phrase: "IDX-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1826562:IDX-1 [Gene or Genome]

Phrase: "STF-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0171961:STF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826562:STF-1 [Gene or Genome]
   861   C0599939:STF [Amino Acid, Peptide, or Protein,Hormone,Immunologic Factor]

Phrase: "PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cosegregate with early-onset diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1833334:Early-onset [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332162:Onset [Qualitative Concept]
   760   C1279919:Early [Temporal Concept]

Phrase: "in a large consanguineous kindred"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0598429:kindred [Qualitative Concept]

Phrase: "(89"

Phrase: ")."
Processing 00000000.tx.53: The index case, who was homozygous for the mutation, was born with pancreatic agenesis, but heterozygous relatives have MODY (88). 

Phrase: "The index case,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C2597943:Index case [Temporal Concept]
  1000   C2987736:Index Case [Population Group]
   861   C0868928:Case [Functional Concept]
   861   C0918012:Index [Intellectual Product]
   861   C1552854:index [Idea or Concept]
   861   C1637833:% index [Quantitative Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: "who"

Phrase: "was"

Phrase: "homozygous for the mutation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019904:Homozygous [Organism Attribute]

Phrase: "was"

Phrase: "born with pancreatic agenesis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0000846:Agenesis [Functional Concept]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   770   C0332907:Agenesis [Congenital Abnormality]
   737   C0004897:Bear [Mammal]

Phrase: "but"

Phrase: "heterozygous relatives"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0080103:Relatives [Family Group]
   827 E C0205345:Relative [Qualitative Concept]
   827 E C1547039:*Relative [Quantitative Concept]

Phrase: "have"

Phrase: "MODY"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
  1000   C2984262:Maturity onset diabetes of the young [Functional Concept]
   833   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C0449989:Maturity [Qualitative Concept]
   753   C0700597:Maturity [Temporal Concept]

Phrase: "(88"

Phrase: ")."
Processing 00000000.tx.54: IPF-1 is known to be critical for the embryonic development of pancreatic islets as well as for transcriptional regulation of endocrine pancreatic tissue-specific genes in adults, such as the insulin, glucose transporter-2 (GLUT2), and GCK genes in -cells and the somatostatin gene in -cells. 

Phrase: "IPF-1"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0248419:insulin promoter factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826562:INSULIN PROMOTER FACTOR 1 [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C2827422:Factor [Conceptual Entity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "critical for the embryonic development of pancreatic islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1511545:Critical [Qualitative Concept]

Phrase: "as well as for transcriptional regulation of endocrine pancreatic tissue-specific genes"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   776   C2245783:regulation of gene-specific transcription [Genetic Function]
   753   C1158770:Transcriptional Regulation [Genetic Function]
   753   C1955394:Tissue specific [Body Substance]
   751   C0017263:genes regulation [Genetic Function]
   751   C0229524:Endocrine tissue [Tissue]
   736   C0014136:Endocrine [Body System]
   736   C0017337:Genes [Gene or Genome]
   736   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   736   C0040300:Tissue [Tissue]
   736   C0040649:Transcriptional [Genetic Function]
           genes transcription
   736   C0205170:Well [Qualitative Concept]
   736   C0205369:Specific [Qualitative Concept]
   736   C0521425:Endocrine [Functional Concept]
   736   C0851285:Regulation [Governmental or Regulatory Activity]
   736   C1327622:Regulation [Biologic Function]
   736   C1547928:Tissue [Intellectual Product]
   736   C1552740:specific [Intellectual Product]
   736   C3146287:Well [Manufactured Object]
   732   C1710463:Transcription Regulation Gene [Gene or Genome]

Phrase: "in adults,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001675:Adults [Age Group]
   966 E C1706450:Adult [Human]

Phrase: "such as the insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "glucose transporter-2 (GLUT2),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "GCK genes in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the somatostatin gene in -cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   902   C0524984:Somatostatin Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.55: The availability of a genetic definition of MODY subtypes has had profound implications for our understanding of this condition. 

Phrase: "The availability of a genetic definition of MODY subtypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0470187:Availability of [Functional Concept]
           Availability

Phrase: "has"

Phrase: "had"

Phrase: "profound implications for our understanding of this condition."
Processing 00000000.tx.56: Previous suspicions about heterogeneity within MODY, which had been apparent on clinical grounds (93), have been confirmed through detailed clinical and physiological investigation (18, 69), and the basis for associated phenotypes (such as the renal disease in HNF-1) has rapidly appreciated. 

Phrase: "Previous suspicions about heterogeneity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0242114:Suspicion [Mental Process]

Phrase: "within MODY,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   954   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   954   C2984262:Maturity onset diabetes of the young [Functional Concept]
   845   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   795   C0011847:Diabetes [Disease or Syndrome]
   795   C0011849:Diabetes [Disease or Syndrome]
   795   C0332162:Onset [Qualitative Concept]
   795   C0332239:Young [Temporal Concept]
   795   C0332285:Within [Spatial Concept]
   795   C0449989:Maturity [Qualitative Concept]
   795   C0700597:Maturity [Temporal Concept]
   724 E C0205286:Mature [Temporal Concept]

Phrase: "which"

Phrase: "had"

Phrase: "been"

Phrase: "apparent on clinical grounds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0750489:apparent [Idea or Concept]

Phrase: "(93"

Phrase: ")"

Phrase: ","

Phrase: "have"

Phrase: "been"

Phrase: "confirmed through detailed clinical"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205210:Clinical [Qualitative Concept]
   770   C0521093:confirmed [Qualitative Concept]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1522508:Detailed [Qualitative Concept]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "physiological investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]

Phrase: "(18,"

Phrase: "69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the basis for associated phenotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1527178:Basis [Functional Concept]
   760   C1874451:Basis [Pharmacologic Substance]

Phrase: "("

Phrase: "such as the renal disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0022658:Renal disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0022646:Renal [Body Part, Organ, or Organ Component]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "in HNF-1"

Phrase: ")"

Phrase: "has"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "appreciated."
Processing 00000000.tx.57: There is, as a result, a growing clinical need for precise molecular diagnosis in early-onset diabetes, given the therapeutic and prognostic value that such information may provide. 

Phrase: "There"

Phrase: "is"

Phrase: ","

Phrase: "as"

Phrase: "a result,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "a growing clinical need for precise molecular diagnosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0027552:Need [Qualitative Concept]
   744   C0686904:need [Functional Concept]

Phrase: "in early-onset diabetes,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1833334:Early-onset [Finding]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C1279919:Early [Temporal Concept]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the therapeutic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
  1000   C0302350:Therapeutic [Functional Concept]

Phrase: "and"

Phrase: "prognostic value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "that"

Phrase: "such information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1533716:Information [Idea or Concept]
   928 E C3242430:informational [Idea or Concept]

Phrase: "may"

Phrase: "provide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]
Processing 00000000.tx.58: However, with current technology, the locus heterogeneity and the high proportion of "private" mutations make diagnostic screening laborious (12, 69). 

Phrase: "However,"

Phrase: "with current technology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:Technology [Occupation or Discipline]

Phrase: "the locus heterogeneity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C2986542:Locus Heterogeneity [Qualitative Concept]
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "and"

Phrase: "the high proportion of ""private"" mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "diagnostic screening laborious"

Phrase: "(12,"

Phrase: "69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.59: There is demonstrable overlap between MODY and multifactorial T2D. 

Phrase: "There"

Phrase: "is"

Phrase: "demonstrable overlap between MODY"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0185027:overlap [Therapeutic or Preventive Procedure]
   742   C1948020:Overlap [Conceptual Entity]
   716   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   716   C2984262:Maturity onset diabetes of the young [Functional Concept]

Phrase: "and"

Phrase: "multifactorial T2D."
Processing 00000000.tx.60: The proportion of subjects diagnosed with T2D who actually have MODY may be as high as 2-5%. 

Phrase: "The proportion of subjects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709707:Proportion [Quantitative Concept]

Phrase: "diagnosed with T2D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011900:Diagnosed [Finding]
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "who actually"

Phrase: "have"

Phrase: "MODY"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
  1000   C2984262:Maturity onset diabetes of the young [Functional Concept]
   833   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C0449989:Maturity [Qualitative Concept]
   753   C0700597:Maturity [Temporal Concept]

Phrase: "may"

Phrase: "be"

Phrase: "as"

Phrase: "high as 2-5%."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.61: However, misdiagnosis aside, apart from IPF-1 (43, 63), there is no clear evidence that variation in any MODY gene has a substantial impact on individual susceptibility to multifactorial T2D. 

Phrase: "However,"

Phrase: "misdiagnosis aside,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679838:Misdiagnosis [Finding]

Phrase: "apart from IPF-1"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0248419:insulin promoter factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826562:INSULIN PROMOTER FACTOR 1 [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C2827422:Factor [Conceptual Entity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(43,"

Phrase: "63"

Phrase: ")"

Phrase: ","

Phrase: "there"

Phrase: "is"

Phrase: "no clear evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that variation in any MODY gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0205419:Variation [Qualitative Concept]

Phrase: "has"

Phrase: "a substantial impact on individual susceptibility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1825598:IMPACT [Gene or Genome]

Phrase: "to multifactorial T2D."
Processing 00000000.tx.62: Positional cloning in multifactorial T2D. 

Phrase: "Positional cloning in multifactorial T2D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1656250:positional cloning [Research Activity]
   753   C0009015:Cloning [Research Activity]
Processing 00000000.tx.63: Efforts to extend such methods to the more common, multifactorial forms of T2D have been one of the dominant models of genetics research into this disease (106), but there have been two principal obstacles. 

Phrase: "Efforts to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015264:Effort [Organism Function]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "such methods to the more common, multifactorial forms of T2D"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   738   C0025663:Methods [Intellectual Product]
   738   C0025664:methods [Intellectual Product]
   738   C0449851:Methods [Functional Concept]
   704 E C0871511:METHOD [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "one of the dominant models of genetics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "research into this disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0012634:Disease [Disease or Syndrome]
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(106"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "there"

Phrase: "have"

Phrase: "been"

Phrase: "two principal obstacles."
Processing 00000000.tx.64: First, the power to detect linkage will generally be considerably lower than in the monogenic setting (81). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the power to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]

Phrase: "will"

Phrase: "generally"

Phrase: "be"

Phrase: "considerably lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "in the monogenic setting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0542559:setting [Functional Concept]
   861   C1318139:{Setting} [Quantitative Concept]

Phrase: "(81"

Phrase: ")."
Processing 00000000.tx.65: It is axiomatic of any complex, multifactorial trait, such as T2D, that individual susceptibility will be determined by the concerted action of many different genes interacting both with one another and with environmental determinants of disease risk. 

Phrase: "It"

Phrase: "is"

Phrase: "axiomatic of any complex,"

Phrase: "multifactorial trait,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599883:Trait [Organism Attribute]

Phrase: "such as T2D,"

Phrase: "that individual susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0012655:Susceptibility [Clinical Attribute]
   861   C0220898:Susceptibility [Organism Attribute]
   861   C1264642:Susceptibility [Functional Concept]
   861   C1547045:*Susceptibility [Quantitative Concept]
   789 E C0231204:Susceptible [Functional Concept]
   789 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "will"

Phrase: "be"

Phrase: "determined by the concerted action of many different genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0017337:Genes [Gene or Genome]
   742   C0441472:Action [Functional Concept]
   742   C1705242:Different [Qualitative Concept]
   742   C3266814:Action [Activity]

Phrase: "interacting"

Phrase: "both with one"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205447:One [Quantitative Concept]
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "another"

Phrase: "and with environmental determinants of disease risk."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1281905:disease risk [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0014406:Environmental [Spatial Concept]
   748   C0035647:Risk [Qualitative Concept]
   748   C1515981:And [Idea or Concept]
   714   C1521761:Determinant [Functional Concept]
Processing 00000000.tx.66: The consequence is that the magnitude of the genetic effect attributable to any single locus [as expressed in terms of the locus-specific sibling relative risk (80)] is likely to be modest (at best), and very large sample sizes (many hundreds or thousands of families) will be required for reasonable power of detection. 

Phrase: "The consequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "is"

Phrase: "that"

Phrase: "the magnitude of the genetic effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449286:magnitude [Quantitative Concept]
   753   C1704240:Magnitude [Quantitative Concept]

Phrase: "attributable to any single locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596130:Attributable [Mental Process]

Phrase: "["

Phrase: "as"

Phrase: "expressed in terms of the locus-specific sibling relative risk"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   760   C0242492:Relative Risk [Quantitative Concept]
   739   C0035647:Risk [Qualitative Concept]
   739   C0037047:Sibling [Family Group]
   739   C0080103:Relative [Family Group]
   739   C0205345:Relative [Qualitative Concept]
   739   C0205369:Specific [Qualitative Concept]
   739   C1547039:*Relative [Quantitative Concept]
   739   C1552740:specific [Intellectual Product]
   739   C1611273:Sibling [Intellectual Product]
   739   C1708726:Locus [Gene or Genome]
   706   C1515273:Term [Temporal Concept]
   706   C1705313:Term [Idea or Concept]
   706   C2826302:TERM [Intellectual Product]

Phrase: "(80"

Phrase: ")"

Phrase: "]"

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "modest"

Phrase: "("

Phrase: "at best"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522427:Best [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "very large sample sizes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242618:Sizes, Sample [Quantitative Concept]
   812   C0456389:SIZES [Spatial Concept]

Phrase: "("

Phrase: "many hundreds"

Phrase: "or"

Phrase: "thousands of families"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1883310:Thousand [Quantitative Concept]

Phrase: ")"

Phrase: "will"

Phrase: "be"

Phrase: "required for reasonable power of detection."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0032863:Power [Human-caused Phenomenon or Process]
   753   C1511790:Detection [Therapeutic or Preventive Procedure]
   753   C1514873:Required [Functional Concept]
Processing 00000000.tx.67: The strong genetic effect in type 1diabetes (T1D) attributable to variation at the major histocompatibility focus HLA, which was readily detected in fewer than 100families, is very much the exception as far as complex trait susceptibility loci are concerned (23). 

Phrase: "The strong genetic effect in type 1diabetes (T1D)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "attributable to variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0596130:Attributable [Mental Process]

Phrase: "at the major histocompatibility focus HLA,"

Phrase: "which"

Phrase: "was"

Phrase: "readily"

Phrase: "detected in fewer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "than 100families,"

Phrase: "is"

Phrase: "very much"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2984081:Very Much [Intellectual Product]
   861   C0442824:Very [Qualitative Concept]

Phrase: "the exception as far as complex trait susceptibility loci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1554961:exception [Idea or Concept]
   742   C1705847:Exception [Conceptual Entity]

Phrase: "are"

Phrase: "concerned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.68: The second difficulty is that, for late-onset diseases like T2D, ascertainment of the large, multigenerational pedigrees that form the typical substrate for studies of Mendelian diseases is difficult. 

Phrase: "The second difficulty"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1299586:Difficulty [Finding]
   789 E C0332218:Difficult [Qualitative Concept]

Phrase: "is"

Phrase: "that,"

Phrase: "for late-onset diseases"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0012634:Diseases [Disease or Syndrome]
   827   C0205087:Late [Temporal Concept]
   827   C0332162:Onset [Qualitative Concept]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]

Phrase: "like T2D,"

Phrase: "ascertainment of the large, multigenerational pedigrees"

Phrase: "that"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "the typical substrate for studies of Mendelian diseases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710236:Substrate [Manufactured Object]

Phrase: "is"

Phrase: "difficult."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332218:Difficult [Qualitative Concept]
   928 E C1299586:Difficulty [Finding]
Processing 00000000.tx.69: Alternative strategies have been developed and applied, mostly focusing on the analysis of small nuclear pedigrees and sibships containing multiple affected siblings (23, 106). 

Phrase: "Alternative strategies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategies [Mental Process]

Phrase: "have"

Phrase: "been"

Phrase: "developed"

Phrase: "and"

Phrase: "applied, mostly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185125:Applied [Health Care Activity]
   861   C0750554:mostly [Idea or Concept]

Phrase: "focusing on the analysis of small nuclear pedigrees"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   744   C0000936:focusing [Clinical Attribute]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0030761:pedigrees [Intellectual Product]
   744   C0521447:Nuclear [Spatial Concept]
   744   C0700321:Small [Quantitative Concept]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C2981153:Focusing [Finding]
   711 E C0205234:Focus [Spatial Concept]
   711 E C1285542:focus [Functional Concept]

Phrase: "and"

Phrase: "sibships"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "multiple affected siblings"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037047:Siblings [Family Group]
   793 E C1611273:Sibling [Intellectual Product]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "106"

Phrase: ")."
Processing 00000000.tx.70: At the same time, other groups have sought to preserve the power available in the analysis of large pedigrees by focusing on the segregation not of diabetes itself but of intermediate traits implicated in the development of the dysmetabolic syndrome (such as insulin sensitivity and fat distribution) (24, 57). 

Phrase: "At the same time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "other groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "have"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "preserve"

Phrase: "the power"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "available in the analysis of large pedigrees"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0470187:Available [Functional Concept]
           Availability of

Phrase: "by focusing"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0000936:focusing [Clinical Attribute]
  1000   C2981153:Focusing [Finding]
   966 E C0205234:Focus [Spatial Concept]
   966 E C1285542:focus [Functional Concept]

Phrase: "on the segregation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080141:segregation [Social Behavior]

Phrase: "not of diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C1518422:Not [Functional Concept]

Phrase: "itself"

Phrase: "but of intermediate traits"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205103:Intermediate [Spatial Concept]
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C0599883:traits [Organism Attribute]
   770   C1427926:TRAITS [Gene or Genome]
   770   C1550465:intermediate [Idea or Concept]
   770   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "implicated in the development of the dysmetabolic syndrome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1262289:dysmetabolic syndrome [Disease or Syndrome]
   744   C0039082:Syndrome [Disease or Syndrome]
   744   C0243107:development [Physiologic Function]
   744   C0678723:Development [Organism Function]
   744   C1527148:Development [Functional Concept]

Phrase: "("

Phrase: "such as insulin sensitivity"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0920563:Insulin Sensitivity [Pathologic Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "fat distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: ")"

Phrase: "(24,"

Phrase: "57"

Phrase: ")."
Processing 00000000.tx.71: Both approaches have their merits and should provide complementary views of the genetic architecture of T2D. 

Phrase: "Both approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449445:Approaches [Spatial Concept]
  1000   C1292724:Approaches [Functional Concept]

Phrase: "have"

Phrase: "their merits"

Phrase: "and"

Phrase: "should"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "complementary views of the genetic architecture of T2D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449911:Views [Spatial Concept]
Processing 00000000.tx.72: The number of genome scans for T2D published is now in double figures (16, 61, 106), and, with a similar number of studies (and/or subanalyses) focusing on quantitative intermediate traits, this is a propitious moment to take stock. 

Phrase: "The number of genome scans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "for T2D"

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "is"

Phrase: "now in double figures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205173:Double [Functional Concept]
   770   C1705764:Double [Activity]
   770   C1705765:Double [Qualitative Concept]
   770   C1948052:Now [Temporal Concept]

Phrase: "(16,"

Phrase: "61,"

Phrase: "106"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: ","

Phrase: "with a similar number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "("

Phrase: "and/or"

Phrase: "subanalyses"

Phrase: ")"

Phrase: "focusing on quantitative intermediate traits,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0000936:focusing [Clinical Attribute]
   760   C2981153:Focusing [Finding]
   726 E C0205234:Focus [Spatial Concept]
   726 E C1285542:focus [Functional Concept]

Phrase: "this"

Phrase: "is"

Phrase: "a propitious moment to"

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "stock."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710198:Stock [Idea or Concept]
Processing 00000000.tx.73: The clearest message is that there is no susceptibility locus of overweaning effect for T2D (akin to HLA in T1D). 

Phrase: "The clearest message"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470166:Message [Intellectual Product]

Phrase: "is"

Phrase: "that there"

Phrase: "is"

Phrase: "no susceptibility locus of overweaning effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1708726:Locus [Gene or Genome]

Phrase: "for T2D"

Phrase: "(akin to HLA"

Phrase: "in T1D"

Phrase: ")."
Processing 00000000.tx.74: In many ways, this comes as no surprise, since the modest sibling relative risk associated with T2D (~3.5 in Europeans) sets an upper bound to the expected effect size of any single contributory locus. 

Phrase: "In many ways,"

Phrase: "this"

Phrase: "comes as no surprise,"

Phrase: "since"

Phrase: "the modest sibling relative risk"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0242492:Relative Risk [Quantitative Concept]
   812   C0035647:Risk [Qualitative Concept]
   812   C0080103:Relative [Family Group]
   812   C0205345:Relative [Qualitative Concept]
   812   C1547039:*Relative [Quantitative Concept]

Phrase: "associated with T2D"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(~3.5 in Europeans"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0442758:3 5 [Quantitative Concept]
   770   C0439086:<3 [Quantitative Concept]
   770   C2827736:3+ [Quantitative Concept]
   770   C2981702:3+ [Classification]
   737   C0239307:European [Population Group]
   737   C1535514:European [Population Group]

Phrase: ")"

Phrase: "sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "an upper"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282910:Upper [Spatial Concept]

Phrase: "bound to the expected effect size of any single contributory locus."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   756   C0814843:effect size [Quantitative Concept]
   738   C0037179:Single [Population Group]
   738   C0087136:single [Finding]
   738   C0205171:Single [Quantitative Concept]
   738   C0332297:bound [Spatial Concept]
   738   C0456389:size [Spatial Concept]
   738   C1145667:Bound [Activity]
   738   C1167622:Bound [Molecular Function]
   738   C1280500:Effect [Qualitative Concept]
   738   C1517001:Expected [Idea or Concept]
   738   C1689898:% bound [Quantitative Concept]
   738   C1708726:Locus [Gene or Genome]
   738   C2348382:Effect [Qualitative Concept]
   738   C2349209:Bound [Conceptual Entity]
Processing 00000000.tx.75: The second conclusion is that, with a few exceptions described below, replication of positive findings between genome scans has proven an infrequent event. 

Phrase: "The second conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707478:Conclusion [Idea or Concept]

Phrase: "is"

Phrase: "that,"

Phrase: "with a few exceptions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1554961:exception [Idea or Concept]
   827   C1705847:Exception [Conceptual Entity]

Phrase: "described below,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "replication of positive findings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0598312:Replication [Genetic Function]
   770   C1883725:replication [Qualitative Concept]

Phrase: "between genome scans"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C1517519:Genome Scan [Molecular Biology Research Technique]
   861   C0017428:Genome [Gene or Genome]
   861   C0034606:Scan [Diagnostic Procedure]
   861   C0441633:Scan [Diagnostic Procedure]
   861   C2338314:Genome [Conceptual Entity]
   861   C2826292:SCAN [Finding]

Phrase: "has"

Phrase: "proven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456369:Proven [Qualitative Concept]

Phrase: "an infrequent event."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]
Processing 00000000.tx.76: It is important to appreciate the likely reasons for this. 

Phrase: "It"

Phrase: "is"

Phrase: "important to"

Phrase: "appreciate"

Phrase: "the likely reasons for this."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392360:reasons [Idea or Concept]
Processing 00000000.tx.77: Given the modest effect sizes expected (locus-specific relative risks ~1.3-1.5), even the largest studies are somewhat underpowered and cannot be guaranteed to detect every locus of modest effect that is segregating in the population studied (48). 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the modest effect sizes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0814843:effect sizes [Quantitative Concept]
   827   C0456389:SIZES [Spatial Concept]

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "(locus-specific relative risks ~1.3-1.5"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   812   C0242492:Risks, Relative [Quantitative Concept]
   795   C0966318:RISK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0035647:Risks [Qualitative Concept]
   793   C0080103:Relative [Family Group]
   793   C0205345:Relative [Qualitative Concept]
   793   C0205369:Specific [Qualitative Concept]
   793   C1547039:*Relative [Quantitative Concept]
   793   C1552740:specific [Intellectual Product]
   793   C1708726:Locus [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "even"

Phrase: "the largest studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "somewhat underpowered"

Phrase: "and"

Phrase: "cannot"

Phrase: "be"

Phrase: "guaranteed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "every locus of modest effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1708726:Locus [Gene or Genome]

Phrase: "that"

Phrase: "is"

Phrase: "segregating in the population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.78: Even a "carbon copy" genome scan performed in a second data set ascertained under the same framework from the same population will not, for stochastic reasons, produce exactly the same pattern of linkage peaks. 

Phrase: "Even a ""carbon copy"" genome scan"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C1517519:Genome Scan [Molecular Biology Research Technique]
   799   C0017428:Genome [Gene or Genome]
   799   C0034606:Scan [Diagnostic Procedure]
   799   C0441633:Scan [Diagnostic Procedure]
   799   C2338314:Genome [Conceptual Entity]
   799   C2826292:SCAN [Finding]

Phrase: "performed in a second data set"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   790   C0150098:Data Set [Intellectual Product]
   790   C1706233:Dataset [Intellectual Product]
   753   C0036849:Set [Mental Process]
   753   C0205436:Second [Quantitative Concept]
   753   C0457385:Second [Temporal Concept]
   753   C0565930:/second [Quantitative Concept]
   753   C0884358:Performed [Functional Concept]
   753   C1442518:Set [Functional Concept]
   753   C1511726:Data [Idea or Concept]
   753   C1561503:second [Idea or Concept]
   753   C1705190:Second [Qualitative Concept]
   753   C1705195:Set [Conceptual Entity]
   753   C3245479:data [Medical Device]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "ascertained under the same framework"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0445247:Same [Qualitative Concept]

Phrase: "from the same population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "will"

Phrase: "not,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "for stochastic reasons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392360:reasons [Idea or Concept]

Phrase: "produce"

Phrase: "exactly"

Phrase: "the same pattern of linkage peaks."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]
Processing 00000000.tx.79: The prospects for replication are further compromised by the diversity of ethnicities, ascertainment criteria, diagnostic approaches, and statistical methods employed in different scans (70). 

Phrase: "The prospects for replication"

Phrase: "are"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "compromised by the diversity of ethnicities,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1880371:Diversity [Qualitative Concept]
   719   C0015031:Ethnicity [Population Group]
   719   C0243103:ethnicity [Qualitative Concept]
   719   C2945640:compromise [Finding]

Phrase: "ascertainment criteria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243161:criteria [Intellectual Product]

Phrase: "diagnostic approaches,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449445:Approaches [Spatial Concept]
   861   C1292724:Approaches [Functional Concept]

Phrase: "and"

Phrase: "statistical methods"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   983   C1710191:Statistical Method [Research Activity]
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "employed in different scans"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0034606:Scan [Diagnostic Procedure]
   770   C0441633:Scan [Diagnostic Procedure]
   770   C0557351:Employed [Finding]
   770   C1705242:Different [Qualitative Concept]
   770   C2826292:SCAN [Finding]
   737 E C0457083:Employ [Functional Concept]

Phrase: "(70"

Phrase: ")."
Processing 00000000.tx.80: With all of these factors serving to diminish the prior likelihood of detecting replication, it is clear that obtaining robust confirmation of linkage within a given region provides strong validation that a susceptibility effect has indeed been localized. 

Phrase: "With all"

Phrase: "of these factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "serving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519269:Serving [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "diminish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:diminish [Quantitative Concept]

Phrase: "the prior likelihood of detecting replication,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033204:Likelihood [Quantitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that obtaining robust confirmation of linkage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0521091:Confirmation of [Qualitative Concept]
           confirmation
   753   C0750484:Confirmation [Idea or Concept]

Phrase: "within a given region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "strong validation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519941:Validation [Research Activity]

Phrase: "that"

Phrase: "a susceptibility effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "has"

Phrase: "indeed"

Phrase: "been"

Phrase: "localized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]
Processing 00000000.tx.81: Among regions with the strongest claims for replication are chromosomes 12q (27, 61, 64, 85), 20q (13,39,54,110), 1q (29, 46, 86, 103, 106), 8p (16, 29, 106), and 3q (47, 57, 103). 

Phrase: "Among regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "with the strongest claims"

Phrase: "for replication"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0598312:Replication [Genetic Function]
  1000   C1883725:replication [Qualitative Concept]
   928 E C0205173:Replicate [Functional Concept]
   928 E C0205341:Replicate [Functional Concept]

Phrase: "are"

Phrase: "chromosomes 12q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520484:12q [Nucleotide Sequence]

Phrase: "(27,"

Phrase: "61,"

Phrase: "64,"

Phrase: "85"

Phrase: ")"

Phrase: ","

Phrase: "20q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521048:20q [Nucleotide Sequence]

Phrase: "(13,"

Phrase: "39,"

Phrase: "54,110"

Phrase: ")"

Phrase: ","

Phrase: "1q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327882:1q [Nucleotide Sequence]

Phrase: "(29,"

Phrase: "46,"

Phrase: "86,"

Phrase: "103,"

Phrase: "106"

Phrase: ")"

Phrase: ","

Phrase: "8p"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0796348:8p [Nucleotide Sequence]
  1000   C1553559:8p [Body Part, Organ, or Organ Component]

Phrase: "(16,"

Phrase: "29,"

Phrase: "106"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "3q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521299:3q [Nucleotide Sequence]

Phrase: "(47,"

Phrase: "57,"

Phrase: "103"

Phrase: ")."
Processing 00000000.tx.82: All of these regions are currently subject to positional cloning efforts to identify the etiological variants. 

Phrase: "All of these regions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]

Phrase: "are"

Phrase: "currently subject to positional cloning efforts to"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C1656250:positional cloning [Research Activity]
   748   C0009015:Cloning [Research Activity]
   748   C0240795:POSITIONAL [Finding]
   748   C0521116:Currently [Temporal Concept]
   748   C0681850:Subject [Group]
   748   C1550501:{Subject} [Idea or Concept]
   748   C1706203:Subject [Idea or Concept]
   748   C2349001:Subject [Human]
   748   C2697811:Subject [Functional Concept]
   714 E C0009013:Clone [Cell]
   714   C0015264:Effort [Organism Function]
   714 E C1522642:Clone [Tissue]

Phrase: "identify"

Phrase: "the etiological variants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]
Processing 00000000.tx.83: To give one example, the 1q21-24 region first came to attention through a subanalysis of genome scan data from young-onset Pima Indian families (46). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "one example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707959:Example [Conceptual Entity]

Phrase: "the 1q21-24 region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "came to attention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0004268:Attention [Mental Process]

Phrase: "through a subanalysis"

Phrase: "of genome scan data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C1517519:Genome Scan [Molecular Biology Research Technique]

Phrase: "from young-onset Pima Indian families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0015576:Families [Family Group]
   804   C1704727:Family [Conceptual Entity]
   721 E C0241888:Familial [Functional Concept]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.84: Corroboration followed in Utah Mormon (29) and Amish families (86). 

Phrase: "Corroboration"

Phrase: "followed in Utah Mormon"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0042124:Utah [Geographic Area]
   770   C0332283:followed [Temporal Concept]
   770   C0337757:Mormon [Idea or Concept]
   770   C0337758:Mormon [Population Group]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "(29"

Phrase: ")"

Phrase: "and"

Phrase: "Amish families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "(86"

Phrase: ")."
Processing 00000000.tx.85: In multiplex French pedigrees (103), evidence for linkage to 1q was particularly strong in leaner subjects, and further replication was evident in analysis of >700 pedigrees from the UK Warren 2genome scan (106). 

Phrase: "In multiplex French pedigrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030761:pedigrees [Intellectual Product]

Phrase: "(103"

Phrase: ")"

Phrase: ","

Phrase: "evidence for linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332120:Evidence [Functional Concept]

Phrase: "to 1q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327882:1q [Nucleotide Sequence]

Phrase: "was"

Phrase: "particularly strong in leaner subjects,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442821:Strong [Qualitative Concept]

Phrase: "and"

Phrase: "further replication"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0598312:Replication [Genetic Function]
   861   C1883725:replication [Qualitative Concept]
   789 E C0205173:Replicate [Functional Concept]
   789 E C0205341:Replicate [Functional Concept]

Phrase: "was"

Phrase: "evident in analysis of >700 pedigrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332120:Evidence of [Functional Concept]

Phrase: "from the UK Warren 2genome scan"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034606:Scan [Diagnostic Procedure]
   812   C0441633:Scan [Diagnostic Procedure]
   812   C2826292:SCAN [Finding]

Phrase: "(106"

Phrase: ")."
Processing 00000000.tx.86: All of these 1q linkage peaks map within 15-20 cM, well within the limits of localization possible in such studies (82). 

Phrase: "All of these 1q linkage peaks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0023745:linkage [Molecular Function]
   753   C0444505:peaks [Quantitative Concept]
   753   C0444868:All [Quantitative Concept]
   753   C1327882:1q [Nucleotide Sequence]
   753   C3539085:All [Idea or Concept]

Phrase: "map within 15-20 cM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1631070:20/15 [Finding]
   760   C0024779:Map [Manufactured Object]
   760   C1706473:Map [Conceptual Entity]

Phrase: "well within the limits of localization"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0205170:Well [Qualitative Concept]
   753   C0439801:limits [Functional Concept]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]
   753   C3146287:Well [Manufactured Object]
   719 E C1549649:Limit [Idea or Concept]
   719 E C2349209:Limit [Conceptual Entity]

Phrase: "possible in such studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332149:Possible [Qualitative Concept]
   770   C1705910:Possible [Qualitative Concept]
   770   C2362652:Possible [Qualitative Concept]

Phrase: "(82"

Phrase: ")."
Processing 00000000.tx.87: Linkage alone has limited power to resolve susceptibility gene location, and the regions that emerge from these scans are typically large, on the order of 10-20 Mb. 

Phrase: "Linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "has"

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "power to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "resolve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699488:Resolve [Conceptual Entity]

Phrase: "susceptibility gene location,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0450429:Location [Spatial Concept]
   827   C1515974:Location [Body Location or Region]
   734   C0919453:Susceptibility Gene [Gene or Genome]

Phrase: "and"

Phrase: "the regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "that"

Phrase: "emerge from these scans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034606:Scan [Diagnostic Procedure]
   770   C0441633:Scan [Diagnostic Procedure]
   770   C2826292:SCAN [Finding]

Phrase: "are"

Phrase: "typically large,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0549177:Large [Quantitative Concept]

Phrase: "on the order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1705175:Order [Intellectual Product]
  1000   C1705176:Order [Qualitative Concept]
  1000   C1705177:Order [Classification]
  1000   C1705178:Order [Activity]
  1000   C1882348:Order [Qualitative Concept]

Phrase: "of 10-20 Mb."
Processing 00000000.tx.88: Identifying the etiological variant(s) underlying the linkage signal within such large regions remains a challenging task, but one which, as recent successes have demonstrated (50, 51, 74, 75, 79), is becoming increasingly tractable. 

Phrase: "Identifying"

Phrase: "the etiological variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "("

Phrase: "s)"

Phrase: "underlying"

Phrase: "the linkage signal within such large regions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "remains"

Phrase: "a challenging task,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540678:Task [Occupational Activity]

Phrase: "but"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "which,"

Phrase: "as"

Phrase: "recent successes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0597535:successes [Social Behavior]
   777 E C1272703:Successful [Qualitative Concept]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "(50,"

Phrase: "51,"

Phrase: "74,"

Phrase: "75,"

Phrase: "79"

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "becoming"

Phrase: "increasingly tractable."
Processing 00000000.tx.89: Among the developments that have transformed the prospects for such positional cloning efforts include advances in bioinformatics [the availability of draft human sequence (53)], in genetic epidemiology [an improved understanding of patterns of linkage disequilibrium in human populations (76)], in technology [particularly, robust high-throughput tools for single nucleotide polymorphism (SNP) genotyping (58)], and in the sophistication of statistical analysis [notably, improved tools for association mapping (73, 92)]. 

Phrase: "Among the developments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0243107:development [Physiologic Function]
   966   C0678723:Development [Organism Function]
   966   C1527148:Development [Functional Concept]
   916 E C0458003:Developmental [Qualitative Concept]

Phrase: "that"

Phrase: "have"

Phrase: "transformed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510411:Transformed [Pathologic Function]

Phrase: "the prospects for such positional cloning efforts"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "advances in bioinformatics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0725066:Advance [Medical Device]

Phrase: "["

Phrase: "the availability of draft human sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0470187:Availability of [Functional Concept]
           Availability

Phrase: "(53"

Phrase: ")"

Phrase: "],"

Phrase: "in genetic epidemiology"
Meta Candidates (Total=20; Excluded=14; Pruned=0; Remaining=6)
  1000   C0872180:Genetic Epidemiology [Occupation or Discipline]
   861   C0014507:Epidemiology [Biomedical Occupation or Discipline]
   861   C0014508:epidemiology [Functional Concept]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C0699910:epidemiology [Health Care Activity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "["

Phrase: "an improved understanding of patterns of linkage disequilibrium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0162340:Understanding [Mental Process]

Phrase: "in human populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "(76"

Phrase: ")"

Phrase: "],"

Phrase: "in technology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039421:Technology [Occupation or Discipline]

Phrase: "[particularly,"

Phrase: "robust high-throughput tools for single nucleotide polymorphism (SNP) genotyping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C0336791:Tool [Manufactured Object]
   708   C2827396:Tool [Manufactured Object]

Phrase: "(58"

Phrase: ")"

Phrase: "],"

Phrase: "and in the sophistication of statistical analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0871424:statistical analysis [Research Activity]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0038215:Statistical [Occupation or Discipline]
   748   C0936012:Analysis [Research Activity]
   748   C1515981:And [Idea or Concept]
   748   C1524024:analysis [Functional Concept]

Phrase: "[notably,"

Phrase: "improved tools for association mapping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0336791:Tool [Manufactured Object]
   726   C2827396:Tool [Manufactured Object]

Phrase: "(73,"

Phrase: "92"

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.90: The principal tool used to refine the location of susceptibility genes within such regions is linkage disequilibrium (LD) analysis, which exploits the cumulative history of recombination within populations to provide much finer localization than is possible through the analysis of observed recombination events within families alone (59). 

Phrase: "The principal tool"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0336791:Tool [Manufactured Object]
   861   C2827396:Tool [Manufactured Object]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "refine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C1947930:Cleanse [Activity]
   916   C1998793:Purified [Functional Concept]

Phrase: "the location of susceptibility genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0450429:Location [Spatial Concept]
   760   C1515974:Location [Body Location or Region]

Phrase: "within such regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "is"

Phrase: "linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "(LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: ")"

Phrase: "analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "which"

Phrase: "exploits"

Phrase: "the cumulative history of recombination"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0019664:History [Occupation or Discipline]
   760   C0019665:history [Intellectual Product]
   760   C0262512:History, NOS [Organism Attribute]
   760   C0262926:History [Finding]
   760   C1705255:History [Conceptual Entity]
   760   C2004062:History [Finding]

Phrase: "within populations to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "much finer localization than"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "is"

Phrase: "possible through the analysis of observed recombination events"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0332149:Possible [Qualitative Concept]
   744   C1705910:Possible [Qualitative Concept]
   744   C2362652:Possible [Qualitative Concept]

Phrase: "within families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.91: There is considerable active debate concerning the most effective strategies for LD mapping within large genomic regions (77, 78, 104), the uncertainty largely reflecting current ignorance as to how susceptibility gene variation maps onto background patterns of LD in outbred populations. 

Phrase: "There"

Phrase: "is"

Phrase: "considerable active debate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0870392:debate [Activity]

Phrase: "concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "the most effective strategies for LD mapping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0679199:strategies [Mental Process]

Phrase: "within large genomic regions"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0017428:Genomic [Gene or Genome]
   827   C0887950:genomic [Biomedical Occupation or Discipline]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "(77,"

Phrase: "78,"

Phrase: "104"

Phrase: ")"

Phrase: ","

Phrase: "the uncertainty largely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0087130:Uncertainty [Idea or Concept]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "current ignorance as to how susceptibility gene variation"

Phrase: "maps onto background patterns of LD"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0023746:Linkage Disequilibrium [Quantitative Concept]
   748   C0023745:linkage [Molecular Function]
   748   C0024779:Map [Manufactured Object]
   748   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0281825:Disequilibrium [Finding]
   748   C0394006:Disequilibrium [Disease or Syndrome]
   748   C0449774:Patterns [Spatial Concept]
   748   C1706473:Map [Conceptual Entity]
   748   C1706907:Background [Conceptual Entity]

Phrase: "in outbred populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.92: Most groups seeking to clone such susceptibility regions are pragmatically following a combination of indirect and direct LD mapping approaches. 

Phrase: "Most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "seeking to clone"

Phrase: "such susceptibility regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "are"

Phrase: "pragmatically"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a combination of indirect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "direct LD mapping approaches."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0449445:Approaches [Spatial Concept]
   804   C1292724:Approaches [Functional Concept]
   717   C1517888:Linkage Disequilibrium Mapping [Molecular Biology Research Technique]
Processing 00000000.tx.93: The former strategy involves fishing for LD using a dense "net" of markers, distributed across the region, whereas the latter focuses on variant detection and association analysis within the strongest positional candidates. 

Phrase: "The former strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategy [Mental Process]

Phrase: "involves"

Phrase: "fishing for LD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0016163:Fish [Fish]
   737   C2349190:Fish [Food]
   737   C2700184:FISH [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a dense ""net"" of markers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   704   C0439739:Reticular [Spatial Concept]

Phrase: "distributed across the region,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]
   770   C1704711:Distributed [Functional Concept]

Phrase: "whereas"

Phrase: "the latter"

Phrase: "focuses on variant detection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205234:Focus [Spatial Concept]
   770   C0205419:Variant [Qualitative Concept]
   770   C1285542:focus [Functional Concept]
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "association analysis within the strongest positional candidates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
Processing 00000000.tx.94: Both approaches expect to benefit from the development of increasingly dense SNP maps (95), and from plans to derive a "haplotype" map of the human genome (76). 

Phrase: "Both approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449445:Approaches [Spatial Concept]
  1000   C1292724:Approaches [Functional Concept]

Phrase: "expect"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "benefit from the development of increasingly dense SNP maps"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   775   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   738   C0024779:Map [Manufactured Object]
   738   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0032529:Polymorphism [Genetic Function]
   738   C0037179:Single [Population Group]
   738   C0087136:single [Finding]
   738   C0205171:Single [Quantitative Concept]
   738   C0243107:development [Physiologic Function]
   738   C0439794:Dense [Qualitative Concept]
   738   C0678723:Development [Organism Function]
   738   C0814225:Benefit [Quantitative Concept]
   738   C1527148:Development [Functional Concept]
   738   C1706473:Map [Conceptual Entity]
   738   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(95"

Phrase: ")"

Phrase: ","

Phrase: "and from plans to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1515981:And [Idea or Concept]
   737   C0270724:PLAN [Disease or Syndrome]
   737   C1301732:Plan [Functional Concept]

Phrase: "derive"

Phrase: "a ""haplotype"" map of the human genome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C3178913:Human Haplotype Map [Organism Attribute]
   748   C0018591:Haplotype [Organism Attribute]
   748   C0024779:Map [Manufactured Object]
   748   C1706473:Map [Conceptual Entity]

Phrase: "(76"

Phrase: ")."
Processing 00000000.tx.95: There is, in addition, increasing confidence that such resources may, in the future, provide a basis for efforts to map complex trait susceptibility genes through genome-wide linkage disequilibrium analyses (81, 83). 

Phrase: "There"

Phrase: "is"

Phrase: ","

Phrase: "in addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "confidence"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0237529:Confidence [Mental Process]
  1000   C1704725:Confidence [Qualitative Concept]
  1000   C1704726:Confidence [Mental Process]
   928 E C0558095:Confident [Individual Behavior]
   900 E C0009669:confidentiality [Idea or Concept]

Phrase: "that"

Phrase: "such resources"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035201:Resources [Idea or Concept]

Phrase: "may"

Phrase: ","

Phrase: "in the future,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016884:Future [Temporal Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a basis for efforts to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1527178:Basis [Functional Concept]
   760   C1874451:Basis [Pharmacologic Substance]

Phrase: "map"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024779:Map [Manufactured Object]
  1000   C1706473:Map [Conceptual Entity]

Phrase: "complex trait susceptibility genes through genome-wide linkage disequilibrium analyses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   743   C0919453:Susceptibility Gene [Gene or Genome]
   739   C0017337:Genes [Gene or Genome]

Phrase: "(81,"

Phrase: "83"

Phrase: ")."
Processing 00000000.tx.96: There is no "roadmap" for the identification of complex trait loci; 

Phrase: "There"

Phrase: "is"

Phrase: "no ""roadmap"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1654610:Roadmap [Intellectual Product]

Phrase: "for the identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "of complex trait loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708726:Locus [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.97: indeed it seems highly improbable that there is a universal strategy that will optimize mapping of all loci for all diseases in all populations. 

Phrase: "indeed"

Phrase: "it"

Phrase: "seems"

Phrase: "highly improbable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1546986:Improbable [Idea or Concept]

Phrase: "that there"

Phrase: "is"

Phrase: "a universal strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategy [Mental Process]

Phrase: "that"

Phrase: "will"

Phrase: "optimize"

Phrase: "mapping of all loci"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1283195:Mapping [Activity]
   737 E C0024779:Map [Manufactured Object]
   737 E C1706473:Map [Conceptual Entity]
   737   C1708726:Locus [Gene or Genome]

Phrase: "for all diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "in all populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]
Processing 00000000.tx.98: Nonetheless, valuable insights can be gained from gene discovery successes such as the identification of variation within the gene for calpain-10 as the likely basis for the chr-2q T2D susceptibility effect first seen in a genome scan of Mexican-American sibships (44, 50). 

Phrase: "Nonetheless,"

Phrase: "valuable insights"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0233820:insights [Mental Process]

Phrase: "can"

Phrase: "be"

Phrase: "gained from gene discovery successes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C2717881:Gene Discovery [Molecular Biology Research Technique]
   760   C0017337:Gene [Gene or Genome]
   760   C0597535:successes [Social Behavior]
   760   C1880355:Discovery [Activity]
   726   C1517378:Gain [Quantitative Concept]

Phrase: "such as the identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "of variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variation [Qualitative Concept]

Phrase: "within the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "for calpain-10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0961737:calpain 10 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413110:CALPAIN 10 [Gene or Genome]
   861   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as the likely basis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1527178:Basis [Functional Concept]
   861   C1874451:Basis [Pharmacologic Substance]

Phrase: "for the chr-2q T2D susceptibility effect first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1280500:Effect [Qualitative Concept]
   795   C2348382:Effect [Qualitative Concept]

Phrase: "seen in a genome scan of Mexican-American sibships"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   764   C0025884:Mexican American [Population Group]
   764   C1517519:Genome Scan [Molecular Biology Research Technique]
   742   C0017428:Genome [Gene or Genome]
   742   C0034606:Scan [Diagnostic Procedure]
   742   C0205397:Seen [Qualitative Concept]
   742   C0240339:Mexican [Population Group]
   742   C0441633:Scan [Diagnostic Procedure]
   742   C0596070:American [Population Group]
   742   C2338314:Genome [Conceptual Entity]
   742   C2826292:SCAN [Finding]
   708 E C0042789:see [Organism Function]
   708 E C1947903:See [Activity]

Phrase: "(44,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.99: Although replication of this original linkage in other populations was limited, LD analyses in Mexican-American cohorts (facilitated by the strong background LD arising from recent genetic admixture) were rewarded with identification of a smaller area of 2q (~250 kb) showing marked association with disease (50). 

Phrase: "Although"

Phrase: "replication of this original linkage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0598312:Replication [Genetic Function]
   760   C1883725:replication [Qualitative Concept]

Phrase: "in other populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "was"

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: ","

Phrase: "LD analyses in Mexican-American cohorts"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0086027:Cohort Analyses [Research Activity]
   757   C0796345:analysis linkage [Laboratory Procedure]
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]

Phrase: "("

Phrase: "facilitated by the strong background LD arising"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023746:Linkage Disequilibrium [Quantitative Concept]
   744   C0023745:linkage [Molecular Function]
   744   C0281825:Disequilibrium [Finding]
   744   C0332284:arising [Qualitative Concept]
   744   C0394006:Disequilibrium [Disease or Syndrome]
   744   C0442821:Strong [Qualitative Concept]
   744   C1706907:Background [Conceptual Entity]

Phrase: "from recent genetic admixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510816:Admixture [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "rewarded with identification of a smaller area of 2q"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0017446:Area [Geographic Area]
   742   C0020792:Identification [Mental Process]
   742   C0205146:Area [Spatial Concept]
   742   C0205396:Identification [Qualitative Concept]
   742   C0547044:Smaller [Qualitative Concept]
   742   C0700321:Smaller [Quantitative Concept]
   742   C1521197:2q [Nucleotide Sequence]
   708   C0035397:Reward [Mental Process]

Phrase: "(~250 kb)"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "marked association with disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C1511978:Disease Association [Temporal Concept]
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.100: Within this interval, the strongest association was with an intronic SNP in the gene encoding calpain-10, a ubiquitously expressed protease with few prior credentials as a T2D candidate. 

Phrase: "Within this interval,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1272706:Interval [Temporal Concept]
  1000   C1552654:Interval [Idea or Concept]
  1000   C1552713:Interval [Intellectual Product]

Phrase: "the strongest association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "was with an intronic SNP"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   748   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0032529:Polymorphism [Genetic Function]
   748   C0037179:Single [Population Group]
   748   C0043194:WAS [Disease or Syndrome]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1421478:WAS [Gene or Genome]
   748   C1882417:Polymorphism [Qualitative Concept]

Phrase: "in the gene encoding calpain-10,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0961737:calpain 10 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1413110:CALPAIN 10 [Gene or Genome]
   812   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017337:Gene [Gene or Genome]
   812   C1547699:Encoding [Idea or Concept]
   812   C2700640:Encoding [Activity]

Phrase: "a ubiquitously expressed protease with few prior credentials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C1947941:Protease [Enzyme]

Phrase: "as a T2D candidate."
Processing 00000000.tx.101: Subsequent analyses have suggested that several variants within the gene combine to influence individual susceptibility to T2D (21, 30, 50). 

Phrase: "Subsequent analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that several variants within the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:variants [Qualitative Concept]

Phrase: "combine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336789:Combine [Manufactured Object]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "individual susceptibility to T2D"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "(21,"

Phrase: "30,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.102: The contribution of this locus to overall T2D susceptibility appears to be significantly less in Europeans than in Mexican-Americans (21, 30). 

Phrase: "The contribution of this locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "to overall T2D susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0012655:Susceptibility [Clinical Attribute]
   812   C0220898:Susceptibility [Organism Attribute]
   812   C1264642:Susceptibility [Functional Concept]
   812   C1547045:*Susceptibility [Quantitative Concept]
   741 E C0231204:Susceptible [Functional Concept]
   741 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "significantly less in Europeans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0239307:European [Population Group]
   737   C1535514:European [Population Group]

Phrase: "than"

Phrase: "in Mexican-Americans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025884:Mexican Americans [Population Group]
   861   C0596070:americans [Population Group]

Phrase: "(21,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.103: The calpain-10 story is, of course, far from over. 

Phrase: "The calpain-10 story"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1547707:Story [Geographic Area]
   734   C0961737:calpain 10 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1413110:CALPAIN 10 [Gene or Genome]

Phrase: "is"

Phrase: ","

Phrase: "of course,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "far from over."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205108:far [Spatial Concept]
Processing 00000000.tx.104: There remains the (diminishing) possibility that variation in the CAPN10 gene is not itself etiological and that the calpain-10 association instead reflects the action of a nearby variant with which it is in LD (2). 

Phrase: "There"

Phrase: "remains"

Phrase: "the (diminishing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:diminishing [Quantitative Concept]

Phrase: ")"

Phrase: "possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "that variation in the CAPN10 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "itself etiological"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0015127:aetiology [Functional Concept]
   928   C1314792:Aetiology [Functional Concept]
   928   C1524003:Etiology [Conceptual Entity]

Phrase: "and"

Phrase: "that"

Phrase: "the calpain-10 association instead"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0004083:Association [Mental Process]
   812   C0439849:Association [Qualitative Concept]
   812   C0596306:Association [Phenomenon or Process]
   812   C0699792:association [Social Behavior]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the action of a nearby variant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441472:Action [Functional Concept]
   753   C3266814:Action [Activity]

Phrase: "with which"

Phrase: "it"

Phrase: "is in LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.105: Extensive analysis of LD on 2q is attempting to address this question (21). 

Phrase: "Extensive analysis of LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0796345:analysis linkage [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "on 2q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521197:2q [Nucleotide Sequence]

Phrase: "is"

Phrase: "attempting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.106: The more interesting question relates to the mechanisms whereby differences in the expression and/or function of calpain-10 translate into an increased risk of T2D, and here the focus has moved to detailed studies of the cellular and physiological consequences of perturbing calpain-10 activity in model systems (2). 

Phrase: "The more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "relates to the mechanisms whereby differences"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0163712:Relate [Organic Chemical]
   753   C0441712:Mechanisms [Functional Concept]
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "in the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and/or"

Phrase: "function of calpain-10"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "translate into an increased risk of T2D,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0035647:Risk [Qualitative Concept]
   744   C0040710:translate [Occupational Activity]
   744   C0205217:Increased [Quantitative Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "here"

Phrase: "the focus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205234:Focus [Spatial Concept]
  1000   C1285542:focus [Functional Concept]

Phrase: "has"

Phrase: "moved to detailed studies of the cellular"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   778   C1299988:Moved to [Functional Concept]
           moved
   748   C0007634:Cellular [Cell]
   748   C0178539:Cellular [Functional Concept]
   748   C0947630:studies [Laboratory Procedure]
   748   C1269909:moved [Functional Concept]
   748   C1522508:Detailed [Qualitative Concept]
   748   C2699029:Moved [Activity]
   714 E C0557651:Study [Manufactured Object]
   714 E C0560560:move [Organism Function]
   714 E C0578671:move [Finding]
   714 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "physiological consequences of perturbing calpain-10 activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "in model systems"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   983   C0026339:Model System [Intellectual Product,Research Device]
   983   C3161035:Model System [Intellectual Product]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.107: Positional cloning in animal models. 

Phrase: "Positional cloning in animal models."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1656250:positional cloning [Research Activity]
   797   C0872096:animal cloning [Research Activity]
   760   C0009015:Cloning [Research Activity]
Processing 00000000.tx.108: Animal models of T2D have obvious advantages for positional cloning efforts, including the capacity for detailed ex vivo physiological (and histological) analysis of target tissues (90). 

Phrase: "Animal models of T2D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0599779:Models, Animal [Animal]
   760   C0003062:Animal [Animal]
   760   C3161035:Models [Intellectual Product]

Phrase: "have"

Phrase: "obvious advantages for positional cloning efforts,"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the capacity for detailed ex vivo physiological"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1516240:Capacity [Quantitative Concept]

Phrase: "("

Phrase: "and"

Phrase: "histological"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205462:Histological [Functional Concept]
   928 E C0019638:Histology [Biomedical Occupation or Discipline]
   928 E C0344441:Histology [Laboratory Procedure]

Phrase: ")"

Phrase: "analysis of target tissues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "(90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.109: Even if the loci underlying diabetes in a given rodent model play no significant role in determining human susceptibility, novel pathways of interest may be highlighted. 

Phrase: "Even"

Phrase: "if"

Phrase: "the loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "underlying"

Phrase: "diabetes in a given rodent model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "no significant role in determining human susceptibility,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "novel pathways of interest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704259:Pathways [Molecular Function]
   770   C1705987:Pathways [Conceptual Entity]

Phrase: "may"

Phrase: "be"

Phrase: "highlighted."
Processing 00000000.tx.110: Analyses of many mouse and rat models of diabetes are currently in progress, with large crosses designed to identify chromosomal regions of interest, typically followed by application of congenic methods to narrow the region and move toward identification of the etiological gene. 

Phrase: "Analyses of many mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "models of diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C3161035:Model [Intellectual Product]

Phrase: "are"

Phrase: "currently in progress,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272688:progress [Functional Concept]
   827   C1280477:Progress [Functional Concept]

Phrase: "with large crosses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828360:Cross [Conceptual Entity]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "chromosomal regions of interest,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   898   C0803113:Region of interest [Clinical Attribute]
   898   C0807727:Region of interest [Spatial Concept]
   898   C2827628:Region of Interest [Spatial Concept]
   847   C1953345:Region of chromosome [Cell]
           Chromosomal region
   770   C0008633:Chromosomal [Cell Component]
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]

Phrase: "typically"

Phrase: "followed by application of congenic methods to"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0025663:Methods [Intellectual Product]
   748   C0025664:methods [Intellectual Product]
   748   C0185125:Application [Health Care Activity]
   748   C0449851:Methods [Functional Concept]
   748   C1947919:Application [Intellectual Product]
   748   C2347934:Application [Intellectual Product]
   748   C3539080:APPLICATION [Quantitative Concept]
   714 E C0871511:METHOD [Intellectual Product]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "narrow"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205168:Narrow [Qualitative Concept]
  1000   C0332463:Narrow [Spatial Concept]
  1000   C0333164:Narrow [Quantitative Concept]

Phrase: "the region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "move toward identification of the etiological gene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0560560:move [Organism Function]
   748   C0578671:move [Finding]
   748   C1269909:move [Functional Concept]
   748   C1299988:move [Functional Concept]
   748   C2699029:Move [Activity]
Processing 00000000.tx.111: For example, in the Goto-Kakizaki rat, an excellent polygenic model of T2D, several regions influencing diabetes and related intermediate traits have been identified (36, 37) and susceptibility genes provisionally identified (32). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "in the Goto-Kakizaki rat,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]

Phrase: "an excellent polygenic model of T2D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]

Phrase: "several regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "influencing"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "related intermediate traits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0599883:traits [Organism Attribute]
   827   C1427926:TRAITS [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "(36,"

Phrase: "37"

Phrase: ")"

Phrase: "and"

Phrase: "susceptibility genes provisionally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0919453:Susceptibility Gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.112: These analyses have illustrated the exquisite complexity of the genetic control of metabolic function, with different loci, for example, seen to influence fasting and postprandial glucose levels. 

Phrase: "These analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "have"

Phrase: "illustrated"

Phrase: "the exquisite complexity of the genetic control of metabolic function,"

Phrase: "with different loci,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "postprandial glucose levels."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.113: This emphasizes once again the importance of maximizing the physiological information obtained from the subjects recruited to human linkage studies. 

Phrase: "This"

Phrase: "emphasizes"

Phrase: "once again"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720092:Once [Intellectual Product]
   861   C1948045:Once [Temporal Concept]

Phrase: "the importance of maximizing"

Phrase: "the physiological information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "obtained from the subjects"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C1301820:Obtained [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737 E C1706701:Obtain [Activity]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "recruited to human linkage studies."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   797   C0178693:human studies [Research Activity]
   760   C0023745:linkage [Molecular Function]
   760   C0086418:Human [Human]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]
Processing 00000000.tx.114: As the various genomic regions described above yield up their secrets in coming years, the hope is that, as with MODY, it will be possible to reconstruct the pathophysiological architecture of T2D and to develop ways in which this information can be used to deliver improved patient care.  

Phrase: "As the various genomic regions"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0017428:Genomic [Gene or Genome]
   827   C0887950:genomic [Biomedical Occupation or Discipline]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "described above yield"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "up their secrets in coming years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: "the hope"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0392347:Hope [Mental Process]
   900 E C3540843:Hopefulness [Mental Process]

Phrase: "is"

Phrase: "that,"

Phrase: "as with MODY,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   909   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   909   C2984262:Maturity onset diabetes of the young [Functional Concept]
   800   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0332162:Onset [Qualitative Concept]
   744   C0332239:Young [Temporal Concept]
   744   C0449989:Maturity [Qualitative Concept]
   744   C0700597:Maturity [Temporal Concept]

Phrase: "it"

Phrase: "will"

Phrase: "be"

Phrase: "possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "reconstruct"

Phrase: "the pathophysiological architecture of T2D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003737:Architecture [Occupation or Discipline]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "develop"

Phrase: "ways in which"

Phrase: "this information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1533716:Information [Idea or Concept]
   928 E C3242430:informational [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "deliver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
  1000   C1705822:Deliver [Activity]
  1000   C1874964:DELIVER [Pharmacologic Substance]

Phrase: "improved patient care."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017313:patient care [Health Care Activity]
   901   C1554098:Patient Care [Idea or Concept]
   827   C1947933:Care [Activity]
Processing 00000000.tx.115: FROM PHYSIOLOGY TO GENES TOP ABSTRACT INTRODUCTION FROM GENES TO PHYSIOLOGY FROM PHYSIOLOGY TO GENES INTEGRATING PHYSIOLOGY AND... 

Phrase: "FROM PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "TO GENES TOP ABSTRACT INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1293116:Introduction [Health Care Activity]
   812   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "FROM GENES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "TO PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "FROM PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "TO GENES INTEGRATING PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0031842:Physiology [Biomedical Occupation or Discipline]
   827   C0031843:physiology [Physiologic Function]
   755 E C0205463:Physiologic [Functional Concept]

Phrase: "AND..."
Processing 00000000.tx.116: REFERENCES The second "classic" paradigm for gene identification has been the "candidate gene" approach. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The second ""classic"" paradigm for gene identification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0681797:paradigm [Research Activity]

Phrase: "has"

Phrase: "been"

Phrase: "the ""candidate gene"" approach."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449445:Approach [Spatial Concept]
   734   C1332838:Candidate Gene [Gene or Genome]
Processing 00000000.tx.117: Given advances in the range of tools available for genome-wide analysis of the transcriptome, proteome, and metabonome, the number of plausible candidates is large and growing. 

Phrase: "Given advances in the range of tools"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0725066:Advance [Medical Device]

Phrase: "available for genome-wide analysis of the transcriptome,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0470187:Available [Functional Concept]
           Availability of

Phrase: "proteome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0751973:Proteome [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "metabonome,"

Phrase: "the number of plausible candidates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "is"

Phrase: "large"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549177:Large [Quantitative Concept]

Phrase: "and"

Phrase: "growing."
Processing 00000000.tx.118: The strongest candidate genes are likely to be those supported by multiple lines of evidence, including chromosomal localization to regions of linkage defined in family studies. 

Phrase: "The strongest candidate genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1332838:Candidate Genes [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "those"

Phrase: "supported by multiple lines of evidence,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   783   C0332120:Evidence of [Functional Concept]
           Evidence
   753   C0205132:lines [Spatial Concept]
   753   C0439064:Multiple [Quantitative Concept]
   753   C1521721:Supported [Conceptual Entity]
   719 E C0183683:Support [Medical Device]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "chromosomal localization to regions of linkage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C1657114:chromosome localisation [Biologic Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "defined in family studies."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0199236:family studies [Diagnostic Procedure]
   770   C0015576:Family [Family Group]
   770   C0947630:studies [Laboratory Procedure]
   770   C1704727:Family [Conceptual Entity]
   770   C1704788:Defined [Conceptual Entity]
   770   C3539106:Defined [Intellectual Product]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.119: The major obstacle to the interpretation of candidate gene studies in T2D (as in other traits) has been the proliferation of reports from small studies, often with inadequate study designs. 

Phrase: "The major obstacle to the interpretation of candidate gene"

Phrase: "studies in T2D"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C0035171:Study Type [Research Activity]
   819   C2985227:Study Type [Research Activity]
   770   C0332307:Type [Qualitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C1547052:*Type [Quantitative Concept]
   770   C2603343:Study [Research Activity]

Phrase: "("

Phrase: "as in other traits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0599883:traits [Organism Attribute]
   770   C1427926:TRAITS [Gene or Genome]

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "the proliferation of reports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0334094:Proliferation [Pathologic Function]
   770   C1514485:Proliferation [Functional Concept]

Phrase: "from small studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "often with inadequate study designs."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   773   C0035171:Study Design [Research Activity]
   773   C2983265:Study Design [Intellectual Product]
           DESIGN
   773   C2986888:Study Design [Research Activity]
   760   C0205412:Inadequate [Qualitative Concept]
   760   C0332183:Often [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
   726   C1707689:Design [Activity]
Processing 00000000.tx.120: These have oftentimes resulted in isolated reports of positive associations that have proved difficult or impossible to replicate. 

Phrase: "These"

Phrase: "have"

Phrase: "oftentimes"

Phrase: "resulted in isolated reports of positive associations"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   748   C0004083:Associations [Mental Process]
   748   C0205409:Isolated [Functional Concept]
   748   C0439178:% Positive [Quantitative Concept]
   748   C0684224:Reports [Intellectual Product]
   748   C0700287:reports [Health Care Activity]
   748   C1446409:Positive [Qualitative Concept]
   748   C1514241:Positive [Finding]
   748   C1548221:Isolated [Idea or Concept]
   748   C2825490:Positive [Qualitative Concept]
   714 E C0439849:Association [Qualitative Concept]
   714 E C0596306:Association [Phenomenon or Process]
   714 E C0699792:association [Social Behavior]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]
   714 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "have"

Phrase: "proved difficult"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "or"

Phrase: "impossible to"

Phrase: "replicate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]
Processing 00000000.tx.121: The promulgation of new "industry standards" for association studies in multifactorial disease (3, 19, 22, 26) should help to remedy these methodological shortcomings. 

Phrase: "The promulgation of new ""industry standards"""

Phrase: "for association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "studies in multifactorial disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0012634:Disease [Disease or Syndrome]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C1837655:Multifactorial [Finding]
   770   C2603343:Study [Research Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "19,"

Phrase: "22,"

Phrase: "26"

Phrase: ")"

Phrase: "should"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remedy"

Phrase: "these methodological shortcomings."
Processing 00000000.tx.122: The aim should be to generate data that have power both to detect and, more importantly in many ways, given the low prior probability that any chosen candidate will influence disease susceptibility, to exclude association with confidence. 

Phrase: "The aim"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1947946:Aim [Idea or Concept]
  1000   C2948600:Aim [Pharmacologic Substance]
  1000   C3540471:AIM [Gene or Genome]
  1000   C3540472:AIM [Functional Concept]

Phrase: "should"

Phrase: "be"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "that"

Phrase: "have"

Phrase: "power"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "both to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "and"

Phrase: ","

Phrase: "more importantly in many ways,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205172:More [Functional Concept]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the low prior probability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0033204:Probability [Quantitative Concept]
   755 E C0332148:Probable [Qualitative Concept]

Phrase: "that"

Phrase: "any chosen candidate"

Phrase: "will"

Phrase: "influence"

Phrase: "disease susceptibility,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0012655:Disease susceptibility [Clinical Attribute]
           Susceptibility
   861   C0220898:Susceptibility [Organism Attribute]
   861   C1264642:Susceptibility [Functional Concept]
   861   C1547045:*Susceptibility [Quantitative Concept]
   789 E C0231204:Susceptible [Functional Concept]
   789 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "association with confidence."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
Processing 00000000.tx.123: The literature on the myriad of candidate genes so far studied is undoubtedly distorted by reporting bias (56), making a synthesis difficult. 

Phrase: "The literature on the myriad of candidate genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0023866:Literature [Intellectual Product]
   744   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "so"

Phrase: "far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205108:far [Spatial Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "undoubtedly"

Phrase: "distorted by reporting bias"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0242568:Bias [Idea or Concept]
   770   C0700135:Distorted [Functional Concept]
   770   C0700287:Reporting [Health Care Activity]
   770   C1504315:Bias [Bird]
   737 E C0684224:Report [Intellectual Product]
   737 E C1061346:Bia [Eukaryote]
   737 E C1704746:BIA [Diagnostic Procedure]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(56"

Phrase: ")"

Phrase: ","

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "a synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220781:synthesis [Biologic Function]
  1000   C1883254:Synthesis [Activity]

Phrase: "difficult."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332218:Difficult [Qualitative Concept]
   928 E C1299586:Difficulty [Finding]
Processing 00000000.tx.124: However, most in the field would accept that a strong case can be made for a susceptibility role of variants in the genes for the peroxisome proliferator-activated receptor- (PPAR; see Candidate genes from the adipocyte), insulin (see Role of variation in the insulin gene), the sulfonylurea receptor (45) and its genetic and cellular neighbor the ATP-sensitive K+ channel Kir6.2 (42), insulin receptor substrate-1 (1), and IPF-1 (the only example to date of a MODY gene that may also influence typical T2D susceptibility) (43, 63). 

Phrase: "However,"

Phrase: "most in the field"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   812   C1521738:Field [Conceptual Entity]
   812   C2346620:Field [Conceptual Entity]
   812   C2349184:Field [Conceptual Entity]
   812   C3539073:FIELD [Spatial Concept]

Phrase: "would"

Phrase: "accept"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272684:accept [Qualitative Concept]
  1000   C1548601:Accept [Idea or Concept]

Phrase: "that"

Phrase: "a strong case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: "can"

Phrase: "be"

Phrase: "made for a susceptibility role of variants"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0012655:Susceptibility [Clinical Attribute]
   748   C0035820:Role [Social Behavior]
   748   C0205419:variants [Qualitative Concept]
   748   C0220898:Susceptibility [Organism Attribute]
   748   C1264642:Susceptibility [Functional Concept]
   748   C1547045:*Susceptibility [Quantitative Concept]
   748   C1705810:Role [Conceptual Entity]
   714   C1881534:Make [Functional Concept]

Phrase: "in the genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "for the peroxisome proliferator-activated receptor-"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]

Phrase: "(PPAR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166418:PPAR [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PPAR [Gene or Genome]
  1000   C2984537:PPAR [Gene or Genome]

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Candidate genes from the adipocyte"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1332838:Candidate Genes [Gene or Genome]
   760   C0017337:Genes [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Role of variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "in the insulin gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337112:Insulin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "the sulfonylurea receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   861   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "(45"

Phrase: ")"

Phrase: "and"

Phrase: "its genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "cellular neighbor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553702:Neighbor [Population Group]

Phrase: "the ATP-sensitive K+ channel Kir6.2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C1416578:Kir6.2 [Gene or Genome]
   799   C0332324:Sensitive [Functional Concept]
   799   C0439799:Channel [Spatial Concept]
   799   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   799   C1550474:sensitive [Idea or Concept]
   799   C1706095:Channel [Conceptual Entity]
   799   C1708601:K' [Quantitative Concept]

Phrase: "(42"

Phrase: ")"

Phrase: ","

Phrase: "insulin receptor substrate-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "IPF-1"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0248419:insulin promoter factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826562:INSULIN PROMOTER FACTOR 1 [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C2827422:Factor [Conceptual Entity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "the only example to date of a MODY gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1707959:Example [Conceptual Entity]

Phrase: "that"

Phrase: "may"

Phrase: "also"

Phrase: "influence"

Phrase: "typical T2D susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0012655:Susceptibility [Clinical Attribute]
   812   C0220898:Susceptibility [Organism Attribute]
   812   C1264642:Susceptibility [Functional Concept]
   812   C1547045:*Susceptibility [Quantitative Concept]
   741 E C0231204:Susceptible [Functional Concept]
   741 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: ")"

Phrase: "(43,"

Phrase: "63"

Phrase: ")."
Processing 00000000.tx.125: Promising data are emerging from studies of the adiponectin gene and PGC-1 (see Candidate genes from the adipocyte). 

Phrase: "Promising data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "emerging from studies of the adiponectin gene"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   774   C1273305:Gene studies [Laboratory Procedure]
   748   C0017337:Gene [Gene or Genome]
   748   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0947630:studies [Laboratory Procedure]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "PGC-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418503:PGC [Gene or Genome]
   861   C3538998:PGC [Laboratory Procedure]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Candidate genes from the adipocyte"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1332838:Candidate Genes [Gene or Genome]
   760   C0017337:Genes [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.126: The data for these and other candidates have been extensively reviewed elsewhere (41); 

Phrase: "The data for these"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "other candidates"

Phrase: "have"

Phrase: "been"

Phrase: "extensively"

Phrase: "reviewed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0282443:reviewed [Intellectual Product]
  1000   C1709940:Reviewed [Qualitative Concept]
   966 E C1552617:Review [Idea or Concept]

Phrase: "elsewhere"

Phrase: "(41"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.127: therefore, this review will focus on two areas of current interest. 

Phrase: "therefore,"

Phrase: "this review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "will"

Phrase: "focus on two areas of current interest."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205234:Focus [Spatial Concept]
   748   C1285542:focus [Functional Concept]
Processing 00000000.tx.128: Role of variation in the insulin gene. 

Phrase: "Role of variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "in the insulin gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337112:Insulin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.129: The insulin gene is the archetypal -cell candidate, among the first to be studied for a role in T2D, not least because a large polymorphic minisatellite repeat immediately upstream of the gene (the variable number tandem repeat, or VNTR) was readily amenable to typing using the technologies available at the time. 

Phrase: "The insulin gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337112:Insulin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "the archetypal -cell candidate,"

Phrase: "among the first to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205435:First [Quantitative Concept]
   861   C1279901:First [Qualitative Concept]

Phrase: "be"

Phrase: "studied for a role"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
   737   C0557651:Study [Manufactured Object]
   737   C2603343:Study [Research Activity]

Phrase: "in T2D,"

Phrase: "not least"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "because"

Phrase: "a large polymorphic minisatellite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242827:Minisatellite [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205341:Repeat [Functional Concept]
  1000   C1547730:Repeat [Temporal Concept]
  1000   C1705914:Repeat [Conceptual Entity]

Phrase: "immediately upstream of the gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0017337:Gene [Gene or Genome]
   760   C0205548:Immediately [Temporal Concept]
   760   C0522505:Upstream [Spatial Concept]

Phrase: "("

Phrase: "the variable number tandem repeat,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0242827:Variable Number Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1710347:Variable Number Tandem Repeat [Cell or Molecular Dysfunction]
   923   C3179163:Variable Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0039290:Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   812   C0205341:Repeat [Functional Concept]
   812   C0237753:*Number [Quantitative Concept]
   812   C0439828:Variable [Qualitative Concept]
   812   C0449788:Number [Quantitative Concept]
   812   C1547730:Repeat [Temporal Concept]
   812   C1705914:Repeat [Conceptual Entity]

Phrase: "or"

Phrase: "VNTR)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242827:VNTR [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1710347:VNTR [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "readily amenable to typing"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039421:technologies [Occupation or Discipline]

Phrase: "available at the time."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]
Processing 00000000.tx.130: The VNTR remains the focus of our interest within this gene even now, some two decades on, as it is clear, largely from studies of T1D, that it is not simply a useful marker polymorphism but also plays a functional role by regulating transcription of the INS gene and its immediate 3' neighbor, the gene for the insulin-like growth factor, IGF-II (7). 

Phrase: "The VNTR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242827:VNTR [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1710347:VNTR [Cell or Molecular Dysfunction]

Phrase: "remains"

Phrase: "the focus of our interest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205234:Focus [Spatial Concept]
   760   C1285542:focus [Functional Concept]

Phrase: "within this gene even now,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017337:Gene [Gene or Genome]
   827   C1948052:Now [Temporal Concept]

Phrase: "some two decades on,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2981279:Decade [Quantitative Concept]

Phrase: "as"

Phrase: "it"

Phrase: "is"

Phrase: "clear, largely from studies of T1D,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   757   C0035171:Study Type [Research Activity]
   757   C2985227:Study Type [Research Activity]
   748   C0332307:Type [Qualitative Concept]
   748   C0947630:studies [Laboratory Procedure]
   748   C1547052:*Type [Quantitative Concept]
   748   C2963144:Clear [Qualitative Concept]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "not simply"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "a useful marker polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "but"

Phrase: "also"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a functional role by"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1705810:Functional Role [Conceptual Entity]
           Role
   770   C0035820:Role [Social Behavior]

Phrase: "regulating"

Phrase: "transcription of the INS gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: "and"

Phrase: "its immediate 3' neighbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1553702:Neighbor [Population Group]

Phrase: "the gene for the insulin-like growth factor,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0812325:Growth Factor Gene [Gene or Genome]
   767   C1337112:Insulin Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]

Phrase: "IGF-II (7"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021666:IGF-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1334091:IGF2 [Gene or Genome]
   901   C2697754:IGF2 [Laboratory Procedure]
   827   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: ")."
Processing 00000000.tx.131: In non-African populations, the diversity of VNTR alleles can be summarized as a bimodal system, with ~70-75% of chromosomes ("class I alleles") having a few dozen repeats, the remainder a few hundred ("class III alleles"). 

Phrase: "In non-African populations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "the diversity of VNTR alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880371:Diversity [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "summarized as a bimodal system,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449913:System [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]

Phrase: "with ~70-75%"

Phrase: "of chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008633:Chromosomes [Cell Component]

Phrase: "(""class I alleles"""
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002085:Alleles [Gene or Genome]
   734   C0441885:Class I [Classification]
   734   C2698967:Class I [Finding]

Phrase: ")"

Phrase: "having"

Phrase: "a few dozen repeats,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205341:repeats [Functional Concept]
   827   C1705914:Repeats [Conceptual Entity]
   793 E C1547730:Repeat [Temporal Concept]

Phrase: "the remainder"

Phrase: "a few hundred"

Phrase: "(""class III alleles"""
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002085:Alleles [Gene or Genome]
   734   C0441887:Class III [Intellectual Product]
   734   C2698969:Class III [Finding]

Phrase: ")."
Processing 00000000.tx.132: It is now firmly established that class III alleles are protective in T1D, a phenomenon thought to relate to different levels of thymic expression of insulin, with consequent differential effects on the generation of tolerance (7). 

Phrase: "It"

Phrase: "is"

Phrase: "now firmly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1880776:Firmly [Qualitative Concept]
   861   C1948052:Now [Temporal Concept]

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that class III alleles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002085:Alleles [Gene or Genome]
   734   C0441887:Class III [Intellectual Product]
   734   C2698969:Class III [Finding]

Phrase: "are"

Phrase: "protective in T1D,"

Phrase: "a phenomenon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "relate to different levels of thymic expression of insulin,"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   762   C0202098:insulin levels [Laboratory Procedure]
   762   C0428405:insulin levels [Laboratory or Test Result]
   745   C3244092:expression level [Idea or Concept]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0040113:Thymic [Body Part, Organ, or Organ Component]
   742   C0163712:Relate [Organic Chemical]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0441889:Levels [Qualitative Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1705242:Different [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "with consequent differential effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "on the generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "of tolerance"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0013220:Tolerance [Finding]
  1000   C0020963:Tolerance [Pathologic Function]
  1000   C0220929:tolerance [Mental Process]
  1000   C0231197:Tolerance [Physiologic Function]
  1000   C1704410:Tolerance [Qualitative Concept]
   944 E C0680282:toleration [Social Behavior]
   928 E C0231198:Tolerant [Functional Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.133: There had been the suspicion, based on small case-control studies in the 1980s, that the susceptibility effects in T2D might be reversed, with class III alleles conferring T2D susceptibility (7). 

Phrase: "There"

Phrase: "had"

Phrase: "been"

Phrase: "the suspicion,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0242114:Suspicion [Mental Process]
   928 E C0750493:suspicious [Idea or Concept]
   900 E C0233519:Suspiciousness [Finding]

Phrase: "based on small case-control studies"
Meta Candidates (Total=21; Excluded=5; Pruned=0; Remaining=16)
   833   C0007328:Case-Control Studies [Research Activity]
           Case-Base Studies
   790   C0872128:case control [Health Care Activity]
   783   C0085973:Case Studies [Intellectual Product]
   753   C0243148:control [Qualitative Concept]
   753   C0700321:Small [Quantitative Concept]
   753   C0868928:Case [Functional Concept]
   753   C0947630:studies [Laboratory Procedure]
   753   C1527178:Based [Functional Concept]
   753   C1550141:Control [Substance]
   753   C1705938:Based [Idea or Concept]
   753   C1706255:CASE [Medical Device]
   753   C1706256:Case [Conceptual Entity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C0557651:Study [Manufactured Object]
   719 E C1880279:Base [Biomedical or Dental Material]
   719 E C2603343:Study [Research Activity]

Phrase: "in the 1980s,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681757:1980s [Temporal Concept]

Phrase: "that"

Phrase: "the susceptibility effects in T2D"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "might"

Phrase: "be"

Phrase: "reversed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1555029:Reverse [Idea or Concept]

Phrase: ","

Phrase: "with class III alleles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002085:Alleles [Gene or Genome]
   734   C0441887:Class III [Intellectual Product]
   734   C2698969:Class III [Finding]

Phrase: "conferring"

Phrase: "T2D susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0012655:Susceptibility [Clinical Attribute]
   827   C0220898:Susceptibility [Organism Attribute]
   827   C1264642:Susceptibility [Functional Concept]
   827   C1547045:*Susceptibility [Quantitative Concept]
   755 E C0231204:Susceptible [Functional Concept]
   755 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.134: This fits well with (limited) transcription data suggesting that the class III VNTR allele is associated with reduced INS expression. 

Phrase: "This fits well with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0036572:Fits NOS [Sign or Symptom]
   737 E C0424576:Fit [Finding]
   737 E C2349186:Fit [Activity]

Phrase: "(limited"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]

Phrase: ")"

Phrase: "transcription data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the class III VNTR allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "associated with reduced"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0392756:Reduced [Qualitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "INS expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.135: Studies in parent-offspring trios ascertained for T2D have confirmed these suspicions but have shown that the class III-dependent T2D-susceptibility effect is restricted to the paternally derived allele (52). 

Phrase: "Studies in parent-offspring trios"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "ascertained for T2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "have"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "these suspicions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   966   C0242114:Suspicion [Mental Process]
   916 E C0750493:suspicious [Idea or Concept]
   893 E C0233519:Suspiciousness [Finding]

Phrase: "but"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the class III-dependent T2D-susceptibility effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1280500:Effect [Qualitative Concept]
   795   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "restricted to the paternally derived allele"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0002085:Allele [Gene or Genome]
   753   C0443288:Restricted [Functional Concept]
   753   C1441547:Derived [Qualitative Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.136: Similar parent-of-origin effects have now been reported at this locus in several other T2D-related traits including polycystic ovarian syndrome (8), childhood obesity (60), and early growth (38). 

Phrase: "Similar parent-of-origin effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1280500:effects [Qualitative Concept]
   771 E C2348382:Effect [Qualitative Concept]

Phrase: "have"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "been"

Phrase: "reported at this locus"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1708726:Locus [Gene or Genome]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "in several"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439064:Several [Quantitative Concept]
  1000   C0443302:Several [Quantitative Concept]

Phrase: "other T2D-related traits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0599883:traits [Organism Attribute]
   812   C1427926:TRAITS [Gene or Genome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "polycystic ovarian syndrome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032460:Polycystic Ovarian Syndrome [Disease or Syndrome]
   827   C0039082:Syndrome [Disease or Syndrome]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "childhood obesity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2362324:Childhood obesity [Disease or Syndrome]
  1000   C3645710:Childhood Obesity [Disease or Syndrome]
   861   C0028754:Obesity [Disease or Syndrome]
   861   C1963185:Obesity [Finding]

Phrase: "(60"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "early growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.137: The obvious conclusion is that these parent-of-origin effects are related to the maternal imprinting of this region. 

Phrase: "The obvious conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707478:Conclusion [Idea or Concept]

Phrase: "is"

Phrase: "that"

Phrase: "these parent-of-origin effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1280500:effects [Qualitative Concept]
   779 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "related to the maternal imprinting of this region."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C1868642:Maternal imprinting [Finding]
   744   C0017446:Region [Geographic Area]
   744   C0021118:imprinting [Mental Process]
   744   C0205147:Region [Spatial Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C2347083:Maternal [Family Group]
   711 E C0163712:Relate [Organic Chemical]
   711 E C1699173:imprint [Intellectual Product]
Processing 00000000.tx.138: In many tissues, expression of IGF-II [and almost certainly of INS, too, at least in early development (72)] is restricted to the paternally derived allele, providing a simple explanation for paternally restricted susceptibility effects. 

Phrase: "In many tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "expression of IGF-II ["
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "almost certainly of"

Phrase: "INS,"

Phrase: "too,"

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in early development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "(72"

Phrase: ")"

Phrase: "]"

Phrase: "is"

Phrase: "restricted to the paternally derived allele,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0002085:Allele [Gene or Genome]
   753   C0443288:Restricted [Functional Concept]
   753   C1441547:Derived [Qualitative Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "a simple explanation for paternally restricted susceptibility effects."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0681841:Explanation [Intellectual Product]
Processing 00000000.tx.139: One intriguing corollary is that these data may indicate, because imprinting in this region is most marked in early development, that the T2D susceptibility effect at INS is established very early in life. 

Phrase: "One intriguing corollary"

Phrase: "is"

Phrase: "that"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "may"

Phrase: "indicate"

Phrase: ","

Phrase: "because"

Phrase: "imprinting in this region"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0017446:Region [Geographic Area]
   770   C0021118:imprinting [Mental Process]
   770   C0205147:Region [Spatial Concept]
   737 E C1699173:imprint [Intellectual Product]

Phrase: "is"

Phrase: "most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "marked in early development,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243107:development [Physiologic Function]
   770   C0522501:Marked [Qualitative Concept]
   770   C0678723:Development [Organism Function]
   770   C1279919:Early [Temporal Concept]
   770   C1527148:Development [Functional Concept]
   770   C1706089:Marked [Qualitative Concept]

Phrase: "that"

Phrase: "the T2D susceptibility effect at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "INS"

Phrase: "is"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "very early in life."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0376558:Life [Idea or Concept]
   812   C1279919:Early [Temporal Concept]
   729 E C0595998:lives [Finding]
Processing 00000000.tx.140: If so, it raises interesting parallels with the "fetal origins" hypothesis, which attributes observed associations between restricted fetal growth and adult metabolic disturbance to the long-lasting effects of poor fetal nutrition. 

Phrase: "If"

Phrase: "so,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "it"

Phrase: "raises"

Phrase: "interesting parallels with the ""fetal origins"" hypothesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C2348042:Parallel [Qualitative Concept]
   714   C2826345:PARALLEL [Research Activity]

Phrase: "which"

Phrase: "attributes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449234:Attribute [Idea or Concept]
  1000   C1704772:Attribute [Conceptual Entity]
  1000   C1882133:Attribute [Qualitative Concept]

Phrase: "observed associations between restricted fetal growth"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0004083:Associations [Mental Process]
   719 E C0439849:Association [Qualitative Concept]
   719 E C0596306:Association [Phenomenon or Process]
   719 E C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "adult metabolic disturbance to the long-lasting effects of poor fetal nutrition."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0746556:metabolic disturbance [Disease or Syndrome]
   736   C2699787:Disturbance [Qualitative Concept]
Processing 00000000.tx.141: It may point to a common mechanism whereby genetic and environmental determinants interact to influence diabetes susceptibility through effects during early development. 

Phrase: "It"

Phrase: "may"

Phrase: "point to a common mechanism"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C2924612:Point A [Body Location or Region]
   760   C0205214:Common [Quantitative Concept]
   760   C0441712:Mechanism [Functional Concept]
   760   C1522138:Common [Functional Concept]
   760   C1552961:Point [Quantitative Concept]
   760   C1706376:Mechanism [Manufactured Object]
   760   C2347617:point [Quantitative Concept]
   760   C3245511:common [Intellectual Product]

Phrase: "whereby genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "environmental determinants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1521761:Determinant [Functional Concept]

Phrase: "interact"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "diabetes susceptibility through effects"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "during early development."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.142: The observation that variation at VNTR influences birth weight (25) lends some succor to this view, although interpretation is complicated by the fact that class III alleles, contrary to expectation, appear to be a feature of large, rather than small, babies (67). 

Phrase: "The observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that variation at VNTR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205419:Variation [Qualitative Concept]

Phrase: "influences"

Phrase: "birth weight"
Meta Candidates (Total=21; Excluded=13; Pruned=0; Remaining=8)
  1000   C0005612:Birth Weight [Organism Attribute]
   861   C0005615:Birth [Organism Function]
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1550722:birth [Idea or Concept]
   861   C1705104:Weight [Idea or Concept]
   861   C3245487:birth [Intellectual Product]
   805 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   805 E C0314603:Genetic [Functional Concept]
   805 E C0454729:Natal [Geographic Area]
   777 E C0035150:Reproduction [Organism Function]
   777 E C0079946:origin [Classification]
   777 E C0439659:Origin [Temporal Concept]
   777 E C1550512:origin [Intellectual Product]
   761 E C0559522:Genital [Body System]
   761 E C1546649:Genital [Intellectual Product]
   761 E C1550642:Genital [Body Substance]
   755 E C0205313:Original [Idea or Concept]
   755 E C2347409:Original [Occupational Activity]
   742 E C0598240:originality [Mental Process]

Phrase: "(25"

Phrase: ")"

Phrase: "lends"

Phrase: "some succor to this view,"

Phrase: "although"

Phrase: "interpretation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0459471:Interpretation [Intellectual Product]
  1000   C3173575:Interpretation [Clinical Attribute]

Phrase: "is"

Phrase: "complicated by the fact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0231242:Complicated [Functional Concept]

Phrase: "that class III alleles,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002085:Alleles [Gene or Genome]
   734   C0441887:Class III [Intellectual Product]
   734   C2698969:Class III [Finding]

Phrase: "contrary to expectation,"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a feature of large,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1521970:Feature [Qualitative Concept]
   770   C1706388:Feature [Conceptual Entity]
   770   C2346469:Feature [Qualitative Concept]
   770   C2348519:Feature [Qualitative Concept]

Phrase: "rather than"

Phrase: "small, babies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0021296:Small baby [Disease or Syndrome]
   861   C0021270:babies [Age Group]

Phrase: "(67"

Phrase: ")."
Processing 00000000.tx.143: Candidate genes from the adipocyte. 

Phrase: "Candidate genes from the adipocyte."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1332838:Candidate Genes [Gene or Genome]
   760   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.144: Adipose tissue was, until recently, considered an organ dedicated exclusively to energy storage. 

Phrase: "Adipose tissue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]

Phrase: "was"

Phrase: ","

Phrase: "until"

Phrase: "recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "an organ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178784:Organ [Body Part, Organ, or Organ Component]

Phrase: "dedicated"

Phrase: "exclusively to energy storage."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0337174:Storage [Spatial Concept]
   770   C0424589:Energy [Finding]
   770   C0542479:Energy [Natural Phenomenon or Process]
   770   C1442080:Energy [Quantitative Concept]
   770   C1698986:Storage [Functional Concept]
   770   C1753314:storage [Cell Component]
Processing 00000000.tx.145: The discovery of leptin has transformed that view and excited interest in the role of adipocyte-secreted signals in the control of energy balance and metabolism. 

Phrase: "The discovery of leptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880355:Discovery [Activity]

Phrase: "has"

Phrase: "transformed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510411:Transformed [Pathologic Function]

Phrase: "that view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "and"

Phrase: "excited interest in the role of adipocyte-secreted signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0543488:Interest [Mental Process]

Phrase: "in the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of energy balance"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0597987:Energy Balance [Organism Function]
   861   C0014653:Balance [Organism Function]
   861   C0205415:Balance [Functional Concept]
   861   C0424589:Energy [Finding]
   861   C0542479:Energy [Natural Phenomenon or Process]
   861   C0560184:Balance [Finding]
   861   C1442080:Energy [Quantitative Concept]

Phrase: "and"

Phrase: "metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.146: It is now recognized that the adipocyte has a complex endocrine function, modulating metabolism and playing a key role in the genesis of the dysmetabolic syndrome. 

Phrase: "It"

Phrase: "is"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "recognized"

Phrase: "that"

Phrase: "the adipocyte"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocyte [Cell]

Phrase: "has"

Phrase: "a complex endocrine function,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0678896:Endocrine function [Physiologic Function]
   827   C0014136:Endocrine [Body System]
   827   C0031843:function [Physiologic Function]
   827   C0521425:Endocrine [Functional Concept]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "modulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulating [Spatial Concept]

Phrase: "metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "playing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:playing [Daily or Recreational Activity]
  1000   C0600138:playing [Finding]

Phrase: "a key role in the genesis of the dysmetabolic syndrome."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.147: Building on these physiological insights, genetic studies have identified several adipose-expressed genes likely to be contributing to individual risk of T2D and related phenotypes. 

Phrase: "Building on these physiological insights,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1547706:Building [Functional Concept]
   760   C1999269:Building [Manufactured Object]

Phrase: "genetic studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C2827447:Genetic Study [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "identified several adipose-expressed genes likely to"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   795   C0017337:Genes [Gene or Genome]
   795   C0205396:Identified [Qualitative Concept]
   795   C0332148:Likely [Qualitative Concept]
   795   C0750492:Likely [Idea or Concept]
   795   C1550043:Identified [Finding]
   795   C1551388:Identified [Functional Concept]
   724   C0028754:Adiposity [Disease or Syndrome]
   724   C1563743:adiposity [Organism Attribute]

Phrase: "be"

Phrase: "contributing to individual risk of T2D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880177:Contributing [Activity]

Phrase: "and"

Phrase: "related phenotypes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031437:Phenotypes [Organism Attribute]
   827 E C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.148: The strongest evidence implicates the gene for PPAR. 

Phrase: "The strongest evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "implicates"

Phrase: "the gene for PPAR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.149: Rare variants that severely decrease the transactivation potential have been found to cosegregate with extreme insulin resistance, diabetes, and hypertension in two families with autosomal dominant inheritance (6). 

Phrase: "Rare variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "that severely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205082:Severely [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the transactivation potential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cosegregate with extreme insulin resistance,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205403:Extreme [Qualitative Concept]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "hypertension in two families"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   777   C0598428:familial hypertension [Disease or Syndrome]
   770   C0020538:Hypertension [Disease or Syndrome]
   770   C1963138:Hypertension [Finding]

Phrase: "with autosomal dominant inheritance"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0443147:Autosomal dominant inheritance [Intellectual Product]
           Autosomal dominant
   913   C0678944:autosomal inheritance [Genetic Function]
   901   C0678942:dominant inheritance [Genetic Function]
   827   C0242538:Inheritance [Quantitative Concept]
   827   C0728826:Inheritance [Functional Concept]
   827   C1527180:Dominant [Functional Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.150: Interestingly, given the proposed role for PPAR in adipogenesis, affected family members had no evidence of lipoatrophy or abnormal fat distribution. 

Phrase: "Interestingly,"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the proposed role for PPAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in adipogenesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596843:Adipogenesis [Molecular Function]

Phrase: "affected family members"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0086282:Family Members [Family Group]
   867 E C1611821:Family Member [Intellectual Product]
   827   C0015576:Family [Family Group]
   827   C0680022:members [Population Group]
   827   C1704727:Family [Conceptual Entity]
   793 E C2698041:Member [Professional or Occupational Group]
   755 E C0241888:Familial [Functional Concept]

Phrase: "had"

Phrase: "no evidence of lipoatrophy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "or"

Phrase: "abnormal fat distribution."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3553572:Abnormal fat distribution [Finding]
   913   C0332619:Abnormal distribution [Qualitative Concept]
   827   C0520511:distribution [Idea or Concept]
   827   C1704711:Distribution [Functional Concept]
Processing 00000000.tx.151: In addition, a common amino acid polymorphism (Pro12Ala) in PPAR has been associated with T2D (3): homozygous carriers of the Pro12 allele are more insulin resistant and have a 1.25-fold increased risk of developing T2D. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "a common amino acid polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(Pro12Ala"

Phrase: ")"

Phrase: "in PPAR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166418:PPAR [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PPAR [Gene or Genome]
  1000   C2984537:PPAR [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "associated with T2D"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ":"

Phrase: "homozygous carriers of the Pro12 allele"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0007294:carriers [Finding]
   719 E C0560175:Carrier [Finding]
   719 E C1706209:Carrier [Medical Device]
   719 E C3273162:Carrier [Intellectual Product]

Phrase: "are"

Phrase: "more insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "resistant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332325:Resistant [Functional Concept]
  1000   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and"

Phrase: "have"

Phrase: "a 1.25-fold increased risk of developing T2D."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0966318:RISK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0035647:Risk [Qualitative Concept]
   739   C0205217:Increased [Quantitative Concept]
   739   C0442805:Increased [Functional Concept]
Processing 00000000.tx.152: There is evidence for an interaction between this polymorphism and the response to elevated free fatty acid (FFA) levels (87). 

Phrase: "There"

Phrase: "is"

Phrase: "evidence for an interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "between this polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "the response to elevated free fatty acid (FFA) levels"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C2753299:response to fatty acid [Cell Function]
   793   C1327572:response to acid [Organism Function]
   750   C1547597:Response level [Idea or Concept]
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]

Phrase: "(87"

Phrase: ")."
Processing 00000000.tx.153: These findings have understandably evoked interest in genes known to influence PPAR function, and a common Gly482Ser polymorphism in the gene for PGC-1, a transcriptional coactivator of a series of nuclear receptors including PPAR, has been associated with a 1.34-fold relative risk of T2D (28), although there is no indication of interaction with the PPAR Pro12Ala variant. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "understandably evoked interest in genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0543488:Interest [Mental Process]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "PPAR function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "a common Gly482Ser polymorphism in the gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0678951:gene polymorphism [Genetic Function]
   748   C0032529:Polymorphism [Genetic Function]
   748   C1882417:Polymorphism [Qualitative Concept]

Phrase: "for PGC-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418503:PGC [Gene or Genome]
   861   C3538998:PGC [Laboratory Procedure]

Phrase: "a transcriptional coactivator of a series of nuclear receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   764   C1336776:Transcriptional Coactivator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "PPAR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166418:PPAR [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PPAR [Gene or Genome]
  1000   C2984537:PPAR [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "associated with a 1.34-fold relative risk of T2D"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   756   C0242492:Relative Risk [Quantitative Concept]
   756   C0332281:Associated with [Qualitative Concept]
           Associated
   754   C0441729:Type 1 [Classification]
   754   C0966318:RISK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0035647:Risk [Qualitative Concept]
   738   C0080103:Relative [Family Group]
   738   C0205345:Relative [Qualitative Concept]
   738   C0332307:Type [Qualitative Concept]
   738   C0332462:Fold [Spatial Concept]
   738   C1547039:*Relative [Quantitative Concept]
   738   C1547052:*Type [Quantitative Concept]
   738   C1880834:FOLD [Phenomenon or Process]
   704 E C0750490:Associate [Idea or Concept]
   704 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "there"

Phrase: "is"

Phrase: "no indication of interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C0521090:No indication of [Qualitative Concept]
   770   C0392360:indication [Idea or Concept]
   770   C3146298:Indication [Functional Concept]

Phrase: "with the PPAR Pro12Ala variant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]
Processing 00000000.tx.154: Another recent candidate is the APM1 gene, encoding the differentiated adipocyte-secreted protein ACRP30/adiponectin, an adipokine abundantly present in plasma. 

Phrase: "Another recent candidate"

Phrase: "is"

Phrase: "the APM1 gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the differentiated adipocyte-secreted protein ACRP30/adiponectin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "an adipokine abundantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1955907:Adipokine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "present in plasma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0032105:Plasma [Body Substance]
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]
   790   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
Processing 00000000.tx.155: The purified COOH-terminal domain of adiponectin has been reported to protect mice on a high-fat diet from obesity and to rescue obese or lipoatrophic mice models from severe insulin resistance by decreasing levels of plasma FFA and enhancing lipid oxidization in muscle (35). 

Phrase: "The purified COOH-terminal domain of adiponectin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "protect"

Phrase: "mice on a high-fat diet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]

Phrase: "from obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "rescue"

Phrase: "obese"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028754:Obese [Disease or Syndrome]

Phrase: "or"

Phrase: "lipoatrophic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "models from severe insulin resistance"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205082:Severe [Qualitative Concept]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3161035:Model [Intellectual Product]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "by decreasing levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of plasma FFA"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0015688:free fatty acid [Lipid]
   923   C2698488:Free Fatty Acid [Laboratory Procedure]
   861   C0015684:Fatty acid [Lipid]
   812   C0001128:Acid [Chemical]
   812   C0032105:Plasma [Body Substance]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0332296:free [Functional Concept]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]

Phrase: "and"

Phrase: "enhancing lipid oxidization in muscle"

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.156: Moreover, plasma levels of adiponectin have been shown to be decreased in obese diabetic subjects and to correlate with insulin sensitivity (4), which makes APM1 an attractive candidate gene for fat-induced metabolic syndrome and T2D. 

Phrase: "Moreover,"

Phrase: "plasma levels of adiponectin"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0032105:Plasma [Body Substance]
   770   C0441889:Levels [Qualitative Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "decreased in obese diabetic subjects"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C0028754:Obese [Disease or Syndrome]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0241863:DIABETIC [Finding]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correlate with insulin sensitivity"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0920563:Insulin Sensitivity [Pathologic Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(4"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "APM1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1540187:APM1 [Gene or Genome]
  1000   C2986675:APM1 [Gene or Genome]

Phrase: "an attractive candidate gene for fat-induced metabolic syndrome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1332838:Candidate Gene [Gene or Genome]
   762   C0812278:FAT Gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "T2D."
Processing 00000000.tx.157: APM1 maps to the region of 3q linked to T2D (47, 103) and the dysmetabolic syndrome (57). 

Phrase: "APM1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1540187:APM1 [Gene or Genome]
  1000   C2986675:APM1 [Gene or Genome]

Phrase: "maps to the region of 3q"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0017446:Region [Geographic Area]
   753   C0024779:Map [Manufactured Object]
   753   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205147:Region [Spatial Concept]
   753   C1521299:3q [Nucleotide Sequence]
   753   C1706473:Map [Conceptual Entity]

Phrase: "linked to T2D"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "(47,"

Phrase: "103"

Phrase: ")"

Phrase: "and"

Phrase: "the dysmetabolic syndrome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1262289:dysmetabolic syndrome [Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.158: Initial indications are that variation within APM1 may modulate adiponectin plasma levels and insulin sensitivity and contribute to an increase in the risk for T2D (47), although further work is required. 

Phrase: "Initial indications"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0392360:Indications [Idea or Concept]
   827 E C3146298:Indication [Functional Concept]

Phrase: "are"

Phrase: "that variation within APM1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205419:Variation [Qualitative Concept]

Phrase: "may"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "adiponectin plasma levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0032105:Plasma [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin sensitivity"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0920563:Insulin Sensitivity [Pathologic Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "contribute to an increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   770   C1880177:Contribute [Activity]

Phrase: "in the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "for T2D"

Phrase: "(47"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "further work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "is"

Phrase: "required."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]
Processing 00000000.tx.159: Additional fat-secreted proteins like secretin, interleukin-6, tumor necrosis factor-, or plasminogen activator inhibitor-1 represent additional attractive candidate genes for insulin resistance associated with obesity.  

Phrase: "Additional fat-secreted proteins like secretin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C2955668:fat proteins [Amino Acid, Peptide, or Protein]
   767 E C1435181:FAT Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interleukin-6,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021760:Interleukin-6 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1527132:interleukin 6 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "tumor necrosis factor-,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "or"

Phrase: "plasminogen activator inhibitor-1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0030190:Plasminogen Activator Inhibitor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418252:PLASMINOGEN ACTIVATOR INHIBITOR 1 [Gene or Genome]
   923   C0032145:Plasminogen activator inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1419349:activator 1 [Gene or Genome]
   861   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1418824:INHIBITOR 1 [Gene or Genome]
   812   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C1367553:PLASMINOGEN [Gene or Genome]
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "additional attractive candidate genes for insulin resistance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1332838:Candidate Genes [Gene or Genome]
   774   C2945710:resistance genes [Gene or Genome]
   757   C1337112:Insulin Gene [Gene or Genome]
   748   C0017337:Genes [Gene or Genome]

Phrase: "associated with obesity."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0028754:Obesity [Disease or Syndrome]
   790   C1963185:Obesity [Finding]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.160: INTEGRATING PHYSIOLOGY AND GENETICS TOP ABSTRACT INTRODUCTION FROM GENES TO PHYSIOLOGY FROM PHYSIOLOGY TO GENES INTEGRATING PHYSIOLOGY AND... 

Phrase: "INTEGRATING PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0031842:Physiology [Biomedical Occupation or Discipline]
   861   C0031843:physiology [Physiologic Function]
   789 E C0205463:Physiologic [Functional Concept]

Phrase: "AND"

Phrase: "GENETICS TOP ABSTRACT INTRODUCTION FROM GENES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1293116:Introduction [Health Care Activity]
   753   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "TO PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "FROM PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "TO GENES INTEGRATING PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0031842:Physiology [Biomedical Occupation or Discipline]
   827   C0031843:physiology [Physiologic Function]
   755 E C0205463:Physiologic [Functional Concept]

Phrase: "AND..."
Processing 00000000.tx.161: REFERENCES It is clear, as reflected in the growth of new terms such as physiological genomics and integrative physiology, that scientific progress in the understanding of multifactorial metabolic conditions such as T2D and obesity increasingly calls for integration of physiological and genetic approaches. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1514811:Reference [Idea or Concept]
   966   C1706462:Reference [Conceptual Entity]

Phrase: "It"

Phrase: "is"

Phrase: "clear,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "as"

Phrase: "reflected in the growth of new terms"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   774   C0027651:New growth [Neoplastic Process]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0205314:New [Temporal Concept]
   748   C0220844:growth [Physiologic Function]
   748   C0558058:reflected [Mental Process]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2911660:Growth [Activity]
   714   C1515273:Term [Temporal Concept]
   714   C1705313:Term [Idea or Concept]
   714   C2826302:TERM [Intellectual Product]

Phrase: "such as physiological genomics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "integrative physiology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0031842:Physiology [Biomedical Occupation or Discipline]
   861   C0031843:physiology [Physiologic Function]
   789 E C0205463:Physiologic [Functional Concept]

Phrase: "that scientific progress in the understanding of multifactorial metabolic conditions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1272688:progress [Functional Concept]
   739   C1280477:Progress [Functional Concept]

Phrase: "such as T2D"

Phrase: "and"

Phrase: "obesity increasingly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0028754:Obesity [Disease or Syndrome]
   861   C1963185:Obesity [Finding]

Phrase: "calls for integration of physiological"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205463:Physiological [Functional Concept]
   760   C0679006:Call [Mental Process]
   760   C1158478:Integration [Genetic Function]
   760   C1705422:Integration [Machine Activity]
   760   C1947967:Call [Functional Concept]

Phrase: "and"

Phrase: "genetic approaches."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449445:Approaches [Spatial Concept]
   861   C1292724:Approaches [Functional Concept]
Processing 00000000.tx.162: Several factors are contributing to the momentum in this direction. 

Phrase: "Several factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "contributing to the momentum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0563597:Momentum [Natural Phenomenon or Process]
   770   C1880177:Contributing [Activity]

Phrase: "in this direction."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0449738:Direction [Spatial Concept]
   900 E C1707761:Directionality [Functional Concept]
   900 E C3274524:Directionality [Functional Concept]
Processing 00000000.tx.163: First, it is increasingly evident that latent pathophysiological heterogeneity has a withering effect on the power of both physiological and genetic approaches to the discovery of etiological pathways. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "increasingly evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0332120:Evidence [Functional Concept]

Phrase: "that latent pathophysiological heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0019409:Heterogeneity [Qualitative Concept]
   743 E C1512426:Heterogenous [Idea or Concept]

Phrase: "has"

Phrase: "a withering effect on the power of both physiological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "genetic approaches to the discovery of etiological pathways."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0449445:Approaches [Spatial Concept]
   744   C1292724:Approaches [Functional Concept]
Processing 00000000.tx.164: Attempts to reduce such heterogeneity through stratification approaches that permit either detailed physiological measurements to be performed on genetically defined subsets (17, 18, 101) or, equally, genetic analyses on physiologically defined strata (64, 103, 106) may enhance capacity to tease out complex genotype-phenotype correlations. 

Phrase: "Attempts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "such heterogeneity through stratification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449445:Approach [Spatial Concept]
  1000   C1292724:Approaches [Functional Concept]

Phrase: "that"

Phrase: "permit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "either detailed physiological measurements to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0242485:measurements [Functional Concept]
   773   C0199213:Physiologic measurement [Diagnostic Procedure]

Phrase: "be"

Phrase: "performed on genetically defined subsets"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0884358:Performed [Functional Concept]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]
   726   C1515021:Subset [Classification]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(17,"

Phrase: "18,"

Phrase: "101"

Phrase: ")"

Phrase: "or"

Phrase: ","

Phrase: "equally,"

Phrase: "genetic analyses on physiologically defined strata"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C0679560:genetic analysis [Laboratory Procedure]
   773   C0796344:Genetic Analysis [Laboratory Procedure]
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "(64,"

Phrase: "103,"

Phrase: "106"

Phrase: ")"

Phrase: "may"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "tease"

Phrase: "out complex genotype-phenotype correlations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C2717879:Genotype-Phenotype Correlations [Finding]
   771   C1707520:Correlation [Qualitative Concept]
Processing 00000000.tx.165: Multivariate approaches to genetic analysis designed to allow combined analysis of multiple physiological parameters (5, 14, 24, 57, 90, 105) have similar objectives. 

Phrase: "Multivariate approaches to genetic analysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449445:Approaches [Spatial Concept]
   760   C1292724:Approaches [Functional Concept]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "combined analysis of multiple physiological parameters"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "14,"

Phrase: "24,"

Phrase: "57,"

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "105"

Phrase: ")"

Phrase: "have"

Phrase: "similar objectives."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0018017:objectives [Intellectual Product]
   827 E C1571702:Objective [Qualitative Concept]
Processing 00000000.tx.166: Second, the increasing power and genome-wide reach of transcriptional, proteomic, and metabonomic analyses provide a multidimensional "bridge" from the genomic to the physiological. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "the increasing power"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "and"

Phrase: "genome-wide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0017428:Genome [Gene or Genome]
   861   C0332464:Wide [Spatial Concept]
   861   C2338314:Genome [Conceptual Entity]

Phrase: "reach of transcriptional, proteomic,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0040649:Transcriptional [Genetic Function]
   770   C0872252:proteomic [Biomedical Occupation or Discipline]
   770   C2584321:Reach [Organism Function]

Phrase: "and"

Phrase: "metabonomic analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a multidimensional ""bridge"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456378:Bridge [Medical Device]

Phrase: "from the genomic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017428:Genomic [Gene or Genome]
  1000   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "to the physiological."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiological [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]
Processing 00000000.tx.167: Researchers now have access to multiple, complementary, intercorrelated descriptions of the cellular and metabolic status of an organism, which are far richer and far more complex than simple, discrete notions of physiological state (such as insulin resistance or diabetes) (102). 

Phrase: "Researchers now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035173:Researchers [Professional or Occupational Group]

Phrase: "have"

Phrase: "access to multiple, complementary, intercorrelated descriptions of the cellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0444454:Access [Spatial Concept]
   742   C1554204:access [Idea or Concept]

Phrase: "and"

Phrase: "metabolic status of an organism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449438:Status [Qualitative Concept]

Phrase: "which"

Phrase: "are"

Phrase: "far richer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0699759:Rich [Qualitative Concept]

Phrase: "and"

Phrase: "far more complex than simple, discrete notions of physiological state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C3546270:FAR complex [Cell Component]
   739   C0439855:Complex [Qualitative Concept]
   739   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "("

Phrase: "such as insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: ")"

Phrase: "(102"

Phrase: ")."
Processing 00000000.tx.168: Integrating the information from such diverse representations is a challenge but holds great promise. 

Phrase: "Integrating"

Phrase: "the information from such diverse representations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1533716:Information [Idea or Concept]

Phrase: "is"

Phrase: "a challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0798503:Challenge [Clinical Attribute]
  1000   C0805586:Challenge [Health Care Activity]
  1000   C3274764:Challenge [Conceptual Entity]

Phrase: "but"

Phrase: "holds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553387:Hold [Idea or Concept]
  1000   C1948035:Hold [Activity]

Phrase: "great promise."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1555307:promise [Idea or Concept]
Processing 00000000.tx.169: For example, such integration may, by relating typically noisy transcriptional data to contemporary or subsequent metabonomic and physiological events, allow those transcriptional changes that are consequential (e.g., those that reflect a given sequence variant) to be distinguished from those that are merely stochastic or epiphenomenal. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "such integration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1158478:Integration [Genetic Function]
  1000   C1705422:Integration [Machine Activity]

Phrase: "may"

Phrase: ","

Phrase: "by relating typically noisy transcriptional data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1511726:Data [Idea or Concept]
   804   C3245479:data [Medical Device]

Phrase: "to contemporary"

Phrase: "or"

Phrase: "subsequent metabonomic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1956136:Metabonomic [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "physiological events,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "those transcriptional changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "consequential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0686907:Consequence [Functional Concept]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "those"

Phrase: "that"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "a given sequence variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "distinguished from those"

Phrase: "that"

Phrase: "are"

Phrase: "merely stochastic"

Phrase: "or"

Phrase: "epiphenomenal."
Processing 00000000.tx.170: Finally, much of the work integrating physiological and genomic approaches will, initially at least, be conducted in animal models. 

Phrase: "Finally,"

Phrase: "much of the work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]

Phrase: "integrating"

Phrase: "physiological"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiological [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]

Phrase: "and"

Phrase: "genomic approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449445:Approaches [Spatial Concept]
   861   C1292724:Approaches [Functional Concept]

Phrase: "will"

Phrase: ","

Phrase: "initially at least,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205265:Initially [Temporal Concept]

Phrase: "be"

Phrase: "conducted in animal models."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0599779:Models, Animal [Animal]
   770   C0003062:Animal [Animal]
   770   C3161035:Models [Intellectual Product]
   737   C0004927:Conduct [Individual Behavior]
Processing 00000000.tx.171: The power of such research will inevitably be accelerated by current developments in the provision of improved rodent genomic resources, high-throughput projects to generate new disease models, and more sophisticated phenotyping tools (15). 

Phrase: "The power of such research"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "will"

Phrase: "inevitably"

Phrase: "be"

Phrase: "accelerated by current developments"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0521110:Accelerated [Functional Concept]
   770   C0521116:Current [Temporal Concept]
   770   C1705970:Current [Natural Phenomenon or Process]
   737   C0243107:development [Physiologic Function]
   737   C0678723:Development [Organism Function]
   737   C1527148:Development [Functional Concept]

Phrase: "in the provision"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1549071:Provisional [Idea or Concept]

Phrase: "of improved rodent genomic resources,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035201:Resources [Idea or Concept]

Phrase: "high-throughput"

Phrase: "projects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709701:Project [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "new disease models,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0683033:disease models [Intellectual Product]
   901   C0684309:disease models [Experimental Model of Disease]
   827   C3161035:Models [Intellectual Product]

Phrase: "and"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "sophisticated"

Phrase: "phenotyping tools"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0336791:Tool [Manufactured Object]
   827   C2827396:Tool [Manufactured Object]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.172: T2D remains an enigma: a strongly inherited, quintessentially metabolic trait that has yielded its secrets only slowly to genetic researchers and physiologists. 

Phrase: "T2D"

Phrase: "remains"

Phrase: "an enigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1427812:ENIGMA [Gene or Genome]

Phrase: ":"

Phrase: "a strongly"

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: ","

Phrase: "quintessentially metabolic trait"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0599883:Trait [Organism Attribute]

Phrase: "that"

Phrase: "has"

Phrase: "yielded"

Phrase: "its secrets only slowly to genetic researchers"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   748   C0035173:Researchers [Professional or Occupational Group]
   748   C0205171:Only [Quantitative Concept]
   748   C0314603:Genetic [Functional Concept]
   748   C0439834:Slowly [Qualitative Concept]
   748   C1720467:Only [Intellectual Product]
   714   C1424652:SECRET [Gene or Genome]

Phrase: "and"

Phrase: "physiologists."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0260141:Physiologists [Professional or Occupational Group]
Processing 00000000.tx.173: There is, however, every prospect, given the range of tools now available to researchers, that recent success in the dissection of monogenic and syndromic forms of diabetes will be followed by improved understanding of the molecular basis of the more common, multifactorial forms of this disease.  

Phrase: "There"

Phrase: "is"

Phrase: ","

Phrase: "however,"

Phrase: "every prospect,"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the range of tools"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514721:Range [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]

Phrase: "now available to researchers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]

Phrase: "that recent success in the dissection of monogenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597535:Success [Social Behavior]

Phrase: "and"

Phrase: "syndromic forms of diabetes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "will"

Phrase: "be"

Phrase: "followed by improved understanding of the molecular basis"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0332283:Followed by [Temporal Concept]
           followed
   770   C1853126:MOLECULAR BASIS [Idea or Concept]
   744   C0162340:Understanding [Mental Process]
   744   C0184511:Improved [Qualitative Concept]
   744   C0332272:Improved [Qualitative Concept]
   744   C1521991:Molecular [Qualitative Concept]
   744   C1527178:Basis [Functional Concept]
   744   C1561611:Improved [Intellectual Product]
   744   C1874451:Basis [Pharmacologic Substance]
   711 E C1719822:Follow [Intellectual Product]

Phrase: "of the more common, multifactorial forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0348078:forms [Qualitative Concept]
   812   C0376315:Forms [Manufactured Object]
   779 E C1522492:Form [Functional Concept]

Phrase: "of this disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.174: FOOTNOTES Address for reprint requests and other correspondence: M.McCarthy, IC Genetics and Genomics Research Institute, 2nd Floor, L Block, Imperial College (Hammersmith Campus), Hammersmith Hospital, Du Cane Road, London W12 0NN, UK (E-mail: m.mccarthy{at}ic.ac.uk ). 

Phrase: "FOOTNOTES Address for reprint requests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0376649:Address [Intellectual Product]
   760   C1442065:Address [Spatial Concept]

Phrase: "and"

Phrase: "other correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "M."

Phrase: "McCarthy,"

Phrase: "IC Genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: "and"

Phrase: "Genomics Research Institute,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0035172:Research Institute [Organization]
   901   C0887950:Genomics Research [Biomedical Occupation or Discipline]
   827   C0021622:institute [Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1272753:Institute [Idea or Concept]

Phrase: "2nd Floor,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0563054:2nd floor [Spatial Concept]
   861   C0016249:Floor [Manufactured Object]
   861   C1547707:Floor [Geographic Area]

Phrase: "L Block,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0028778:Block [Pathologic Function]
   861   C0332206:Block [Functional Concept]
   861   C1533157:Block [Substance]
   861   C1706084:Block [Geographic Area]
   861   C2828370:Block [Quantitative Concept]
   789 E C2983591:BLOCKED [Research Activity]

Phrase: "Imperial College"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0557806:College [Manufactured Object]

Phrase: "(Hammersmith Campus"

Phrase: ")"

Phrase: ","

Phrase: "Hammersmith Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Du Cane Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442650:Road [Manufactured Object]

Phrase: "London W12 0NN,"

Phrase: "UK"

Phrase: "(E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "m."

Phrase: "mccarthy{at}ic.ac.uk"

Phrase: ")."
Processing 00000000.tx.175: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.176: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.177: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.178: 10.1152/ajpendo.00099.2002  REFERENCES TOP ABSTRACT INTRODUCTION FROM GENES TO PHYSIOLOGY FROM PHYSIOLOGY TO GENES INTEGRATING PHYSIOLOGY AND... 

Phrase: "10.1152/ajpendo.00099.2002"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION FROM GENES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1293116:Introduction [Health Care Activity]
   760   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "TO PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "FROM PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "TO GENES INTEGRATING PHYSIOLOGY"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0031842:Physiology [Biomedical Occupation or Discipline]
   827   C0031843:physiology [Physiologic Function]
   755 E C0205463:Physiologic [Functional Concept]

Phrase: "AND..."
Processing 00000000.tx.179: REFERENCES 1.  

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.180: Almind, K, Inoue G, Pedersen O, and Kahn C. 

Phrase: "Almind,"

Phrase: "K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Inoue G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Pedersen O,"

Phrase: "and"

Phrase: "Kahn C."
Processing 00000000.tx.181: A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signalling. 

Phrase: "A common amino acid polymorphism in insulin receptor substrate-1 causes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0032529:Polymorphism [Genetic Function]
   738   C1882417:Polymorphism [Qualitative Concept]

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "insulin signalling."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C3537152:signalling [Biologic Function]
   827 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.182: Evidence from transfection studies. 

Phrase: "Evidence from transfection studies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.183: J Clin Invest 97: 2569-2575, 1996[Abstract/Free FullText]. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: ":"

Phrase: "2569-2575,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.184: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.185: Altshuler, D, Daly M, and Kruglyak L. 

Phrase: "Altshuler,"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Daly M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Kruglyak L."
Processing 00000000.tx.186: Guilt by association. 

Phrase: "Guilt by association."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0018379:Guilt [Mental Process]
Processing 00000000.tx.187: Nat Genet 26: 135-137, 2000[ISI][Medline]. 

Phrase: "Nat Genet 26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "135-137,"

Phrase: "2000"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.188: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.189: Altshuler, D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, and Lander ES. 

Phrase: "Altshuler,"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Hirschhorn JN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428813:JN [Gene or Genome]

Phrase: "Klannemark M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lindgren CM,"

Phrase: "Vohl MC,"

Phrase: "Nemesh J,"

Phrase: "Lane CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Schaffner SF,"

Phrase: "Bolk S,"

Phrase: "Brewer C,"

Phrase: "Tuomi T,"

Phrase: "Gaudet D,"

Phrase: "Hudson TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: "Daly M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Groop L,"

Phrase: "and"

Phrase: "Lander ES."
Processing 00000000.tx.190: The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2diabetes. 

Phrase: "The common PPARgamma Pro12Ala polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "associated with decreased risk of type 2diabetes."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0035647:Risk [Qualitative Concept]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C1547052:*Type [Quantitative Concept]
   714 E C0547047:Decrease [Quantitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.191: Nat Genet 26: 76-80, 2000[ISI][Medline]. 

Phrase: "Nat Genet 26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "76-80,"

Phrase: "2000"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.192: 4.  

Phrase: "4."
Processing 00000000.tx.193: Arita, Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, and Matsuzawa Y. 

Phrase: "Arita,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2811087:Arita [Eukaryote]

Phrase: "Y,"

Phrase: "Kihara S,"

Phrase: "Ouchi N,"

Phrase: "Takahashi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Maeda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Miyagawa J,"

Phrase: "Hotta K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Shimomura I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Nakamura T,"

Phrase: "Miyaoka K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kuriyama H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Nishida M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yamashita S,"

Phrase: "Okubo K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Matsubara K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Muraguchi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ohmoto Y,"

Phrase: "Funahashi T,"

Phrase: "and"

Phrase: "Matsuzawa Y."
Processing 00000000.tx.194: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. 

Phrase: "Paradoxical decrease of an adipose-specific protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "adiponectin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0389071:Adiponectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in obesity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]
Processing 00000000.tx.195: Biochem Biophys Res Commun 257: 79-83, 1999[ISI][Medline]. 

Phrase: "Biochem Biophys Res Commun 257"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "79-83,"

Phrase: "1999"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.196: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.197: Arya, R, Duggirala R, Almasy L, Rainwater DL, Mahaney MC, Cole S, Dyer TD, Williams K, Leach RJ, Hixson JE, MacCluer JW, O'Connell P, Stern MP, and Blangero J. 

Phrase: "Arya,"

Phrase: "R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Duggirala R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Almasy L,"

Phrase: "Rainwater DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Mahaney MC,"

Phrase: "Cole S,"

Phrase: "Dyer TD,"

Phrase: "Williams K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Leach"

Phrase: "RJ,"

Phrase: "Hixson JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "MacCluer JW,"

Phrase: "O'Connell P,"

Phrase: "Stern MP,"

Phrase: "and"

Phrase: "Blangero J."
Processing 00000000.tx.198: Linkage of high-density lipoprotein-cholesterol concentrations to a locus on chromosome 9p in Mexican Americans. 

Phrase: "Linkage of high-density lipoprotein-cholesterol concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0023745:linkage [Molecular Function]

Phrase: "to a locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708726:Locus [Gene or Genome]

Phrase: "on chromosome 9p"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1327811:chromosome 9p [Gene or Genome]
   861   C1515492:9p [Nucleotide Sequence]
   861   C1553562:9p [Body Part, Organ, or Organ Component]

Phrase: "in Mexican Americans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025884:Mexican Americans [Population Group]
   861   C0596070:americans [Population Group]
Processing 00000000.tx.199: Nat Genet 30: 102-105, 2002[ISI][Medline]. 

Phrase: "Nat Genet 30"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "102-105,"

Phrase: "2002"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.200: 6.  

Phrase: "6."
Processing 00000000.tx.201: Barroso, I, Gurnell M, Crowley VEF, Agostini M, Schwabe JW, Soos MA, Maslen GL, Williams TDM, Lewis H, Schafer AJ, Chatterjee VKK, and O'Rahilly S. 

Phrase: "Barroso,"

Phrase: "I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gurnell M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Crowley VEF,"

Phrase: "Agostini M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Schwabe JW,"

Phrase: "Soos MA,"

Phrase: "Maslen GL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018229:GL [Geographic Area]
   861   C1423073:GL [Gene or Genome]
   861   C1427674:GL [Gene or Genome]

Phrase: "Williams TDM,"

Phrase: "Lewis H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Schafer AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Chatterjee VKK,"

Phrase: "and"

Phrase: "O'Rahilly S."
Processing 00000000.tx.202: Dominant negative mutations in human PPAR associated with severe insulin resistance, diabetes mellitus, and hypertension. 

Phrase: "Dominant negative mutations in human PPAR"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   816   C1512032:Dominant-Negative Mutation [Cell or Molecular Dysfunction]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with severe insulin resistance,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205082:Severe [Qualitative Concept]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "diabetes mellitus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "hypertension."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]
Processing 00000000.tx.203: Nature 402: 880-883, 1999[ISI][Medline]. 

Phrase: "Nature 402"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "880-883,"

Phrase: "1999"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.204: 7.  

Phrase: "7."
Processing 00000000.tx.205: Bennett, ST, and Todd JA. 

Phrase: "Bennett,"

Phrase: "ST,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]

Phrase: "and"

Phrase: "Todd JA."
Processing 00000000.tx.206: Human type 1diabetes and the insulin gene: principles of mapping polygenes. 

Phrase: "Human type 1diabetes"

Phrase: "and"

Phrase: "the insulin gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337112:Insulin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: ":"

Phrase: "principles of mapping polygenes."
Processing 00000000.tx.207: Annu Rev Genet 30: 343-370, 1996[ISI][Medline]. 

Phrase: "Annu Rev Genet 30"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0325074:Genet [Mammal]
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "343-370,"

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.208: 8.  

Phrase: "8."
Processing 00000000.tx.209: Bennett, ST, Todd JA, Waterworth DM, Franks S, and McCarthy MI. 

Phrase: "Bennett,"

Phrase: "ST,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]

Phrase: "Todd JA,"

Phrase: "Waterworth DM,"

Phrase: "Franks S,"

Phrase: "and"

Phrase: "McCarthy MI."
Processing 00000000.tx.210: Association of insulin VNTR polymorphism with polycystic ovarian syndrome. 

Phrase: "Association of insulin VNTR polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with polycystic ovarian syndrome."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032460:Polycystic Ovarian Syndrome [Disease or Syndrome]
   827   C0039082:Syndrome [Disease or Syndrome]
Processing 00000000.tx.211: Lancet 349: 1771-1772, 1997[ISI][Medline]. 

Phrase: "Lancet 349"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ":"

Phrase: "1771-1772,"

Phrase: "1997"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.212: 9.  

Phrase: "9."
Processing 00000000.tx.213: Bingham, C, Bulman MP, Ellard S, Allen LI, Lipkin GW, Hoff WG, Woolf AS, Rizzoni G, Novelli G, Nicholls AJ, and Hattersley AT. 

Phrase: "Bingham,"

Phrase: "C,"

Phrase: "Bulman MP,"

Phrase: "Ellard S,"

Phrase: "Allen LI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Lipkin GW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018387:GW [Geographic Area]

Phrase: "Hoff WG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043092:WG [Disease or Syndrome]

Phrase: "Woolf AS,"

Phrase: "Rizzoni G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Novelli G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Nicholls AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "and"

Phrase: "Hattersley AT."
Processing 00000000.tx.214: Mutations in the HNF1-beta gene are associated with familial hypoplastic glomerulocystic kidney disease. 

Phrase: "Mutations in the HNF1-beta gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "associated with familial hypoplastic glomerulocystic kidney disease."
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   853   C0431693:Glomerulocystic kidney, familial hypoplastic [Congenital Abnormality,Disease or Syndrome]
   778   C0022658:Kidney disease [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C0243083:associated disease [Pathologic Function]
   774   C0266295:Hypoplastic kidney [Congenital Abnormality]
   774   C0277558:Familial disease [Disease or Syndrome]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0015576:familial [Family Group]
   748   C0022646:Kidney [Body Part, Organ, or Organ Component]
   748   C0227665:kidney [Body Part, Organ, or Organ Component]
   748   C0241888:Familial [Functional Concept]
   748   C0543481:Hypoplastic [Functional Concept]
   748   C1278978:Kidney [Body Part, Organ, or Organ Component]
   748   C1514845:KIDNEY [Tissue]
   738 E C0344339:disease family [Finding]
   728   C0027706:Nephritis, Familial [Disease or Syndrome]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.215: Am J Hum Genet 68: 219-224, 2001[ISI][Medline]. 

Phrase: "Am"

Phrase: "J Hum Genet 68"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0325074:Genet [Mammal]
   812   C0450387:68 [Intellectual Product]

Phrase: ":"

Phrase: "219-224,"

Phrase: "2001"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.216: 10.  

Phrase: "10."
Processing 00000000.tx.217: Bingham, C, Ellard S, Allen L, Bulman M, Shepherd M, Frayling T, Berry PJ, Clark PM, Lindner T, Bell GI, Ryffel GU, Nicholls AJ, and Hattersley AT. 

Phrase: "Bingham,"

Phrase: "C,"

Phrase: "Ellard S,"

Phrase: "Allen L,"

Phrase: "Bulman M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Shepherd M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Frayling T,"

Phrase: "Berry PJ,"

Phrase: "Clark PM, Lindner T,"

Phrase: "Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Ryffel GU,"

Phrase: "Nicholls AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "and"

Phrase: "Hattersley AT."
Processing 00000000.tx.218: Abnormal nephron development associated with a frameshift mutation in the transcription factor HNF-1 beta. 

Phrase: "Abnormal nephron development"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   913   C0000768:Abnormal development [Congenital Abnormality]
   901   C2755024:nephron development [Organ or Tissue Function]
   827   C0243107:development [Physiologic Function]
   827   C0678723:Development [Organism Function]
   827   C1527148:Development [Functional Concept]
   755 E C0458003:Developmental [Qualitative Concept]

Phrase: "associated with a frameshift mutation"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0079380:Frame Shift Mutation [Cell or Molecular Dysfunction]
           Frameshift
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1282684:Frame-shift mutation [Laboratory or Test Result]
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the transcription factor HNF-1 beta."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0126037:HNF-1 Beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0330390:Beta [Plant]
   804   C0439096:Beta [Intellectual Product]
   804   C2004068:Beta [Qualitative Concept]
   722   C0209278:Transcription Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   722   C1420631:TRANSCRIPTION FACTOR 1 [Gene or Genome]
Processing 00000000.tx.219: Kidney Int 57: 898-907, 2000[ISI][Medline]. 

Phrase: "Kidney Int 57"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0022646:Kidney [Body Part, Organ, or Organ Component]
   827   C0063789:INT [Organic Chemical]
   827   C0227665:kidney [Body Part, Organ, or Organ Component]
   827   C1278978:Kidney [Body Part, Organ, or Organ Component]
   827   C1514845:KIDNEY [Tissue]
   827   C3272375:INT [Intellectual Product]
   734 E C0027697:Nephritides [Disease or Syndrome]

Phrase: ":"

Phrase: "898-907,"

Phrase: "2000"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.220: 11.  

Phrase: "11."
Processing 00000000.tx.221: Boj, SF, Parrizas M, Maestro MA, and Ferrer J. 

Phrase: "Boj,"

Phrase: "SF,"

Phrase: "Parrizas M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Maestro MA,"

Phrase: "and"

Phrase: "Ferrer J."
Processing 00000000.tx.222: A transcription factor regulatory circuit in differentiated pancreatic cells. 

Phrase: "A transcription factor regulatory circuit in differentiated pancreatic cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   764   C0678662:regulatory circuit [Physiologic Function]
Processing 00000000.tx.223: Proc Natl Acad Sci USA 98: 14481-14486, 2001[Abstract/Free FullText]. 

Phrase: "Proc Natl Acad Sci USA 98"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "14481-14486,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.224: 12.  

Phrase: "12."
Processing 00000000.tx.225: Boutin, P, Chvre JC, Hani EH, Gomis R, Pardini VC, Guillausseau P-J, Vaxillaire M, Velho G, and Froguel P. 

Phrase: "Boutin,"

Phrase: "P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Chvre JC,"

Phrase: "Hani EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Gomis R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Pardini VC,"

Phrase: "Guillausseau P-J,"

Phrase: "Vaxillaire M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Velho G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Froguel P."
Processing 00000000.tx.226: An automated fluorescent single-strand conformation polymorphism technique for screening mutations in the hepatocyte nuclear factor-1 gene (maturity-onset diabetes of the young). 

Phrase: "An automated fluorescent single-strand conformation polymorphism technique for screening mutations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0456979:Automated technique [Therapeutic or Preventive Procedure]
   738   C0449851:Technique [Functional Concept]
   712   C0807878:screening techniques [Finding]

Phrase: "in the hepatocyte nuclear factor-1 gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0017337:Gene [Gene or Genome]
   771   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
   717   C0069116:Nuclear Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(maturity-onset diabetes of the young"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
  1000   C2984262:Maturity onset diabetes of the young [Functional Concept]
   833   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C0449989:Maturity [Qualitative Concept]
   753   C0700597:Maturity [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.227: Diabetes 46: 2108-2109, 1997[ISI][Medline]. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "2108-2109,"

Phrase: "1997"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.228: 13.  

Phrase: "13."
Processing 00000000.tx.229: Bowden, DW, Sale M, Howard TD, Qadri A, Spray BJ, Rothschild CB, Akots G, Rich SS, and Freedman BI. 

Phrase: "Bowden,"

Phrase: "DW,"

Phrase: "Sale M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Howard TD,"

Phrase: "Qadri A,"

Phrase: "Spray BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Rothschild CB,"

Phrase: "Akots G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Rich SS,"

Phrase: "and"

Phrase: "Freedman BI."
Processing 00000000.tx.230: Linkage of genetic markers on human chromosomes 20and 12to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. 

Phrase: "Linkage of genetic markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0023745:genetic linkage [Molecular Function]
           linkage

Phrase: "on human chromosomes 20and 12to NIDDM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0011860:NIDDM [Disease or Syndrome]
   804   C3273872:NIDDM [Gene or Genome]

Phrase: "in Caucasian sib pairs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037047:Sib [Family Group]
   827   C1709450:Pair [Qualitative Concept]

Phrase: "with a history"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0019664:History [Occupation or Discipline]
  1000   C0019665:history [Intellectual Product]
  1000   C0262512:History, NOS [Organism Attribute]
  1000   C0262926:History [Finding]
  1000   C1705255:History [Conceptual Entity]
  1000   C2004062:History [Finding]
   928 E C1552658:Historical [Idea or Concept]
   928 E C1552723:Historical [Idea or Concept]

Phrase: "of diabetic nephropathy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0011881:Diabetic Nephropathy [Disease or Syndrome]
  1000   C1442864:diabetic nephropathy [Gene or Genome]
   861   C0022658:Nephropathy [Disease or Syndrome]
   861   C0241863:DIABETIC [Finding]
Processing 00000000.tx.231: Diabetes 46: 882-886, 1997[Abstract]. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "882-886,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.232: 14.  

Phrase: "14."
Processing 00000000.tx.233: Broeckel, U, Hengstenberg C, Mayer B, Holmer S, Martin LJ, Comuzzie AG, Blangero J, Nrnberg P, Reis A, Riegger GAJ, Jacob HJ, and Schunkert H. 

Phrase: "Broeckel,"

Phrase: "U,"

Phrase: "Hengstenberg C,"

Phrase: "Mayer B,"

Phrase: "Holmer S,"

Phrase: "Martin LJ,"

Phrase: "Comuzzie AG,"

Phrase: "Blangero J,"

Phrase: "Nrnberg P,"

Phrase: "Reis A,"

Phrase: "Riegger GAJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826262:GAJ [Gene or Genome]

Phrase: "Jacob HJ,"

Phrase: "and"

Phrase: "Schunkert H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.234: A comprehensive linkage analysis for myocardial infarction and its related risk factors. 

Phrase: "A comprehensive linkage analysis for myocardial infarction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0796345:linkage analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0023745:linkage [Molecular Function]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "its related risk factors."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035648:risk factors [Quantitative Concept]
   901   C1553898:risk factors [Idea or Concept]
   827   C0035647:Risk [Qualitative Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.235: Nat Genet 30: 210-214, 2002[ISI][Medline]. 

Phrase: "Nat Genet 30"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "210-214,"

Phrase: "2002"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.236: 15.  

Phrase: "15."
Processing 00000000.tx.237: Brown, SDM, and Nolan PM. 

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "SDM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0643808:SDM [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Nolan"

Phrase: "PM."
Processing 00000000.tx.238: Mouse mutagenesissystematic studies of mammalian gene function. 

Phrase: "Mouse mutagenesissystematic studies of mammalian gene function."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   774   C1273305:Gene studies [Laboratory Procedure]
   748   C0947630:studies [Laboratory Procedure]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]
Processing 00000000.tx.239: Hum Mol Genet 7: 1627-1633, 1998[Abstract/Free FullText]. 

Phrase: "Hum Mol Genet 7"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "1627-1633,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.240: 16.  

Phrase: "16."
Processing 00000000.tx.241: Busfield, F, Duffy DL, Kesting JB, Walker SM, Lovelock PK, Good D, Tate H, Watego D, Marczak M, Hayman N, and Shaw JTE A genomewide search for type 2diabetes-susceptibility genes in indigenous Australians. 

Phrase: "Busfield,"

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Duffy DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Kesting JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Walker SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Lovelock PK,"

Phrase: "Good D,"

Phrase: "Tate H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Watego D,"

Phrase: "Marczak M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hayman N,"

Phrase: "and"

Phrase: "Shaw JTE"

Phrase: "A genomewide search for type 2diabetes-susceptibility genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1552603:search [Intellectual Product]
   744   C1706202:Search [Activity]

Phrase: "in indigenous Australians."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0238711:australians [Finding]
Processing 00000000.tx.242: Am J Hum Genet 70: 349-357, 2002[ISI][Medline]. 

Phrase: "Am"

Phrase: "J Hum Genet 70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "349-357,"

Phrase: "2002"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.243: 17.  

Phrase: "17."
Processing 00000000.tx.244: Byrne, MM, Sturis J, Clement K, Vionnet N, Pueyo ME, Stoffel M, Takeda J, Passa P, Cohen D, and Bell GI. 

Phrase: "Byrne,"

Phrase: "MM,"

Phrase: "Sturis J,"

Phrase: "Clement K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Vionnet N,"

Phrase: "Pueyo"

Phrase: "ME,"

Phrase: "Stoffel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Takeda J,"

Phrase: "Passa P,"

Phrase: "Cohen D,"

Phrase: "and"

Phrase: "Bell GI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]
Processing 00000000.tx.245: Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. 

Phrase: "Insulin secretory abnormalities in subjects"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   726 E C1704258:Abnormality [Finding]

Phrase: "with hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "due to glucokinase mutations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.246: J Clin Invest 93: 1120-1130, 1994[ISI][Medline]. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "93"

Phrase: ":"

Phrase: "1120-1130,"

Phrase: "1994"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.247: 18.  

Phrase: "18."
Processing 00000000.tx.248: Byrne, MM, Sturis J, Menzel S, Yamagata K, Fajans SS, Dronsfield MJ, Bain SC, Hattersley AT, Velho G, Froguel P, Bell GI, and Polonsky KS. 

Phrase: "Byrne,"

Phrase: "MM,"

Phrase: "Sturis J,"

Phrase: "Menzel S,"

Phrase: "Yamagata K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Fajans SS,"

Phrase: "Dronsfield MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Bain SC,"

Phrase: "Hattersley AT,"

Phrase: "Velho G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Froguel P,"

Phrase: "Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "and"

Phrase: "Polonsky KS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]
Processing 00000000.tx.249: Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. 

Phrase: "Altered insulin secretory responses to glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "in diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "nondiabetic subjects with mutations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "in the diabetes susceptibility gene MODY3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1838100:MODY3 [Disease or Syndrome]
   812   C3273648:MODY3 [Gene or Genome]

Phrase: "on chromosome 12."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008654:Chromosome 12 [Cell Component]
   861   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.250: Diabetes 45: 1503-1510, 1996[Abstract]. 

Phrase: "Diabetes 45"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "1503-1510,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.251: 19.  

Phrase: "19."
Processing 00000000.tx.252: Cardon, LR, and Bell JI. 

Phrase: "Cardon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0997028:Cardoon [Plant]

Phrase: "LR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023617:LR [Geographic Area]
  1000   C2986899:LR [Idea or Concept]

Phrase: "and"

Phrase: "Bell JI."
Processing 00000000.tx.253: Association study designs for complex diseases. 

Phrase: "Association study designs for complex diseases."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C0035171:Study Design [Research Activity]
   756   C2983265:Study Design [Intellectual Product]
           DESIGN
   756   C2986888:Study Design [Research Activity]
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]
   719   C1707689:Design [Activity]
Processing 00000000.tx.254: Nat Rev Genet 2: 91-99, 2001[ISI][Medline]. 

Phrase: "Nat Rev Genet 2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0796518:NAT-2 [Gene or Genome]
   902   C1261253:NAT-2 [Amino Acid, Peptide, or Protein,Enzyme]
   902   C1705514:NAT-2 [Gene or Genome]
   812   C0325074:Genet [Mammal]
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "91-99,"

Phrase: "2001"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.255: 20.  

Phrase: "20."
Processing 00000000.tx.256: Chvre, J-C, Hani EH, Boutin P, Vaxillaire M, Blanche H, Vionnet N, Pardini VC, Timsit J, Larger E, Charpentier G, Beckers D, Maes M, Bellanne-Chantelot C, Velho G, and Froguel P. 

Phrase: "Chvre,"

Phrase: "J-C,"

Phrase: "Hani EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Boutin P,"

Phrase: "Vaxillaire M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Blanche H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Vionnet N,"

Phrase: "Pardini VC,"

Phrase: "Timsit J,"

Phrase: "Larger E,"

Phrase: "Charpentier G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Beckers D,"

Phrase: "Maes M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bellanne-Chantelot C,"

Phrase: "Velho G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Froguel P."
Processing 00000000.tx.257: Mutation screening in 18Caucasian families suggest the existence of other MODY genes. 

Phrase: "Mutation screening in 18Caucasian families"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0220908:Screening [Health Care Activity]
   760   C0220909:screening [Functional Concept]
   760   C1698960:screening [Intellectual Product]
   760   C1710031:Screening [Diagnostic Procedure]
   760   C1710477:SCREENING [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the existence of other MODY genes."
Processing 00000000.tx.258: Diabetologia 41: 1017-1023, 1998[ISI][Medline]. 

Phrase: "Diabetologia 41"

Phrase: ":"

Phrase: "1017-1023,"

Phrase: "1998"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.259: 21.  

Phrase: "21."
Processing 00000000.tx.260: Cox, NJ. 

Phrase: "Cox,"

Phrase: "NJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]
Processing 00000000.tx.261: Challenges in identifying genetic variation affecting susceptibility to type 2diabetes: examples from studies of the calpain-10 gene. 

Phrase: "Challenges in identifying genetic variation affecting susceptibility"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0805586:challenges [Health Care Activity]
   714 E C0798503:Challenge [Clinical Attribute]
   714 E C3274764:Challenge [Conceptual Entity]

Phrase: "to type 2diabetes"

Phrase: ":"

Phrase: "examples from studies of the calpain-10 gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1707959:Example [Conceptual Entity]
Processing 00000000.tx.262: Hum Mol Genet 10: 2301-2305, 2001[Abstract/Free FullText]. 

Phrase: "Hum Mol Genet 10"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "2301-2305,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.263: 22.  

Phrase: "22."
Processing 00000000.tx.264: Dahlman, I, Eaves IA, Kosoy R, Morrison VA, Heward J, Gough SCL, Allahabadia A, Franklyn JA, Tuomilehto J, Tuomilehto-Wolf E, Cucca F, Guja C, Ionescu-Tirgoviste C, Stevens H, Carr P, Nutland S, McKinney P, Shield JP, Wang W, Cordell HJ, Walker N, Todd JA, and Concannon P. 

Phrase: "Dahlman,"

Phrase: "I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Eaves IA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947960:Ia [Mammal]

Phrase: "Kosoy R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Morrison VA,"

Phrase: "Heward J,"

Phrase: "Gough SCL,"

Phrase: "Allahabadia A,"

Phrase: "Franklyn JA,"

Phrase: "Tuomilehto J,"

Phrase: "Tuomilehto-Wolf E,"

Phrase: "Cucca F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Guja C,"

Phrase: "Ionescu-Tirgoviste C,"

Phrase: "Stevens H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Carr P,"

Phrase: "Nutland S,"

Phrase: "McKinney P,"

Phrase: "Shield JP,"

Phrase: "Wang W,"

Phrase: "Cordell HJ,"

Phrase: "Walker N,"

Phrase: "Todd JA,"

Phrase: "and"

Phrase: "Concannon P."
Processing 00000000.tx.265: Parameters for reliable results in genetic association studies in common disease. 

Phrase: "Parameters for reliable results"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0449381:Parameters [Finding]
   737 E C0549193:Parameter [Spatial Concept]
   737 E C1704769:Parameter [Conceptual Entity]
   737 E C2350001:Parameter [Quantitative Concept]

Phrase: "in genetic association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1328885:genetic association [Occupation or Discipline]
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "studies in common disease."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205214:Common [Quantitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C1522138:Common [Functional Concept]
   770   C2603343:Study [Research Activity]
   770   C3245511:common [Intellectual Product]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.266: Nat Genet 30: 149-150, 2002[ISI][Medline]. 

Phrase: "Nat Genet 30"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "149-150,"

Phrase: "2002"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.267: 23.  

Phrase: "23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.268: Davies, JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SCL, Jenkins SC, Palmer SM, Balfour KM, Rowe BR, Farrall M, Barnett AH, Bain SC, and Todd JA. 

Phrase: "Davies,"

Phrase: "JL,"

Phrase: "Kawaguchi Y,"

Phrase: "Bennett ST,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "Copeman JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Cordell HJ,"

Phrase: "Pritchard LE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439090:LE [Idea or Concept]
   861   C1423767:LE [Gene or Genome]

Phrase: "Reed PW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242397:PW [Geographic Area]

Phrase: "Gough SCL,"

Phrase: "Jenkins SC,"

Phrase: "Palmer SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Balfour KM,"

Phrase: "Rowe BR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704648:Br. [Conceptual Entity]

Phrase: "Farrall M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Barnett AH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1836672:AH [Disease or Syndrome]

Phrase: "Bain SC,"

Phrase: "and"

Phrase: "Todd JA."
Processing 00000000.tx.269: A genome-wide search for human type 1diabetes susceptibility genes. 

Phrase: "A genome-wide search for human type 1diabetes susceptibility genes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1552603:search [Intellectual Product]
   739   C1706202:Search [Activity]
Processing 00000000.tx.270: Nature 371: 130-136, 1994[ISI][Medline]. 

Phrase: "Nature 371"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "130-136,"

Phrase: "1994"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.271: 24.  

Phrase: "24."
Processing 00000000.tx.272: Duggirala, R, Blangero J, Almasy L, Arya R, Dyer TD, Williams KL, Leach RJ, O'Connell P, and Stern MP. 

Phrase: "Duggirala,"

Phrase: "R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Blangero J,"

Phrase: "Almasy L,"

Phrase: "Arya R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Dyer TD,"

Phrase: "Williams KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1366480:KL [Gene or Genome]
   861   C1416656:KL [Gene or Genome]

Phrase: "Leach"

Phrase: "RJ,"

Phrase: "O'Connell P,"

Phrase: "and"

Phrase: "Stern MP."
Processing 00000000.tx.273: A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans. 

Phrase: "A major locus for fasting insulin concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: "insulin resistance on chromosome 6q"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "with strong pleiotropic effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "on obesity-related phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0031437:Phenotypes [Organism Attribute]
   793 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "in nondiabetic Mexican Americans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0025884:Mexican Americans [Population Group]
   827   C0596070:americans [Population Group]
Processing 00000000.tx.274: Am J Hum Genet 68: 1149-1164, 2001[ISI][Medline]. 

Phrase: "Am"

Phrase: "J Hum Genet 68"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0325074:Genet [Mammal]
   812   C0450387:68 [Intellectual Product]

Phrase: ":"

Phrase: "1149-1164,"

Phrase: "2001"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.275: 25.  

Phrase: "25."
Processing 00000000.tx.276: Dunger, DB, Ong KKL, Huxtable SJ, Sherriff A, Woods KA, Ahmed ML, Golding J, Pembrey ME, Ring S, the ALSPAC Study Team, Bennett ST, and Todd JA. 

Phrase: "Dunger,"

Phrase: "DB,"

Phrase: "Ong KKL,"

Phrase: "Huxtable SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Sherriff A,"

Phrase: "Woods KA,"

Phrase: "Ahmed ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Golding J,"

Phrase: "Pembrey"

Phrase: "ME,"

Phrase: "Ring S,"

Phrase: "the ALSPAC Study Team,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0871489:Team [Group]

Phrase: "Bennett ST,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "and"

Phrase: "Todd JA."
Processing 00000000.tx.277: Association of the INS VNTR with size at birth. 

Phrase: "Association of the INS VNTR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "at birth."
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
  1000   C0005615:Birth [Organism Function]
  1000   C1550722:birth [Idea or Concept]
  1000   C3245487:birth [Intellectual Product]
   944 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   944 E C0314603:Genetic [Functional Concept]
   944 E C0454729:Natal [Geographic Area]
   916 E C0035150:Reproduction [Organism Function]
   916 E C0079946:origin [Classification]
   916 E C0439659:Origin [Temporal Concept]
   916 E C1550512:origin [Intellectual Product]
   900 E C0559522:Genital [Body System]
   900 E C1546649:Genital [Intellectual Product]
   900 E C1550642:Genital [Body Substance]
   893 E C0205313:Original [Idea or Concept]
   893 E C2347409:Original [Occupational Activity]
   880 E C0598240:originality [Mental Process]
Processing 00000000.tx.278: Nat Genet 19: 98-100, 1998[ISI][Medline]. 

Phrase: "Nat Genet 19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "98-100,"

Phrase: "1998"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.279: 26.  

Phrase: "26."
Processing 00000000.tx.280: Editorial Freely associating. 

Phrase: "Editorial Freely associating."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0332281:associating [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.281: Nat Genet 22: 1-2, 1999[ISI][Medline]. 

Phrase: "Nat Genet 22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "1-2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0580272:1/2 [Intellectual Product]
  1000   C1519043:1-2 [Research Activity]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "1999"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.282: 27.  

Phrase: "27."
Processing 00000000.tx.283: Ehm, MG, Kkarnoub MC, Sakul H, Gottschalk K, Holt DC, Weber JL, Vaske D, Briley D, Briley L, Kopf J, McMillen P, Nguyen Q, Reisman M, Lai EH, Joslyn G, Shepherd NS, Bell C, Wagner MJ, Burns DK, and and the American Diabetes Association GENNID Study Group Genomewide search for type 2diabetes susceptibility genes in four American populations. 

Phrase: "Ehm,"

Phrase: "MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439269:mg% [Quantitative Concept]
  1000   C1960952:mg % [Quantitative Concept]
  1000   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Kkarnoub MC,"

Phrase: "Sakul H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Gottschalk K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Holt DC,"

Phrase: "Weber JL,"

Phrase: "Vaske D,"

Phrase: "Briley D,"

Phrase: "Briley L,"

Phrase: "Kopf J,"

Phrase: "McMillen P,"

Phrase: "Nguyen Q,"

Phrase: "Reisman M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lai EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Joslyn G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Shepherd NS,"

Phrase: "Bell C,"

Phrase: "Wagner MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Burns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006434:Burn [Injury or Poisoning]
  1000   C1550619:Burn [Substance]

Phrase: "DK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011318:DK [Geographic Area]

Phrase: "and"

Phrase: "and"

Phrase: "the American Diabetes Association GENNID Study Group Genomewide search for type 2diabetes susceptibility genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C1552603:search [Intellectual Product]
   734   C1706202:Search [Activity]

Phrase: "in four American populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
Processing 00000000.tx.284: Am J Hum Genet 66: 1871-1881, 2000[ISI][Medline]. 

Phrase: "Am"

Phrase: "J Hum Genet 66"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "1871-1881,"

Phrase: "2000"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.285: 28.  

Phrase: "28."
Processing 00000000.tx.286: Ek, J, Andersen G, Urhammer SA, Gaede PH, Drivsholm T, Borch-Johnsen K, Hansen T, and Pedersen O. 

Phrase: "Ek,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008415:EK [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "J,"

Phrase: "Andersen G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Urhammer SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Gaede PH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "Drivsholm T,"

Phrase: "Borch-Johnsen K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Hansen T,"

Phrase: "and"

Phrase: "Pedersen O."
Processing 00000000.tx.287: Mutation analysis of peroxisome proliferator-activated receptor- coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to type II diabetes mellitus. 

Phrase: "Mutation analysis of peroxisome proliferator-activated receptor- coactivator-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0796357:mutation analysis [Laboratory Procedure]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "(PGC-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418503:PGC [Gene or Genome]
   861   C3538998:PGC [Laboratory Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "relationships of identified amino acid polymorphisms"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0439849:Relationships [Qualitative Concept]
   719 E C1705630:Relationship [Idea or Concept]
   719 E C1706279:Relationship [Idea or Concept]
   719 E C3540605:Relationship [Intellectual Product]

Phrase: "to type II diabetes mellitus."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
  1000   C2984301:Type II diabetes mellitus [Functional Concept]
   875   C1320657:type diabetes [Finding]
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0441730:Type II [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.288: Diabetologia 44: 2220-2226, 2001[ISI][Medline]. 

Phrase: "Diabetologia 44"

Phrase: ":"

Phrase: "2220-2226,"

Phrase: "2001"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.289: 29.  

Phrase: "29."
Processing 00000000.tx.290: Elbein, SC, Hoffman MD, Teng K, Leppert MF, and Hasstedt SJ. 

Phrase: "Elbein,"

Phrase: "SC,"

Phrase: "Hoffman MD,"

Phrase: "Teng K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Leppert MF,"

Phrase: "and"

Phrase: "Hasstedt SJ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]
Processing 00000000.tx.291: A genome-wide search for type 2diabetes susceptibility genes in Utah Caucasians. 

Phrase: "A genome-wide search for type 2diabetes susceptibility genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1552603:search [Intellectual Product]
   742   C1706202:Search [Activity]

Phrase: "in Utah Caucasians."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007457:Caucasians [Population Group]
   861   C0043157:Caucasians [Population Group]
Processing 00000000.tx.292: Diabetes 48: 1175-1182, 1999[Abstract]. 

Phrase: "Diabetes 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "1175-1182,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.293: 30.  

Phrase: "30."
Processing 00000000.tx.294: Evans, JC, Frayling TM, Cassell PG, Saker PJ, Hitman GA, Walker M, Levy JC, O'Rahilly S, Subba Rao PV, Bennett AJ, Jones EC, Menzel S, Prestwich P, Simecek N, Wishart M, Dhillon R, Fletcher C, Millward A, Demaine A, Wilkin T, Horikawa Y, Cox NJ, Bell GI, Ellard S, McCarthy MI, and Hattersley AT. 

Phrase: "Evans,"

Phrase: "JC,"

Phrase: "Frayling TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Cassell PG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]

Phrase: "Saker PJ,"

Phrase: "Hitman GA,"

Phrase: "Walker M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Levy JC,"

Phrase: "O'Rahilly S,"

Phrase: "Subba Rao PV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032463:PV [Neoplastic Process]

Phrase: "Bennett AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Jones EC,"

Phrase: "Menzel S,"

Phrase: "Prestwich P,"

Phrase: "Simecek N,"

Phrase: "Wishart M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Dhillon R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Fletcher C,"

Phrase: "Millward A,"

Phrase: "Demaine A,"

Phrase: "Wilkin T,"

Phrase: "Horikawa Y,"

Phrase: "Cox NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Ellard S,"

Phrase: "McCarthy MI,"

Phrase: "and"

Phrase: "Hattersley AT."
Processing 00000000.tx.295: Association studies of the calpain-10 gene with type 2diabetes mellitus in the United Kingdom. 

Phrase: "Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "studies of the calpain-10 gene"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0961737:calpain 10 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1413110:CALPAIN 10 [Gene or Genome]
   783   C1273305:Gene studies [Laboratory Procedure]
   753   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017337:Gene [Gene or Genome]
   753   C0557651:Study [Manufactured Object]
   753   C0947630:studies [Laboratory Procedure]
   753   C2603343:Study [Research Activity]

Phrase: "with type 2diabetes mellitus"

Phrase: "in the United Kingdom."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]
Processing 00000000.tx.296: Am J Hum Genet 69: 544-552, 2001[Medline]. 

Phrase: "Am"

Phrase: "J Hum Genet 69"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0325074:Genet [Mammal]
   812   C0450388:69 [Intellectual Product]

Phrase: ":"

Phrase: "544-552,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.297: 31.  

Phrase: "31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.298: Fajans, SS, Bell GI, and Polonsky KS. 

Phrase: "Fajans,"

Phrase: "SS,"

Phrase: "Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "and"

Phrase: "Polonsky KS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]
Processing 00000000.tx.299: Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. 

Phrase: "Molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "clinical pathophysiology of maturity-onset diabetes of the young."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031847:pathophysiology [Functional Concept]
   742   C0277785:Pathophysiology [Qualitative Concept]
Processing 00000000.tx.300: N Engl J Med 345: 971-980, 2001[Free FullText]. 

Phrase: "N Engl J Med 345"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1414400:ENGL [Gene or Genome]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ":"

Phrase: "971-980,"

Phrase: "2001"

Phrase: "[Free FullText"

Phrase: "]."
Processing 00000000.tx.301: 32.  

Phrase: "32."
Processing 00000000.tx.302: Fakhrai-Rad, H, Nikoshkov A, Kamel A, Fernstrm M, Zierath JR, Norgren S, Luthman H, and Galli J. 

Phrase: "Fakhrai-Rad,"

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nikoshkov A,"

Phrase: "Kamel A,"

Phrase: "Fernstrm M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zierath JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Norgren S,"

Phrase: "Luthman H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Galli J."
Processing 00000000.tx.303: Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. 

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "identified as a candidate diabetes susceptibility gene"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0919453:Susceptibility Gene [Gene or Genome]
   774   C1332838:Candidate Gene [Gene or Genome]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0012655:Susceptibility [Clinical Attribute]
   748   C0017337:Gene [Gene or Genome]
   748   C0205396:Identified [Qualitative Concept]
   748   C0220898:Susceptibility [Organism Attribute]
   748   C1264642:Susceptibility [Functional Concept]
   748   C1547045:*Susceptibility [Quantitative Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]

Phrase: "in GK rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.304: Hum Mol Genet 9: 2149-2158, 2000[Abstract/Free FullText]. 

Phrase: "Hum Mol Genet 9"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "2149-2158,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.305: 33.  

Phrase: "33."
Processing 00000000.tx.306: Froguel, P, and Velho G. 

Phrase: "Froguel,"

Phrase: "P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Velho G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.307: Molecular genetics of maturity-onset diabetes of the young. 

Phrase: "Molecular genetics of maturity-onset diabetes of the young."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   742   C0017398:Genetics [Biomedical Occupation or Discipline]
   742   C0017399:genetics [Biologic Function]
   742   C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.308: Trends Endocrinol Metab 10: 142-146, 1999[ISI][Medline]. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Endocrinol Metab 10"

Phrase: ":"

Phrase: "142-146,"

Phrase: "1999"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.309: 34.  

Phrase: "34."
Processing 00000000.tx.310: Froguel, P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, Permutt MA, Beckmann JS, Bell GI, and Cohen D. 

Phrase: "Froguel,"

Phrase: "P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Zouali H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Vionnet N,"

Phrase: "Velho G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Vaxillaire M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sun F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lesage S,"

Phrase: "Stoffel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Takeda J,"

Phrase: "Passa P,"

Phrase: "Permutt MA,"

Phrase: "Beckmann JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "and"

Phrase: "Cohen D."
Processing 00000000.tx.311: Familial hyperglycaemia due to mutations in glucokinase. 

Phrase: "Familial hyperglycaemia due to mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "in glucokinase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415014:GLUCOKINASE [Gene or Genome]
Processing 00000000.tx.312: Definition of a subtype of diabetes mellitus. 

Phrase: "Definition of a subtype of diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1550452:definition [Idea or Concept]
   748   C1704788:Definition [Conceptual Entity]
   748   C3539107:Definition [Intellectual Product]
Processing 00000000.tx.313: N Engl J Med 328: 697-702, 1993[Abstract/Free FullText]. 

Phrase: "N Engl J Med 328"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1414400:ENGL [Gene or Genome]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ":"

Phrase: "697-702,"

Phrase: "1993"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.314: 35.  

Phrase: "35."
Processing 00000000.tx.315: Fruebis, J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, and Lodish HF. 

Phrase: "Fruebis,"

Phrase: "J,"

Phrase: "Tsao TS,"

Phrase: "Javorschi S,"

Phrase: "Ebbets-Reed D,"

Phrase: "Erickson MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Yen FT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881534:ft. [Functional Concept]

Phrase: "Bihain"

Phrase: "BE"

Phrase: ","

Phrase: "and"

Phrase: "Lodish HF."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018488:Hf [Element, Ion, or Isotope]
   861   C1538440:HF [Gene or Genome]
   861   C3273279:HF [Gene or Genome]
Processing 00000000.tx.316: Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. 

Phrase: "Proteolytic cleavage product of 30-kDa adipocyte complement-related protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C0597304:Protein Cleavage [Molecular Function]
   739   C0010813:cleavage [Cell Function]
   739   C0596311:Cleavage [Phenomenon or Process]
   739   C1330957:cleavage [Cell Function]
   739   C1514468:product [Entity]
   739   C1704444:Product [Quantitative Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "fatty acid oxidation in muscle"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C1158366:fatty acid oxidation [Molecular Function]
   806   C0015684:Fatty acid [Lipid]
   760   C0001128:Acid [Chemical]
   760   C0030011:Oxidation [Molecular Function]
   760   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "weight loss in mice."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0043096:WEIGHTLOSS [Finding]
   833   C2911645:Weight loss [Finding]
   770   C0005910:weight [Organism Attribute]
   770   C0043100:Weight [Quantitative Concept]
   770   C1305866:weight [Diagnostic Procedure]
   770   C1517945:Loss [Quantitative Concept]
   770   C1705104:Weight [Idea or Concept]
Processing 00000000.tx.317: Proc Natl Acad Sci USA 98: 2005-2010, 2001[Abstract/Free FullText]. 

Phrase: "Proc Natl Acad Sci USA 98"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "2005-2010,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.318: 36.  

Phrase: "36."
Processing 00000000.tx.319: Galli, J, Li LS, Glaser A, stenson CG, Jiao H, Fakhrai-Rad H, Jacob HJ, Lander ES, and Luthman H. 

Phrase: "Galli,"

Phrase: "J,"

Phrase: "Li LS,"

Phrase: "Glaser A,"

Phrase: "stenson CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "Jiao H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Fakhrai-Rad H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Jacob HJ,"

Phrase: "Lander ES,"

Phrase: "and"

Phrase: "Luthman H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.320: Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat. 

Phrase: "Genetic analysis of non-insulin dependent diabetes mellitus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0679560:genetic analysis [Laboratory Procedure]
   770   C0796344:Genetic Analysis [Laboratory Procedure]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   703   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
   703   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]

Phrase: "in the GK rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
Processing 00000000.tx.321: Nat Genet 12: 31-37, 1996[ISI][Medline]. 

Phrase: "Nat Genet 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "31-37,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.322: 37.  

Phrase: "37."
Processing 00000000.tx.323: Gauguier, D, Froguel P, Parent V, Bernard C, Bihoreau MT, Portha B, James MR, Penicaud L, Lathrop M, and Ktorza A. 

Phrase: "Gauguier,"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Froguel P,"

Phrase: "Parent V,"

Phrase: "Bernard C,"

Phrase: "Bihoreau MT,"

Phrase: "Portha B,"

Phrase: "James MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Penicaud L,"

Phrase: "Lathrop M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Ktorza A."
Processing 00000000.tx.324: Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat. 

Phrase: "Chromosomal mapping of genetic loci"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0008630:genetic mapping [Laboratory Procedure,Molecular Biology Research Technique]
           Chromosome Mapping
   760   C1283195:Mapping [Activity]

Phrase: "associated with non-insulin dependent diabetes"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   882   C0011860:Non-Insulin Dependent Diabetes [Disease or Syndrome]
   833   C0011854:Insulin Dependent Diabetes [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1518422:Non [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the GK rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
Processing 00000000.tx.325: Nat Genet 12: 38-43, 1996[ISI][Medline]. 

Phrase: "Nat Genet 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "38-43,"

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.326: 38.  

Phrase: "38."
Processing 00000000.tx.327: Gharani, N, Huxtable S, Li L-K, Humphries S, Hindmarsh P, and McCarthy M. 

Phrase: "Gharani,"

Phrase: "N,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Huxtable S,"

Phrase: "Li L-K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Humphries S,"

Phrase: "Hindmarsh P,"

Phrase: "and"

Phrase: "McCarthy M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.328: Parent-of-origin effect at the insulin gene locus: common genetic mechanism modulating disturbed early growth and risk of type 2diabetes (Abstract). 

Phrase: "Parent-of-origin effect at the insulin gene locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: ":"

Phrase: "common genetic mechanism modulating disturbed early growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0018270:'growth' NOS [Organism Function]
   795   C0220844:growth [Physiologic Function]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "risk of type 2diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.329: Diabetologia 44, Suppl1: A88, 2001. 

Phrase: "Diabetologia 44,"

Phrase: "Suppl1"

Phrase: ":"

Phrase: "A88,"

Phrase: "2001."
Processing 00000000.tx.330: 39.  

Phrase: "39."
Processing 00000000.tx.331: Ghosh, S, Watanabe RM, Hauser ER, Valle T, Magnuson VL, Erdos MR, Langefeld CD, Balow J, Ally DS, Kohtamaki K, Chines P, Birznieks G, Kaleta HS, Musick A, Te C, Tannenbaum J, Eldridge W, Shapiro S, Martin C, Witt A, So A, Chang J, Shurtleff B, Porter R, Kudelko K, Unni A, Segal L, Sharaf R, Blaschak-Harvan J, Eriksson J, Tenkula T, Vidgren G, Ehnholm C, Tuomilehto-Wolf E, Hagopian W, Buchanan TA, Tuomilehto J, Bergman RN, Collins FS, and Boehnke M. 

Phrase: "Ghosh,"

Phrase: "S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "Watanabe RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Hauser ER,"

Phrase: "Valle T,"

Phrase: "Magnuson VL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0228339:VL [Body Part, Organ, or Organ Component]
   861   C1424729:VL [Gene or Genome]
   861   C1858854:VL [Disease or Syndrome]

Phrase: "Erdos MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Langefeld CD,"

Phrase: "Balow J,"

Phrase: "Ally DS,"

Phrase: "Kohtamaki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Chines P,"

Phrase: "Birznieks G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Kaleta HS,"

Phrase: "Musick A,"

Phrase: "Te C,"

Phrase: "Tannenbaum J,"

Phrase: "Eldridge W,"

Phrase: "Shapiro S,"

Phrase: "Martin C,"

Phrase: "Witt A,"

Phrase: "So"

Phrase: "A,"

Phrase: "Chang J,"

Phrase: "Shurtleff B,"

Phrase: "Porter R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kudelko K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Unni A,"

Phrase: "Segal L,"

Phrase: "Sharaf R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Blaschak-Harvan J,"

Phrase: "Eriksson J,"

Phrase: "Tenkula T,"

Phrase: "Vidgren G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Ehnholm C,"

Phrase: "Tuomilehto-Wolf E,"

Phrase: "Hagopian W,"

Phrase: "Buchanan TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Tuomilehto J,"

Phrase: "Bergman RN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540639:RN [Gene or Genome]

Phrase: "Collins FS,"

Phrase: "and"

Phrase: "Boehnke M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.332: Type 2diabetes: evidence for linkage on chromosome 20in 716Finnish affected sib pairs. 

Phrase: "Type 2diabetes"

Phrase: ":"

Phrase: "evidence for linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332120:Evidence [Functional Concept]

Phrase: "on chromosome 20in 716Finnish"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "sib pairs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037047:Sib [Family Group]
   861   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.333: Proc Natl Acad Sci USA 96: 2198-2203, 1999[Abstract/Free FullText]. 

Phrase: "Proc Natl Acad Sci USA 96"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "2198-2203,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.334: 40.  

Phrase: "40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.335: Gidh-Jain, M, Taleda J, Xu LZ, Lange AJ, Vionnet N, Stoffel M, Froguel P, Velho G, Sun F, Cohen D, Patel P, Lo YMD, Hattersley AT, Luthman H, Wedell A, St Charles R, Harrison RW, Weber IT, Bell GI, and Pilkis SJ. 

Phrase: "Gidh-Jain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337694:Jain [Idea or Concept]
   861   C1998092:Jain [Population Group]

Phrase: "M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "Taleda J,"

Phrase: "Xu LZ,"

Phrase: "Lange AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Vionnet N,"

Phrase: "Stoffel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Froguel P,"

Phrase: "Velho G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Sun F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Cohen D,"

Phrase: "Patel P,"

Phrase: "Lo YMD,"

Phrase: "Hattersley AT,"

Phrase: "Luthman H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Wedell A,"

Phrase: "St Charles R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "Harrison RW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035978:RW [Geographic Area]
   861   C2700310:RW [Fish]

Phrase: "Weber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:weber [Quantitative Concept]

Phrase: "IT,"

Phrase: "Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "and"

Phrase: "Pilkis SJ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]
Processing 00000000.tx.336: Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. 

Phrase: "Glucokinase mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with non-insulin-dependent"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0851827:Dependent [Qualitative Concept]
   760   C1518422:Non [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(type 2) diabetes mellitus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
  1000   C2984301:Type II diabetes mellitus [Functional Concept]
   875   C1320657:type diabetes [Finding]
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "have"

Phrase: "decreased enzymatic activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0086439:Decreased activity [Sign or Symptom]
   901   C2267219:Enzymatic Activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: ":"

Phrase: "implications for structure/function relationships."
Processing 00000000.tx.337: Proc Natl Acad Sci USA 90: 1932-1936, 1993[Abstract]. 

Phrase: "Proc Natl Acad Sci USA 90"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C0439083:>90 [Quantitative Concept]
   799   C0439087:<90 [Quantitative Concept]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "1932-1936,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.338: 41.  

Phrase: "41."
Processing 00000000.tx.339: Gloyn, AL, and McCarthy MI. 

Phrase: "Gloyn,"

Phrase: "AL,"

Phrase: "and"

Phrase: "McCarthy MI."
Processing 00000000.tx.340: The genetics of type 2diabetes. 

Phrase: "The genetics of type 2diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017398:Genetics [Biomedical Occupation or Discipline]
   760   C0017399:genetics [Biologic Function]
Processing 00000000.tx.341: Best Pract Res Clin Endocrinol Metab 15: 293-308, 2001[ISI][Medline]. 

Phrase: "Best Pract Res Clin Endocrinol Metab 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C1315013:CLIN [Intellectual Product]
   795   C1522427:Best [Qualitative Concept]
   795   C2347379:RES [Finding]

Phrase: ":"

Phrase: "293-308,"

Phrase: "2001"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.342: 42.  

Phrase: "42."
Processing 00000000.tx.343: Hani, EH, Boutin P, Durand E, Inoue H, Permutt MA, Velho G, and Froguel P. 

Phrase: "Hani,"

Phrase: "EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520135:EH [Geographic Area]

Phrase: "Boutin P,"

Phrase: "Durand E,"

Phrase: "Inoue H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Permutt MA,"

Phrase: "Velho G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Froguel P."
Processing 00000000.tx.344: Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of type II diabetes mellitus in Caucasians. 

Phrase: "Missense mutations in the pancreatic islet beta cell inwardly"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   764   C0599155:Mutations, Missense [Genetic Function]
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "rectifying"

Phrase: "K+ channel gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "(KIR6.2/BIR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1416578:BIR [Gene or Genome]
           Kir6.2
   827   C3272365:BIR [Genetic Function]

Phrase: ")"

Phrase: ":"

Phrase: "a meta-analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a role in the polygenic basis of type II diabetes mellitus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]

Phrase: "in Caucasians."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007457:Caucasians [Population Group]
  1000   C0043157:Caucasians [Population Group]
Processing 00000000.tx.345: Diabetologia 41: 1511-1515, 1998[ISI][Medline]. 

Phrase: "Diabetologia 41"

Phrase: ":"

Phrase: "1511-1515,"

Phrase: "1998"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.346: 43.  

Phrase: "43."
Processing 00000000.tx.347: Hani, EH, Stoffers DA, Chvre J-C, Durand E, Stanojevic V, Dina C, Habener JF, and Froguel P. 

Phrase: "Hani,"

Phrase: "EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520135:EH [Geographic Area]

Phrase: "Stoffers DA,"

Phrase: "Chvre J-C,"

Phrase: "Durand E,"

Phrase: "Stanojevic V,"

Phrase: "Dina C,"

Phrase: "Habener JF,"

Phrase: "and"

Phrase: "Froguel P."
Processing 00000000.tx.348: Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2diabetes mellitus. 

Phrase: "Defective mutations in the insulin promoter factor-1 (IPF-1) gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C0596611:gene mutations [Genetic Function]
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in late-onset type 2diabetes mellitus."
Processing 00000000.tx.349: J Clin Invest 104: R41-R48, 1999[ISI][Medline]. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "104"

Phrase: ":"

Phrase: "R41-R48,"

Phrase: "1999"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.350: 44.  

Phrase: "44."
Processing 00000000.tx.351: Hanis, CL, Boerwinkle E, Chakraborty R, Ellsworth DL, Concannon P, Stirling B, Morrison VA, Wapelhorst B, Spielman RS, Gogolin-Ewens KJ, Shephard JM, Williams SR, Risch N, Hinds D, Iwasaki N, Ogata M, Omori Y, Petzold C, Rietzsch H, Schroder HE, Schulze J, Cox NJ, Menzel S, Boriraj VV, Chen X, Lim LR, Lindner T, Mereu LE, Wang YQ, Xiang K, Yamagata K, Yang Y, and Bell GI. 

Phrase: "Hanis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551922:Hanis [Language]

Phrase: "CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Boerwinkle E,"

Phrase: "Chakraborty R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Ellsworth DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Concannon P,"

Phrase: "Stirling B,"

Phrase: "Morrison VA,"

Phrase: "Wapelhorst B,"

Phrase: "Spielman RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Gogolin-Ewens KJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439255:kJ [Quantitative Concept]

Phrase: "Shephard JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Williams SR,"

Phrase: "Risch N,"

Phrase: "Hinds D,"

Phrase: "Iwasaki N,"

Phrase: "Ogata M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Omori Y,"

Phrase: "Petzold C,"

Phrase: "Rietzsch H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Schroder"

Phrase: "HE,"

Phrase: "Schulze J,"

Phrase: "Cox NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Menzel S,"

Phrase: "Boriraj VV,"

Phrase: "Chen X,"

Phrase: "Lim LR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023617:LR [Geographic Area]
   861   C2986899:LR [Idea or Concept]

Phrase: "Lindner T,"

Phrase: "Mereu LE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439090:LE [Idea or Concept]
   861   C1423767:LE [Gene or Genome]

Phrase: "Wang YQ,"

Phrase: "Xiang K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yamagata K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "Y,"

Phrase: "and"

Phrase: "Bell GI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]
Processing 00000000.tx.352: A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. 

Phrase: "A genome-wide search for human"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1552603:search [Intellectual Product]
   753   C1706202:Search [Activity]

Phrase: "non-insulin-dependent"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0851827:Dependent [Qualitative Concept]
   827   C1518422:Non [Functional Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C1701901:Dependent [Qualitative Concept]
   827   C3244310:dependent [Functional Concept]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(type 2) diabetes genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0017337:Genes [Gene or Genome]
   756   C0011860:Type 2 Diabetes [Disease or Syndrome]
   708   C1320657:type diabetes [Finding]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a major susceptibility locus on chromosome 2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.353: Nat Genet 13: 161-171, 1996[ISI][Medline]. 

Phrase: "Nat Genet 13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "161-171,"

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.354: 45.  

Phrase: "45."
Processing 00000000.tx.355: Hansen, T, Echwald SM, Hansen L, Mller AM, Almind K, Clausen JO, Urhammer SA, Inoue H, Ferrer J, Bryan J, Aguilar-Bryan L, Permutt MA, and Pedersen O. 

Phrase: "Hansen,"

Phrase: "T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Echwald SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Hansen L,"

Phrase: "Mller"

Phrase: "AM"

Phrase: ","

Phrase: "Almind K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Clausen JO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022418:JO [Geographic Area]

Phrase: "Urhammer SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Inoue H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ferrer J,"

Phrase: "Bryan J,"

Phrase: "Aguilar-Bryan L,"

Phrase: "Permutt MA,"

Phrase: "and"

Phrase: "Pedersen O."
Processing 00000000.tx.356: Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. 

Phrase: "Decreased tolbutamide-stimulated insulin secretion in healthy subjects"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   793   C1371675:Decreased Insulin Secretion [Organ or Tissue Function]
   770   C1256369:insulin secretion [Cell Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "with sequence variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "in the high-affinity sulfonylurea receptor gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1335671:Receptor Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.357: Diabetes 47: 598-605, 1998[Abstract]. 

Phrase: "Diabetes 47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "598-605,"

Phrase: "1998"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.358: 46.  

Phrase: "46."
Processing 00000000.tx.359: Hanson, RL, Ehm MG, Pettitt DJ, Prochazka M, Thompson DB, Timberlake D, Foroud T, Kobes S, Baier L, Burns DK, Almasy L, Blangero J, Garvey WT, Bennett PH, and Knowler WC. 

Phrase: "Hanson,"

Phrase: "RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419337:RL [Gene or Genome]
  1000   C3539667:RL [Gene or Genome]

Phrase: "Ehm MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Pettitt DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Prochazka M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Thompson DB,"

Phrase: "Timberlake D,"

Phrase: "Foroud T,"

Phrase: "Kobes S,"

Phrase: "Baier L,"

Phrase: "Burns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006434:Burn [Injury or Poisoning]
  1000   C1550619:Burn [Substance]

Phrase: "DK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011318:DK [Geographic Area]

Phrase: "Almasy L,"

Phrase: "Blangero J,"

Phrase: "Garvey WT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2700323:WT [Fish]

Phrase: "Bennett PH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "Knowler WC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]
Processing 00000000.tx.360: An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. 

Phrase: "An autosomal genomic scan for loci"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0034606:Scan [Diagnostic Procedure]
   753   C0441633:Scan [Diagnostic Procedure]
   753   C2826292:SCAN [Finding]

Phrase: "linked to type II diabetes mellitus"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   882   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
   882   C2984301:Type II diabetes mellitus [Functional Concept]
   790   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   790   C0441730:Type II [Classification]
   783   C1320657:Diabetes type [Finding]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "body-mass index in Pima Indians."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0005893:Body Mass Index [Diagnostic Procedure]
   833   C1305855:Body mass index [Clinical Attribute]
   790   C0518010:body mass [Finding]
   753   C0242821:body [Human]
   753   C0460148:Body [Anatomical Structure]
   753   C0577559:Mass [Finding]
   753   C0918012:Index [Intellectual Product]
   753   C1268086:Body [Anatomical Structure]
   753   C1306372:*Mass [Quantitative Concept]
   753   C1552854:index [Idea or Concept]
   753   C1637833:% index [Quantitative Concept]
   753   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.361: Am J Hum Genet 63: 1124-1132, 1998. 

Phrase: "Am"

Phrase: "J Hum Genet 63"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "1124-1132,"

Phrase: "1998."
Processing 00000000.tx.362: 47.  

Phrase: "47."
Processing 00000000.tx.363: Hara, K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, Kadowaki H, Hagura R, Akanuma Y, Yazaki Y, Nagai R, Taniyama M, Matsubara K, Yoda M, Nakano Y, Kimura S, Tomita M, Kimura S, Ito C, Froguel P, and Kadowaki T. 

Phrase: "Hara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2758676:Hara [Fish]

Phrase: "K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Boutin P,"

Phrase: "Mori Y,"

Phrase: "Tobe K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Dina C,"

Phrase: "Yasuda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yamauchi T,"

Phrase: "Otabe S,"

Phrase: "Okada T,"

Phrase: "Eto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kadowaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hagura R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Akanuma Y,"

Phrase: "Yazaki Y,"

Phrase: "Nagai R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Taniyama M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Matsubara K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yoda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nakano Y,"

Phrase: "Kimura S,"

Phrase: "Tomita M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kimura S,"

Phrase: "Ito C,"

Phrase: "Froguel P,"

Phrase: "and"

Phrase: "Kadowaki T."
Processing 00000000.tx.364: Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2diabetes in the Japanese population. 

Phrase: "Genetic variation in the gene encoding adiponectin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0042333:Genetic Variation [Natural Phenomenon or Process]
   748   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "associated with an increased risk of type 2diabetes"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0035647:Risk [Qualitative Concept]
   744   C0205217:Increased [Quantitative Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the Japanese population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.365: Diabetes 51: 536-540, 2002[Abstract/Free FullText]. 

Phrase: "Diabetes 51"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "536-540,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.366: 48.  

Phrase: "48."
Processing 00000000.tx.367: Hirschhorn, JN, Lindgren CM, Daly MJ, Kirby A, Schaffner SF, Burtt NP, Altshuler D, Parker A, Rioux JD, Platko J, Gaudet D, Hudson TJ, Groop LC, and Lander ES. 

Phrase: "Hirschhorn,"

Phrase: "JN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428813:JN [Gene or Genome]

Phrase: "Lindgren CM,"

Phrase: "Daly MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Kirby A,"

Phrase: "Schaffner SF,"

Phrase: "Burtt NP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706141:NP [Gene or Genome]

Phrase: "Altshuler D,"

Phrase: "Parker A,"

Phrase: "Rioux JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Platko J,"

Phrase: "Gaudet D,"

Phrase: "Hudson TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: "Groop LC,"

Phrase: "and"

Phrase: "Lander ES."
Processing 00000000.tx.368: Genomewide linkage analysis of stature in multiple populations reveals several regions with evidence of linkage to adult height. 

Phrase: "Genomewide linkage analysis of stature"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0796345:linkage analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0023745:linkage [Molecular Function]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in multiple populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "several regions with evidence of linkage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0017446:Region [Geographic Area]
   719   C0205147:Region [Spatial Concept]

Phrase: "to adult height."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0489786:Height [Organism Attribute]
   789 E C0205250:High [Qualitative Concept]
   789 E C1299351:High [Qualitative Concept]
   789 E C1522410:Highest [Qualitative Concept]
   789 E C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.369: Am J Hum Genet 69: 106-116, 2001[ISI][Medline]. 

Phrase: "Am"

Phrase: "J Hum Genet 69"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0325074:Genet [Mammal]
   812   C0450388:69 [Intellectual Product]

Phrase: ":"

Phrase: "106-116,"

Phrase: "2001"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.370: 49.  

Phrase: "49."
Processing 00000000.tx.371: Horikawa, Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Iwamoto Y, and Bell GI. 

Phrase: "Horikawa,"

Phrase: "Y,"

Phrase: "Iwasaki N,"

Phrase: "Hara M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Furuta H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hinokio Y,"

Phrase: "Cockburn BN,"

Phrase: "Lindner T,"

Phrase: "Yamagata K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ogata M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tomonaga O,"

Phrase: "Kuroki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kasahara T,"

Phrase: "Iwamoto Y,"

Phrase: "and"

Phrase: "Bell GI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]
Processing 00000000.tx.372: Mutation in hepatocyte nuclear factor-1 gene (TCF2) associated with MODY. 

Phrase: "Mutation in hepatocyte nuclear factor-1 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0596611:Gene Mutation [Genetic Function]
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(TCF2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420636:TCF2 [Gene or Genome]
  1000   C2348633:TCF2 [Gene or Genome]

Phrase: ")"

Phrase: "associated with MODY."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   909   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   909   C2984262:Maturity onset diabetes of the young [Functional Concept]
   800   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0332162:Onset [Qualitative Concept]
   744   C0332239:Young [Temporal Concept]
   744   C0449989:Maturity [Qualitative Concept]
   744   C0700597:Maturity [Temporal Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.373: Nat Genet 17: 384-385, 1997[ISI][Medline]. 

Phrase: "Nat Genet 17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "384-385,"

Phrase: "1997"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.374: 50.  

Phrase: "50."
Processing 00000000.tx.375: Horikawa, Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TM, Mashima H, Schwarz PEH, del Bosque-Plata L, Horikawa Y, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, and Bell GI. 

Phrase: "Horikawa,"

Phrase: "Y,"

Phrase: "Oda N,"

Phrase: "Cox NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Li X,"

Phrase: "Orho-Melander M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Hara M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hinokio Y,"

Phrase: "Lindner TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Mashima H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Schwarz PEH,"

Phrase: "del Bosque-Plata L,"

Phrase: "Horikawa Y,"

Phrase: "Oda Y,"

Phrase: "Yoshiuchi I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Colilla S,"

Phrase: "Polonsky KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Wei S,"

Phrase: "Concannon P,"

Phrase: "Iwasaki N,"

Phrase: "Schulze J,"

Phrase: "Baier LJ,"

Phrase: "Bogardus C,"

Phrase: "Groop L,"

Phrase: "Boerwinkle E,"

Phrase: "Hanis CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "Bell GI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]
Processing 00000000.tx.376: Genetic variation in the gene encoding calpain-10 is associated with type 2diabetes mellitus. 

Phrase: "Genetic variation in the gene encoding calpain-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0042333:Genetic Variation [Natural Phenomenon or Process]
   744   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "associated with type 2diabetes mellitus."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.377: Nat Genet 26: 163-175, 2000[ISI][Medline]. 

Phrase: "Nat Genet 26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "163-175,"

Phrase: "2000"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.378: 51.  

Phrase: "51."
Processing 00000000.tx.379: Hugot, J-P, Chamaillard M, Zouali H, Lesage S, Czard J-P, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel J-F, Sahbatou M, and Thomas G. 

Phrase: "Hugot,"

Phrase: "J-P,"

Phrase: "Chamaillard M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zouali H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Lesage S,"

Phrase: "Czard J-P,"

Phrase: "Belaiche J,"

Phrase: "Almer S,"

Phrase: "Tysk C,"

Phrase: "O'Morain CA,"

Phrase: "Gassull M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Binder V,"

Phrase: "Finkel Y,"

Phrase: "Cortot A,"

Phrase: "Modigliani R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Laurent-Puig P,"

Phrase: "Gower-Rousseau C,"

Phrase: "Macry J,"

Phrase: "Colombel J-F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Sahbatou M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Thomas G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.380: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. 

Phrase: "Association of NOD2 leucine-rich repeat variants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0012655:Susceptibility [Clinical Attribute]
  1000   C0220898:Susceptibility [Organism Attribute]
  1000   C1264642:Susceptibility [Functional Concept]
  1000   C1547045:*Susceptibility [Quantitative Concept]
   928 E C0231204:Susceptible [Functional Concept]
   928 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to Crohn's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0010346:Crohn Disease [Disease or Syndrome]
           Crohn's
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.381: Nature 411: 599-603, 2001[ISI][Medline]. 

Phrase: "Nature 411"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "599-603,"

Phrase: "2001"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.382: 52.  

Phrase: "52."
Processing 00000000.tx.383: Huxtable, SJ, Saker PJ, Haddad L, Hattersley AT, Walker M, Frayling TM, Levy JC, Hitman GA, O'Rahilly S, and McCarthy MI. 

Phrase: "Huxtable,"

Phrase: "SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515101:SJ [Geographic Area]
  1000   C2986905:SJ [Idea or Concept]

Phrase: "Saker PJ,"

Phrase: "Haddad L,"

Phrase: "Hattersley AT,"

Phrase: "Walker M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Frayling TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Levy JC,"

Phrase: "Hitman GA,"

Phrase: "O'Rahilly S,"

Phrase: "and"

Phrase: "McCarthy MI."
Processing 00000000.tx.384: Analysis of parent-offspring trios provides evidence for linkage and association between the insulin gene and type 2diabetes mediated exclusively through paternally transmitted class III variable number tandem repeat alleles. 

Phrase: "Analysis of parent-offspring trios"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "evidence for linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332120:Evidence [Functional Concept]

Phrase: "and"

Phrase: "association between the insulin gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "type 2diabetes"

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "exclusively through paternally transmitted class III variable number tandem repeat alleles."
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   797   C0242827:Variable Number Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   797   C1710347:Variable Number Tandem Repeat [Cell or Molecular Dysfunction]
   772   C3179163:Variable Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0039290:Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0441887:Class III [Intellectual Product]
   756   C2698969:Class III [Finding]
   738   C0002085:Alleles [Gene or Genome]
   738   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   738   C0205341:Repeat [Functional Concept]
   738   C0237753:*Number [Quantitative Concept]
   738   C0242781:Transmitted [Pathologic Function]
   738   C0332289:transmitted [Functional Concept]
   738   C0439070:III [Intellectual Product]
   738   C0439828:Variable [Qualitative Concept]
   738   C0449788:Number [Quantitative Concept]
   738   C0456387:Class [Intellectual Product]
   738   C1521797:Transmitted [Natural Phenomenon or Process]
   738   C1547730:Repeat [Temporal Concept]
   738   C1705160:III [Qualitative Concept]
   738   C1705914:Repeat [Conceptual Entity]
   738   C1705943:Class [Classification]
Processing 00000000.tx.385: Diabetes 49: 126-130, 2000[Abstract]. 

Phrase: "Diabetes 49"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "126-130,"

Phrase: "2000"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.386: 53.  

Phrase: "53."
Processing 00000000.tx.387: International Human Genome Sequencing Consortium. 

Phrase: "International Human Genome Sequencing Consortium."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1513822:Consortium [Professional or Occupational Group]
   804   C1880171:Consortium [Professional or Occupational Group]
Processing 00000000.tx.388: Initial sequencing and analysis of the human genome. 

Phrase: "Initial sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]

Phrase: "and"

Phrase: "analysis of the human genome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.389: Nature 409: 860-921, 2001[ISI][Medline]. 

Phrase: "Nature 409"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "860-921,"

Phrase: "2001"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.390: 54.  

Phrase: "54."
Processing 00000000.tx.391: Ji, L, Malecki M, Warram JH, Yang Y, Rich SS, and Krolewski AS. 

Phrase: "Ji,"

Phrase: "L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Malecki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Warram JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "Y,"

Phrase: "Rich SS,"

Phrase: "and"

Phrase: "Krolewski"

Phrase: "AS."
Processing 00000000.tx.392: New susceptibility locus for NIDDM is localized to human chromosome 20q. 

Phrase: "New susceptibility locus for NIDDM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1708726:Locus [Gene or Genome]

Phrase: "is"

Phrase: "localized to human chromosome 20q."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0008643:Human Chromosome [Cell Component]
   797   C2599609:20q chromosome [Cell or Molecular Dysfunction]
   760   C0008633:Chromosome [Cell Component]
   760   C0086418:Human [Human]
   760   C0392752:Localized [Spatial Concept]
   760   C1521048:20q [Nucleotide Sequence]
Processing 00000000.tx.393: Diabetes 46: 876-881, 1997[Abstract]. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "876-881,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.394: 55.  

Phrase: "55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.395: Kadowaki, T, Kadowaki H, Mori Y, Tobe K, Sakuta R, Suzuki Y, Tanabe Y, Sakura H, Awata T, Goto Y, Hayakawa T, Matsuoka K, Kawamori R, Kamada T, Horai S, Nonaka I, Hagura R, Akanuma Y, and Yazaki Y. 

Phrase: "Kadowaki,"

Phrase: "T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kadowaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mori Y,"

Phrase: "Tobe K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Sakuta R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Suzuki Y,"

Phrase: "Tanabe Y,"

Phrase: "Sakura H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Awata T,"

Phrase: "Goto Y,"

Phrase: "Hayakawa T,"

Phrase: "Matsuoka K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kawamori R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kamada T,"

Phrase: "Horai S,"

Phrase: "Nonaka I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Hagura R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Akanuma Y,"

Phrase: "and"

Phrase: "Yazaki Y."
Processing 00000000.tx.396: A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. 

Phrase: "A subtype of diabetes mellitus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449560:Subtype [Classification]

Phrase: "associated with a mutation of mitochondrial DNA."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1819717:mitochondrial DNA [Cell Component]
   774   C2315666:Mitochondrial mutation [Genetic Function]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0026237:Mitochondrial [Cell Component]
   748   C0026882:Mutation [Genetic Function]
   748   C0521451:Mitochondrial [Functional Concept]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.397: N Engl J Med 330: 962-968, 1994[Abstract/Free FullText]. 

Phrase: "N Engl J Med 330"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1414400:ENGL [Gene or Genome]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ":"

Phrase: "962-968,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.398: 56.  

Phrase: "56."
Processing 00000000.tx.399: Keavney, B, McKenzie C, Parish S, Palmer A, Clark S, Youngman L, Delepine M, Lathrop M, Peto R, and and Collins R for the ISIS Collaborators Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000cases and 6000controls. 

Phrase: "Keavney,"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "McKenzie C,"

Phrase: "Parish S,"

Phrase: "Palmer A,"

Phrase: "Clark S,"

Phrase: "Youngman L,"

Phrase: "Delepine M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lathrop M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Peto R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "and"

Phrase: "Collins R for the ISIS Collaborators Large-scale test of hypothesised associations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0205090:R- [Spatial Concept]
   736   C0684010:R. [Professional or Occupational Group]
   736   C2603358:R' [Clinical Attribute]

Phrase: "between the angiotensin-converting-enzyme insertion/deletion polymorphism"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   799   C0021107:Insertion [Therapeutic or Preventive Procedure]
   799   C0032529:Polymorphism [Genetic Function]
   799   C0441587:Insertion [Health Care Activity]
   799   C1442161:Deletion [Cell or Molecular Dysfunction]
   799   C1511760:Deletion [Genetic Function]
   799   C1512796:Insertion [Genetic Function]
   799   C1880274:Deletion [Activity]
   799   C1882417:Polymorphism [Qualitative Concept]
   799   C1883719:Insertion [Functional Concept]

Phrase: "and"

Phrase: "myocardial infarction in about 5000cases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0027051:Myocardial Infarction [Disease or Syndrome]
   806   C0428953:MYOCARDIAL INFARCTION [Finding]
   806   C2926063:Myocardial infarction [Clinical Attribute]
   760   C0021308:Infarction [Pathologic Function]
   760   C0027061:Myocardial [Tissue]
   760   C1522564:Myocardial [Spatial Concept]

Phrase: "and"

Phrase: "6000controls."
Processing 00000000.tx.400: Lancet 355: 434-442, 2000[ISI][Medline]. 

Phrase: "Lancet 355"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ":"

Phrase: "434-442,"

Phrase: "2000"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.401: 57.  

Phrase: "57."
Processing 00000000.tx.402: Kissebah, AH, Sonnenberg GE, Myklebust J, Goldstein M, Broman K, James RG, Marks JA, Krakower GR, Jacob HJ, Weber J, Martin L, Blangero J, and Comuzzie AG. 

Phrase: "Kissebah,"

Phrase: "AH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1836672:AH [Disease or Syndrome]

Phrase: "Sonnenberg GE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:GE [Gene or Genome]

Phrase: "Myklebust J,"

Phrase: "Goldstein M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Broman K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "James RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Marks JA,"

Phrase: "Krakower GR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: "Jacob HJ,"

Phrase: "Weber J,"

Phrase: "Martin L,"

Phrase: "Blangero J,"

Phrase: "and"

Phrase: "Comuzzie AG."
Processing 00000000.tx.403: Quantitative trait loci on chromosomes 3and 17influence phenotypes of the metabolic syndrome. 

Phrase: "Quantitative trait loci on chromosomes 3and 17influence phenotypes of the metabolic syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0597336:Quantitative Trait Loci [Gene or Genome]
   736   C0392762:Quantitative [Quantitative Concept]
   736   C0599883:Trait [Organism Attribute]
   703   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.404: Proc Natl Acad Sci USA 97: 14478-14483, 2000[Abstract/Free FullText]. 

Phrase: "Proc Natl Acad Sci USA 97"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C0439073:97 [Intellectual Product]
   799   C0439082:>97 [Quantitative Concept]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "14478-14483,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.405: 58.  

Phrase: "58."
Processing 00000000.tx.406: Kwok, PY. 

Phrase: "Kwok,"

Phrase: "PY."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030428:PY [Geographic Area]
  1000   C3538810:PY [Idea or Concept]
Processing 00000000.tx.407: High-throughput genotyping assay approaches. 

Phrase: "High-throughput genotyping assay approaches."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C0580530:High approach [Spatial Concept]
   804   C0449445:Approaches [Spatial Concept]
   804   C1292724:Approaches [Functional Concept]
   722   C0872187:High Throughput Assay [Diagnostic Procedure]
Processing 00000000.tx.408: Pharmacogenomics 1: 95-100, 2000[Medline]. 

Phrase: "Pharmacogenomics 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1138555:Pharmacogenomics [Biomedical Occupation or Discipline]
   861   C1882354:Pharmacogenomics [Idea or Concept]

Phrase: ":"

Phrase: "95-100,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.409: 59.  

Phrase: "59."
Processing 00000000.tx.410: Lander, ES, and Schork NJ. 

Phrase: "Lander,"

Phrase: "ES,"

Phrase: "and"

Phrase: "Schork NJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]
Processing 00000000.tx.411: Genetic dissection of complex traits. 

Phrase: "Genetic dissection of complex traits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012737:Dissection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.412: Science 265: 2037-2048, 1994[ISI][Medline]. 

Phrase: "Science 265"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "2037-2048,"

Phrase: "1994"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.413: 60.  

Phrase: "60."
Processing 00000000.tx.414: Le Stunff, C, Fallin D, and Bougnres P. 

Phrase: "Le Stunff,"

Phrase: "C,"

Phrase: "Fallin D,"

Phrase: "and"

Phrase: "Bougnres P."
Processing 00000000.tx.415: Paternal transmission of the very common class I INS VNTR alleles predisposes to childhood obesity. 

Phrase: "Paternal transmission of the very common class I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0040722:transmission [Idea or Concept]
   744   C0242781:Transmission [Pathologic Function]
   744   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "INS VNTR alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "predisposes to childhood obesity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2362324:Childhood obesity [Disease or Syndrome]
   833   C3645710:Childhood Obesity [Disease or Syndrome]
   770   C0028754:Obesity [Disease or Syndrome]
   770   C0231335:Childhood [Temporal Concept]
   770   C1963185:Obesity [Finding]
Processing 00000000.tx.416: Nat Genet 29: 96-99, 2001[ISI][Medline]. 

Phrase: "Nat Genet 29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "96-99,"

Phrase: "2001"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.417: 61.  

Phrase: "61."
Processing 00000000.tx.418: Lindgren, CM, Mahtani MM, Widn E, McCarthy MI, Daly MJ, Kirby A, Reeve MP, Kruglyak L, Lehto M, Kanninen T, Almgren Tuomi T P, Groop LC, and Lander ES. 

Phrase: "Lindgren,"

Phrase: "CM,"

Phrase: "Mahtani MM,"

Phrase: "Widn E,"

Phrase: "McCarthy MI,"

Phrase: "Daly MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Kirby A,"

Phrase: "Reeve MP,"

Phrase: "Kruglyak L,"

Phrase: "Lehto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kanninen T,"

Phrase: "Almgren Tuomi T P,"

Phrase: "Groop LC,"

Phrase: "and"

Phrase: "Lander ES."
Processing 00000000.tx.419: Genome wide search for type 2diabetes mellitus susceptibility loci in Finnish families (The Botnia Study). 

Phrase: "Genome wide search for type 2diabetes mellitus susceptibility loci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1552603:search [Intellectual Product]
   742   C1706202:Search [Activity]

Phrase: "in Finnish families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "("

Phrase: "The Botnia Study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: ")."
Processing 00000000.tx.420: Am J Hum Genet 70: 509-516, 2002[ISI][Medline]. 

Phrase: "Am"

Phrase: "J Hum Genet 70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "509-516,"

Phrase: "2002"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.421: 62.  

Phrase: "62."
Processing 00000000.tx.422: Lindner, T, Gragnoli C, Furuta H, Cockburn BN, Petzold C, Rietzsch H, Weiss U, Schulze J, and Bell GI. 

Phrase: "Lindner,"

Phrase: "T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Gragnoli C,"

Phrase: "Furuta H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Cockburn BN,"

Phrase: "Petzold C,"

Phrase: "Rietzsch H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Weiss U,"

Phrase: "Schulze J,"

Phrase: "and"

Phrase: "Bell GI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]
Processing 00000000.tx.423: Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4alpha/MODY1 gene. 

Phrase: "Hepatic function in a family"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0232741:Hepatic function [Organ or Tissue Function]
   797   C0680051:family function [Social Behavior]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "with a nonsense mutation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0544885:Mutation, Nonsense [Cell or Molecular Dysfunction]
   861   C0026882:Mutation [Genetic Function]
   861   C0746939:nonsense [Idea or Concept]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(R154X"

Phrase: ")"

Phrase: "in the hepatocyte nuclear factor-4alpha/MODY1 gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.424: J Clin Invest 100: 1400-1405, 1997[Abstract/Free FullText]. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "100"

Phrase: ":"

Phrase: "1400-1405,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.425: 63.  

Phrase: "63."
Processing 00000000.tx.426: MacFarlane, WM, Frayling TM, Ellard S, Evans JC, Allen LIS, Bulman MP, Ayres S, Shepherd M, Clark P, Millward A, Demaine A, Wilkin T, Docherty K, and Hattersley AT. 

Phrase: "MacFarlane,"

Phrase: "WM,"

Phrase: "Frayling TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Ellard S,"

Phrase: "Evans JC,"

Phrase: "Allen LIS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2247545:LIS [Molecular Function]

Phrase: "Bulman MP,"

Phrase: "Ayres S,"

Phrase: "Shepherd M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Clark P,"

Phrase: "Millward A,"

Phrase: "Demaine A,"

Phrase: "Wilkin T,"

Phrase: "Docherty K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Hattersley AT."
Processing 00000000.tx.427: Missense mutations in the insulin promoter factor-1 gene predispose to type 2diabetes. 

Phrase: "Missense mutations in the insulin promoter factor-1 gene"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   764   C0599155:Mutations, Missense [Genetic Function]
   762   C0596611:gene mutations [Genetic Function]
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "predispose to type 2diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.428: J Clin Invest 104: R33-R39, 1999[ISI][Medline]. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "104"

Phrase: ":"

Phrase: "R33-R39,"

Phrase: "1999"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.429: 64.  

Phrase: "64."
Processing 00000000.tx.430: Mahtani, MM, Widn E, Lehto M, Thomas J, McCarthy M, Brayer J, Bryant B, Chan G, Daly M, Forsblom C, Kanninen T, Kirby A, Kruglyak L, Munnelly K, Parkkonen M, Reeve-Daly MP, Weaver A, Brettin T, Duyk G, Lander ES, and Groop LC. 

Phrase: "Mahtani,"

Phrase: "MM,"

Phrase: "Widn E,"

Phrase: "Lehto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Thomas J,"

Phrase: "McCarthy M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Brayer J,"

Phrase: "Bryant B,"

Phrase: "Chan G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Daly M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Forsblom C,"

Phrase: "Kanninen T,"

Phrase: "Kirby A,"

Phrase: "Kruglyak L,"

Phrase: "Munnelly K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Parkkonen M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Reeve-Daly MP,"

Phrase: "Weaver A,"

Phrase: "Brettin T,"

Phrase: "Duyk G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Lander ES,"

Phrase: "and"

Phrase: "Groop LC."
Processing 00000000.tx.431: Mapping of a gene for NIDDM associated with an insulin secretion defect by a genome scan in Finnish families. 

Phrase: "Mapping of a gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0008630:Gene Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   770   C1283195:Mapping [Activity]

Phrase: "for NIDDM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011860:NIDDM [Disease or Syndrome]
  1000   C3273872:NIDDM [Gene or Genome]

Phrase: "associated with an insulin secretion defect"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1256369:insulin secretion [Cell Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1457869:Defect [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1861101:DEFECT [Disease or Syndrome]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "by a genome scan"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1517519:Genome Scan [Molecular Biology Research Technique]
   861   C0017428:Genome [Gene or Genome]
   861   C0034606:Scan [Diagnostic Procedure]
   861   C0441633:Scan [Diagnostic Procedure]
   861   C2338314:Genome [Conceptual Entity]
   861   C2826292:SCAN [Finding]

Phrase: "in Finnish families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.432: Nat Genet 14: 90-95, 1996[ISI][Medline]. 

Phrase: "Nat Genet 14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "90-95,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.433: 65.  

Phrase: "65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]
Processing 00000000.tx.434: Malecki, MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, Saad M, Warram JH, Montminy M, and Krolewski AS. 

Phrase: "Malecki,"

Phrase: "MT,"

Phrase: "Jhala"

Phrase: "US,"

Phrase: "Antonellis A,"

Phrase: "Fields L,"

Phrase: "Doria A,"

Phrase: "Orban T,"

Phrase: "Saad M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Warram JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Montminy M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Krolewski"

Phrase: "AS."
Processing 00000000.tx.435: Mutations in NEUROD1 are associated with the development of type 2diabetes mellitus. 

Phrase: "Mutations in NEUROD1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "associated with the development of type 2diabetes mellitus."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0243107:development [Physiologic Function]
   744   C0332307:Type [Qualitative Concept]
   744   C0678723:Development [Organism Function]
   744   C1527148:Development [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.436: Nat Genet 23: 323-328, 1999[ISI][Medline]. 

Phrase: "Nat Genet 23"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0325074:Genet [Mammal]
   827   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "323-328,"

Phrase: "1999"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.437: 66.  

Phrase: "66."
Processing 00000000.tx.438: Matschinsky, FM. 

Phrase: "Matschinsky,"

Phrase: "FM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540627:FM [Gene or Genome]
Processing 00000000.tx.439: A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. 

Phrase: "A lesson in metabolic regulation"

Phrase: "inspired by the glucokinase glucose sensor paradigm."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0872382:GLUCOSE SENSOR [Medical Device]
   778   C1625163:glucose sensor [Molecular Function]
   748   C0004048:Inspired [Organism Function]
   748   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0183210:Sensor [Medical Device]
   748   C0681797:paradigm [Research Activity]
   748   C1415014:GLUCOKINASE [Gene or Genome]
   748   C1705193:Sensor [Manufactured Object]
Processing 00000000.tx.440: Diabetes 45: 223-241, 1996[Abstract]. 

Phrase: "Diabetes 45"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "223-241,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.441: 67.  

Phrase: "67."
Processing 00000000.tx.442: McCarthy, MI. 

Phrase: "McCarthy,"

Phrase: "MI."
Processing 00000000.tx.443: Weighing in on diabetes risk. 

Phrase: "Weighing in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1305866:Weighing [Diagnostic Procedure]

Phrase: "on diabetes risk."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171304:diabetes risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.444: Nat Genet 19: 209-210, 1998[ISI][Medline]. 

Phrase: "Nat Genet 19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "209-210,"

Phrase: "1998"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.445: 68.  

Phrase: "68."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]
Processing 00000000.tx.446: McCarthy, MI. 

Phrase: "McCarthy,"

Phrase: "MI."
Processing 00000000.tx.447: Susceptibility gene discovery in common metabolic and endocrine traits. 

Phrase: "Susceptibility gene discovery in common metabolic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2717881:Gene Discovery [Molecular Biology Research Technique]
   753   C1880355:Discovery [Activity]

Phrase: "and"

Phrase: "endocrine traits."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0599883:traits [Organism Attribute]
   861   C1427926:TRAITS [Gene or Genome]
Processing 00000000.tx.448: J Mol Endocrinol 28: 1-17, 2002[Abstract/Free FullText]. 

Phrase: "J Mol Endocrinol 28"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C2346604:J/mol [Quantitative Concept]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "1-17,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.449: 69.  

Phrase: "69."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]
Processing 00000000.tx.450: McCarthy, MI, and Hattersley AT. 

Phrase: "McCarthy,"

Phrase: "MI,"

Phrase: "and"

Phrase: "Hattersley AT."
Processing 00000000.tx.451: Molecular diagnostics in monogenic and multifactorial forms of type 2diabetes. 

Phrase: "Molecular diagnostics in monogenic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C2121080:Molecular Diagnostics [Laboratory Procedure]
   737   C0011900:Diagnostic [Finding]
   737   C0348026:Diagnostic [Functional Concept]

Phrase: "and"

Phrase: "multifactorial forms of type 2diabetes."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   824   C3463805:Type of Form [Intellectual Product]
           form type
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]
Processing 00000000.tx.452: Expert Rev Mol Diagn 1: 89-98, 2001. 

Phrase: "Expert Rev Mol Diagn 1"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   804   C0027960:Mole [Neoplastic Process]
   804   C0324740:Mole [Mammal]
   804   C0439189:Mole [Quantitative Concept]
   804   C1456781:mole [Neoplastic Process]
   804   C1824986:mol [Gene or Genome]
   804   C2347961:Rev. [Professional or Occupational Group]
   721 E C0026367:Molar [Body Part, Organ, or Organ Component]
   704 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "89-98,"

Phrase: "2001."
Processing 00000000.tx.453: 70.  

Phrase: "70."
Processing 00000000.tx.454: McCarthy, MI, Kruglyak L, and Lander ES. 

Phrase: "McCarthy,"

Phrase: "MI,"

Phrase: "Kruglyak L,"

Phrase: "and"

Phrase: "Lander ES."
Processing 00000000.tx.455: Sib pair collection strategies for complex diseases. 

Phrase: "Sib pair collection strategies for complex diseases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0679199:strategies [Mental Process]
Processing 00000000.tx.456: Genet Epidemiol 15: 317-340, 1998[ISI][Medline]. 

Phrase: "Genet Epidemiol 15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "317-340,"

Phrase: "1998"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.457: 71.  

Phrase: "71."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]
Processing 00000000.tx.458: Moller, DE. 

Phrase: "Moller,"

Phrase: "DE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011198:DE [Geographic Area]
  1000   C0017480:DE [Geographic Area]
  1000   C3541240:DE [Idea or Concept]
Processing 00000000.tx.459: New drug targets for type 2diabetes and the metabolic syndrome. 

Phrase: "New drug"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0013227:Drug [Pharmacologic Substance]
   861   C1254351:Drug [Pharmacologic Substance]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "targets for type 2diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332307:Type [Qualitative Concept]
   770   C1521840:Target [Functional Concept]
   770   C1547052:*Type [Quantitative Concept]
   770   C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "the metabolic syndrome."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0524620:Metabolic syndrome [Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   861   C0311400:Metabolic [Functional Concept]
   861   C1524026:Metabolic [Cell Function]
   861   C2707259:Metabolic [Clinical Attribute]
Processing 00000000.tx.460: Nature 414: 821-827, 2001[ISI][Medline]. 

Phrase: "Nature 414"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "821-827,"

Phrase: "2001"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.461: 72.  

Phrase: "72."
Processing 00000000.tx.462: Moore, GE, Abu-Amero SN, Bell G, Wakeling EL, Kingsnorth A, Stanier P, Jauniaux E, and Bennett ST. 

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "GE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538705:GE [Gene or Genome]

Phrase: "Abu-Amero SN,"

Phrase: "Bell G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Wakeling EL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416870:EL [Gene or Genome]
   861   C1823249:EL [Gene or Genome]

Phrase: "Kingsnorth A,"

Phrase: "Stanier P,"

Phrase: "Jauniaux E,"

Phrase: "and"

Phrase: "Bennett ST."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]
Processing 00000000.tx.463: Evidence that insulin is imprinted in the human yolk sac. 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "imprinted in the human yolk sac."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0043425:Yolk Sac [Embryonic Structure]
   753   C0021118:imprinted [Mental Process]
   753   C0086418:Human [Human]
   753   C1325744:SAC [Cell Component]
   753   C1854580:SAC [Gene or Genome]
   753   C2610566:yolk [Cell Component]
   753   C2754376:SAC [Cell Function]
   719 E C1699173:imprint [Intellectual Product]
Processing 00000000.tx.464: Diabetes 50: 199-203, 2001[Abstract/Free FullText]. 

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "199-203,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.465: 73.  

Phrase: "73."
Processing 00000000.tx.466: Niu, T, Qin ZS, Xu X, and Liu JS. 

Phrase: "Niu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028219:NIU [Geographic Area]

Phrase: "T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Qin ZS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043459:ZS [Congenital Abnormality,Disease or Syndrome]

Phrase: "Xu X,"

Phrase: "and"

Phrase: "Liu JS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]
Processing 00000000.tx.467: Bayesian haplotype inference for single-nucleotide polymorphisms. 

Phrase: "Bayesian haplotype inference for single-nucleotide polymorphisms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0679201:Inference [Mental Process]
Processing 00000000.tx.468: Am J Hum Genet 70: 157-169, 2002[ISI][Medline]. 

Phrase: "Am"

Phrase: "J Hum Genet 70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "157-169,"

Phrase: "2002"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.469: 74.  

Phrase: "74."
Processing 00000000.tx.470: Ogura, Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar J-P, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nuez G, and Cho JH. 

Phrase: "Ogura,"

Phrase: "Y,"

Phrase: "Bonen DK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "Inohara N,"

Phrase: "Nicolae DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Chen FF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539653:FF [Idea or Concept]

Phrase: "Ramos R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Britton H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Moran T,"

Phrase: "Karaliuskas R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Duerr RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Achkar J-P,"

Phrase: "Brant SR,"

Phrase: "Bayless TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Kirschner BS,"

Phrase: "Hanauer SB,"

Phrase: "Nuez G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Cho JH."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]
Processing 00000000.tx.471: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. 

Phrase: "A frameshift mutation in NOD2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0079380:Frame Shift Mutation [Cell or Molecular Dysfunction]
           Frameshift
   806   C1282684:Frame-shift mutation [Laboratory or Test Result]
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with susceptibility"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0012655:Susceptibility [Clinical Attribute]
   790   C0220898:Susceptibility [Organism Attribute]
   790   C1264642:Susceptibility [Functional Concept]
   790   C1547045:*Susceptibility [Quantitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718 E C0231204:Susceptible [Functional Concept]
   718 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to Crohn's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0010346:Crohn Disease [Disease or Syndrome]
           Crohn's
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.472: Nature 411: 603-607, 2001[ISI][Medline]. 

Phrase: "Nature 411"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "603-607,"

Phrase: "2001"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.473: 75.  

Phrase: "75."
Processing 00000000.tx.474: Oka, A, Tamiya F, Tomizawa M, Ota M, Katsuyama Y, Makino S, Shiina T, Yoshitome M, Lizuka M, Sasao Y, Iwashita K, Kawakubo Y, Sugai J, Ozawa A, Ohkido M, Kimura M, Bahram S, and Inoko H. 

Phrase: "Oka,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069389:OKA [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "A,"

Phrase: "Tamiya F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Tomizawa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ota M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Katsuyama Y,"

Phrase: "Makino S,"

Phrase: "Shiina T,"

Phrase: "Yoshitome M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lizuka M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sasao Y,"

Phrase: "Iwashita K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kawakubo Y,"

Phrase: "Sugai J,"

Phrase: "Ozawa A,"

Phrase: "Ohkido M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kimura M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bahram S,"

Phrase: "and"

Phrase: "Inoko H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.475: Association analysis using refined microsatellite markers localizes a susceptibility locus for psoriasis vulgaris within a 111kb segment telomeric to the HLA-C gene. 

Phrase: "Association analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "refined microsatellite markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1519302:Microsatellite Markers [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0005516:Marker [Clinical Attribute]

Phrase: "localizes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:localize [Spatial Concept]

Phrase: "a susceptibility locus for psoriasis vulgaris"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1708726:Locus [Gene or Genome]

Phrase: "within a 111kb"

Phrase: "segment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441635:Segment [Spatial Concept]

Phrase: "telomeric to the HLA-C gene."
Processing 00000000.tx.476: Hum Mol Genet 8: 2165-2170, 1999[Abstract/Free FullText]. 

Phrase: "Hum Mol Genet 8"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "2165-2170,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.477: 76.  

Phrase: "76."
Processing 00000000.tx.478: Patil, N, Berno AJ, Hinds DA, Barrett WA, Doshi JM, Hacker CR, Kautzer CR, Lee DH, Marjoribanks C, McDonough DP, Nguyen BTN, Norris MC, Sheehan JB, Shen N, Stern D, Stokowski RP, Thomas DJ, Trulson MO, Vyas KR, Frazer KA, Fodor SPA, and Cox DR. 

Phrase: "Patil,"

Phrase: "N,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Berno AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Hinds DA,"

Phrase: "Barrett WA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:WA [Geographic Area]

Phrase: "Doshi JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Hacker CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Kautzer CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Lee DH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832586:DH [Disease or Syndrome]

Phrase: "Marjoribanks C,"

Phrase: "McDonough DP,"

Phrase: "Nguyen BTN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005341:BTN [Geographic Area]
   861   C1412842:BTN [Gene or Genome]

Phrase: "Norris MC,"

Phrase: "Sheehan JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Shen N,"

Phrase: "Stern D,"

Phrase: "Stokowski RP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: "Thomas DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Trulson MO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538743:MO [Idea or Concept]

Phrase: "Vyas KR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022773:KR [Geographic Area]

Phrase: "Frazer KA,"

Phrase: "Fodor SPA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420002:SPA [Gene or Genome]

Phrase: "and"

Phrase: "Cox DR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]
Processing 00000000.tx.479: Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. 

Phrase: "Blocks of limited haplotype diversity"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0028778:blocks [Pathologic Function]
   760   C0332206:Blocks [Functional Concept]
   760   C1533157:Blocks [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "revealed by high-resolution scanning of human chromosome 21."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C0008643:Human Chromosome [Cell Component]
   764   C0008664:Chromosome 21 [Cell Component]
   764   C1719039:High resolution [Laboratory Procedure]
   742   C0008633:Chromosome [Cell Component]
   742   C0034606:Scanning [Diagnostic Procedure]
   742   C0086418:Human [Human]
   742   C0205250:High [Qualitative Concept]
   742   C0441633:Scanning [Diagnostic Procedure]
   742   C0443289:Revealed [Qualitative Concept]
   742   C1299351:High [Qualitative Concept]
   742   C1514893:Resolution [Idea or Concept]
   742   C1706463:Resolution [Quantitative Concept]
   742   C2699488:Resolution [Conceptual Entity]
   742   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.480: Science 294: 1719-1723, 2001[Abstract/Free FullText]. 

Phrase: "Science 294"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "1719-1723,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.481: 77.  

Phrase: "77."
Processing 00000000.tx.482: Pritchard, JK. 

Phrase: "Pritchard,"

Phrase: "JK."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420098:JK [Gene or Genome]
Processing 00000000.tx.483: Are rare variants responsible for susceptibility to complex diseases? 

Phrase: "Are"

Phrase: "rare variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "responsible for susceptibility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "to complex diseases?"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.484: Am J Hum Genet 69: 124-137, 2001[ISI][Medline]. 

Phrase: "Am"

Phrase: "J Hum Genet 69"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0325074:Genet [Mammal]
   812   C0450388:69 [Intellectual Product]

Phrase: ":"

Phrase: "124-137,"

Phrase: "2001"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.485: 78.  

Phrase: "78."
Processing 00000000.tx.486: Reich, DE, and Lander ES. 

Phrase: "Reich,"

Phrase: "DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011198:DE [Geographic Area]
  1000   C0017480:DE [Geographic Area]
  1000   C3541240:DE [Idea or Concept]

Phrase: "and"

Phrase: "Lander ES."
Processing 00000000.tx.487: On the allelic spectrum of human disease. 

Phrase: "On the allelic spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "of human disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.488: Trends Genet 17: 502-510, 2001[ISI][Medline]. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Genet 17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "502-510,"

Phrase: "2001"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.489: 79.  

Phrase: "79."
Processing 00000000.tx.490: Rioux, JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen C, Delmonte T, Kocher K, Miller K, Guschwan S, Kulbokas EJ, O'Leary S, Winchester E, Dewar K, Green T, Stone V, Chow C, Cohen A, Langelier D, Lapointe G, Guadet D, Faith J, Branco N, Bull SB, McLeod RS, Griffiths AM, Bitton A, Greenberg GR, Lander ES, Siminovitch KA, and Hudson TJ. 

Phrase: "Rioux,"

Phrase: "JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1549972:JD [Intellectual Product]

Phrase: "Daly MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Silverberg MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Lindblad K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Steinhart H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Cohen C,"

Phrase: "Delmonte T,"

Phrase: "Kocher K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Miller K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Guschwan S,"

Phrase: "Kulbokas EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "O'Leary S,"

Phrase: "Winchester E,"

Phrase: "Dewar K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Green T,"

Phrase: "Stone V,"

Phrase: "Chow C,"

Phrase: "Cohen A,"

Phrase: "Langelier D,"

Phrase: "Lapointe G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Guadet D,"

Phrase: "Faith J,"

Phrase: "Branco N,"

Phrase: "Bull SB,"

Phrase: "McLeod RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Griffiths"

Phrase: "AM"

Phrase: ","

Phrase: "Bitton A,"

Phrase: "Greenberg GR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: "Lander ES,"

Phrase: "Siminovitch KA,"

Phrase: "and"

Phrase: "Hudson TJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]
Processing 00000000.tx.491: Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. 

Phrase: "Genetic variation in the 5q31 cytokine gene cluster"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0042333:Genetic Variation [Natural Phenomenon or Process]
   744   C0205419:Variation [Qualitative Concept]

Phrase: "confers"

Phrase: "susceptibility to Crohn disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0012655:Disease susceptibility [Clinical Attribute]
           Susceptibility
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
Processing 00000000.tx.492: Nat Genet 29: 223-228, 2001[ISI][Medline]. 

Phrase: "Nat Genet 29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "223-228,"

Phrase: "2001"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.493: 80.  

Phrase: "80."
Processing 00000000.tx.494: Risch, N. 

Phrase: "Risch,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.495: Linkage strategies for genetically complex traits. 

Phrase: "Linkage strategies for genetically complex traits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679199:strategies [Mental Process]
Processing 00000000.tx.496: I.

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.497: Multilocus models. 

Phrase: "Multilocus models."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]
Processing 00000000.tx.498: Am J Hum Genet 46: 222-228, 1990[ISI][Medline]. 

Phrase: "Am"

Phrase: "J Hum Genet 46"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "222-228,"

Phrase: "1990"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.499: 81.  

Phrase: "81."
Processing 00000000.tx.500: Risch, N, and Merikangas K. 

Phrase: "Risch,"

Phrase: "N,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Merikangas K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.501: The future of genetic studies of complex human diseases. 

Phrase: "The future of genetic studies of complex human diseases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0016884:Future [Temporal Concept]
Processing 00000000.tx.502: Science 273: 1516-1517, 1996[ISI][Medline]. 

Phrase: "Science 273"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "1516-1517,"

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.503: 82.  

Phrase: "82."
Processing 00000000.tx.504: Roberts, SB, MacLean CJ, Neale MC, Eaves LJ, and Kendler LS. 

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "SB,"

Phrase: "MacLean CJ,"

Phrase: "Neale MC,"

Phrase: "Eaves LJ,"

Phrase: "and"

Phrase: "Kendler LS."
Processing 00000000.tx.505: Replication of linkage studies of complex traits: an examination of variance in location estimates. 

Phrase: "Replication of linkage"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0598312:Replication [Genetic Function]
   790   C1883725:replication [Qualitative Concept]
   718 E C0205173:Replicate [Functional Concept]
   718 E C0205341:Replicate [Functional Concept]

Phrase: "studies of complex traits"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0439855:Complex [Qualitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0599883:traits [Organism Attribute]
   770   C0947630:studies [Laboratory Procedure]
   770   C1427926:TRAITS [Gene or Genome]
   770   C1704241:Complex [Chemical Viewed Structurally]
   770   C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "an examination of variance"

Phrase: "in location estimates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750572:estimates [Quantitative Concept]
Processing 00000000.tx.506: Am J Hum Genet 65: 876-884, 1999[ISI][Medline]. 

Phrase: "Am"

Phrase: "J Hum Genet 65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0325074:Genet [Mammal]
   812   C0450385:65 [Intellectual Product]

Phrase: ":"

Phrase: "876-884,"

Phrase: "1999"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.507: 83.  

Phrase: "83."
Processing 00000000.tx.508: Roses, AD. 

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "AD."
Processing 00000000.tx.509: Pharmacogenetics and the practice of medicine. 

Phrase: "Pharmacogenetics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031325:Pharmacogenetics [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "the practice of medicine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237607:practice [Mental Process]
   770   C3245512:practice [Intellectual Product]
Processing 00000000.tx.510: Nature 405: 857-865, 2000[ISI][Medline]. 

Phrase: "Nature 405"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "857-865,"

Phrase: "2000"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.511: 84.  

Phrase: "84."
Processing 00000000.tx.512: Savkur, RS, Philips AV, and Cooper TA. 

Phrase: "Savkur,"

Phrase: "RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539879:RS [Idea or Concept]

Phrase: "Philips AV,"

Phrase: "and"

Phrase: "Cooper TA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]
Processing 00000000.tx.513: Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. 

Phrase: "Aberrant regulation of insulin receptor alternative splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "is"

Phrase: "associated with insulin resistance"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in myotonic dystrophy."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0027126:Myotonic Dystrophy [Disease or Syndrome]
  1000   C0410226:Myotonic Dystrophy [Disease or Syndrome]
   861   C0333606:Dystrophy [Pathologic Function]
   789 E C0333607:Dystrophic [Functional Concept]
Processing 00000000.tx.514: Nat Genet 29: 40-47, 2001[ISI][Medline]. 

Phrase: "Nat Genet 29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "40-47,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "2001"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.515: 85.  

Phrase: "85."
Processing 00000000.tx.516: Shaw, JTE, Lovelock PK, Kesting JB, Cardinal J, Duffy D, Wainwright B, and Cameron DP. 

Phrase: "Shaw,"

Phrase: "JTE,"

Phrase: "Lovelock PK,"

Phrase: "Kesting JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Cardinal J,"

Phrase: "Duffy D,"

Phrase: "Wainwright B,"

Phrase: "and"

Phrase: "Cameron DP."
Processing 00000000.tx.517: Novel susceptibility gene for late-onset NIDDM is localized to human chromosome 12q. 

Phrase: "Novel susceptibility gene for late-onset NIDDM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0919453:Susceptibility Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "localized to human chromosome 12q."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0008643:Human Chromosome [Cell Component]
   760   C0008633:Chromosome [Cell Component]
   760   C0086418:Human [Human]
   760   C0392752:Localized [Spatial Concept]
   760   C1520484:12q [Nucleotide Sequence]
Processing 00000000.tx.518: Diabetes 47: 1793-1796, 1998[Abstract]. 

Phrase: "Diabetes 47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "1793-1796,"

Phrase: "1998"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.519: 86.  

Phrase: "86."
Processing 00000000.tx.520: St Jean, P, Hsueh W-C, Mitchell B, Ehm M, Wagner M, Burns D, and Shuldiner AR. 

Phrase: "St Jean,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0453932:jean [Manufactured Object]

Phrase: "P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hsueh W-C,"

Phrase: "Mitchell B,"

Phrase: "Ehm M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wagner M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Burns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006434:Burn [Injury or Poisoning]
  1000   C1550619:Burn [Substance]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Shuldiner AR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986463:AR+ [Finding]
Processing 00000000.tx.521: Association between diabetes, obesity, glucose and insulin levels in the Old Order Amish and SNPs on 1q21-23 (Abstract). 

Phrase: "Association between diabetes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "obesity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin levels in the Old Order Amish"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0202098:insulin levels [Laboratory Procedure]
   778   C0428405:insulin levels [Laboratory or Test Result]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0441889:Levels [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "SNPs on 1q21-23"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0752046:SNPs [Nucleotide Sequence]
   737 E C1527094:SNP [Conceptual Entity]

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.522: Am J Hum Genet 67, Suppl2: 1848, 2000. 

Phrase: "Am"

Phrase: "J Hum Genet 67,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: "Suppl2"

Phrase: ":"

Phrase: "1848,"

Phrase: "2000."
Processing 00000000.tx.523: 87.  

Phrase: "87."
Processing 00000000.tx.524: Stefan, N, Fritsche A, Haring H, and Stumvoll M. 

Phrase: "Stefan,"

Phrase: "N,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Fritsche A,"

Phrase: "Haring"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0242372:haring [Mammal]
   966 E C1425660:HARE [Gene or Genome]

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Stumvoll M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.525: Effect of experimental elevation of free fatty acids on insulin secretion and insulin sensitivity in healthy carriers of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene. 

Phrase: "Effect of experimental elevation of free fatty acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin sensitivity in healthy carriers of the Pro12Ala polymorphism"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0920563:Insulin Sensitivity [Pathologic Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0036667:Sensitivity [Quantitative Concept]
   742   C0312418:Sensitivity [Mental Process]
   742   C0427965:Sensitivity [Finding]
   742   C1511883:Sensitivity [Quantitative Concept]
   742   C1522640:Sensitivity [Qualitative Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C2346484:SENSITIVITY [Phenomenon or Process]
   742   C2349185:Sensitivity [Qualitative Concept]

Phrase: "of the peroxisome proliferator-activated receptor-gamma2 gene."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   839   C1335671:Receptor Gene [Gene or Genome]
   799   C0017337:Gene [Gene or Genome]
   734   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
Processing 00000000.tx.526: Diabetes 50: 1143-1148, 2001[Abstract/Free FullText]. 

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "1143-1148,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.527: 88.  

Phrase: "88."
Processing 00000000.tx.528: Stoffers, DA, Ferrer J, Clarke WL, and Habener JF. 

Phrase: "Stoffers,"

Phrase: "DA,"

Phrase: "Ferrer J,"

Phrase: "Clarke WL,"

Phrase: "and"

Phrase: "Habener JF."
Processing 00000000.tx.529: Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. 

Phrase: "Early-onset type-II diabetes mellitus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
   901   C2984301:Type II diabetes mellitus [Functional Concept]
   839   C1320657:type diabetes [Finding]
   827   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   827   C0441730:Type II [Classification]
   799   C0011847:Diabetes [Disease or Syndrome]
   799   C0332307:Type [Qualitative Concept]
   799   C1547052:*Type [Quantitative Concept]

Phrase: "(MODY4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1826562:MODY4 [Gene or Genome]
  1000   C1833382:MODY4 [Disease or Syndrome]

Phrase: ")"

Phrase: "linked to IPF1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1826562:IPF1 [Gene or Genome]
   756   C1517892:Link [Intellectual Product]
   756   C1704666:Link [Intellectual Product]
Processing 00000000.tx.530: Nat Genet 17: 138-139, 1997[ISI][Medline]. 

Phrase: "Nat Genet 17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "138-139,"

Phrase: "1997"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.531: 89.  

Phrase: "89."
Processing 00000000.tx.532: Stoffers, DA, Zinkin NT, Stanojevic V, Clarke WL, and Habener JF. 

Phrase: "Stoffers,"

Phrase: "DA,"

Phrase: "Zinkin NT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332126:NT [Qualitative Concept]
   861   C1449832:NT [Diagnostic Procedure]

Phrase: "Stanojevic V,"

Phrase: "Clarke WL,"

Phrase: "and"

Phrase: "Habener JF."
Processing 00000000.tx.533: Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. 

Phrase: "Pancreatic agenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0000846:Agenesis [Functional Concept]
   861   C0332907:Agenesis [Congenital Abnormality]

Phrase: "attributable to a single nucleotide deletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596130:Attributable [Mental Process]

Phrase: "in the human IPF1 gene coding sequence."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   840   C0079941:Coding Sequence [Gene or Genome]
   804   C0004793:Sequence [Nucleotide Sequence]
   804   C0009219:Coding [Occupational Activity]
   804   C0162326:Sequence [Nucleotide Sequence]
   804   C0162327:Sequence [Nucleotide Sequence]
   804   C1519249:Sequence [Functional Concept]
   771 E C0805701:Code [Intellectual Product]
   733 E C1548958:Sequential [Idea or Concept]
   733 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.534: Nat Genet 15: 106-110, 1997[ISI][Medline]. 

Phrase: "Nat Genet 15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "106-110,"

Phrase: "1997"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.535: 90.  

Phrase: "90."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]
Processing 00000000.tx.536: Stoll, M, Cowley AW, Tonellato PJ, Greene AS, Kaldunski ML, Roman RJ, Dumas P, Schork NJ, Wang Z, and Jacob HJ. 

Phrase: "Stoll,"

Phrase: "M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "Cowley AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "Tonellato PJ,"

Phrase: "Greene AS,"

Phrase: "Kaldunski ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Roman RJ,"

Phrase: "Dumas P,"

Phrase: "Schork NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Wang Z,"

Phrase: "and"

Phrase: "Jacob HJ."
Processing 00000000.tx.537: A genomic-systems biology map for cardiovascular function. 

Phrase: "A genomic-systems biology map for cardiovascular function."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1706473:Map Function [Conceptual Entity]
           Map
   744   C0024779:Map [Manufactured Object]
Processing 00000000.tx.538: Science 294: 1723-1725, 2001[Abstract/Free FullText]. 

Phrase: "Science 294"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "1723-1725,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.539: 91.  

Phrase: "91."
Processing 00000000.tx.540: Sturis, J, Kurland IJ, Byrne MM, Mosekilde E, Froguel P, Pilkis S, Bell GI, and Polonsky KS. 

Phrase: "Sturis,"

Phrase: "J,"

Phrase: "Kurland IJ,"

Phrase: "Byrne MM,"

Phrase: "Mosekilde E,"

Phrase: "Froguel P,"

Phrase: "Pilkis S,"

Phrase: "Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "and"

Phrase: "Polonsky KS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]
Processing 00000000.tx.541: Compensation in pancreatic -cell function in subjects with glucokinase mutations. 

Phrase: "Compensation in pancreatic -cell function"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0152057:Compensation [Mental Process]
   760   C0152058:Compensation [Physiologic Function]
   760   C0220808:Compensation [Quantitative Concept]

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "with glucokinase mutations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.542: Diabetes 43: 718-723, 1994[Abstract]. 

Phrase: "Diabetes 43"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "718-723,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.543: 92.  

Phrase: "92."
Processing 00000000.tx.544: Sun, L, Cox NJ, and McPeek MS. 

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Cox NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "and"

Phrase: "McPeek MS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]
Processing 00000000.tx.545: A statistical method for identification of polymorphisms that explain a linkage result. 

Phrase: "A statistical method for identification of polymorphisms"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C1301921:Method of identification [Qualitative Concept]
   778   C1710191:Statistical Method [Research Activity]
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]

Phrase: "that"

Phrase: "explain"

Phrase: "a linkage result."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]
Processing 00000000.tx.546: Am J Hum Genet 70: 399-411, 2002[ISI][Medline]. 

Phrase: "Am"

Phrase: "J Hum Genet 70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "399-411,"

Phrase: "2002"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.547: 93.  

Phrase: "93."
Processing 00000000.tx.548: Tattersall, RB, and Mansell PI. 

Phrase: "Tattersall,"

Phrase: "RB,"

Phrase: "and"

Phrase: "Mansell PI."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0429863:PI [Clinical Attribute]
   861   C3537219:PI [Gene or Genome]
   861   C3539772:PI [Intellectual Product]
Processing 00000000.tx.549: Maturity onset-type diabetes of the young (MODY): one condition or many? 

Phrase: "Maturity onset-type diabetes of the young"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   910   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   910   C2984262:Maturity onset diabetes of the young [Functional Concept]
   804   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   778   C1320657:type diabetes [Finding]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(MODY"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
  1000   C2984262:Maturity onset diabetes of the young [Functional Concept]
   833   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C0449989:Maturity [Qualitative Concept]
   753   C0700597:Maturity [Temporal Concept]

Phrase: ")"

Phrase: ":"

Phrase: "one condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0012634:condition [Disease or Syndrome]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]

Phrase: "or"

Phrase: "many?"
Processing 00000000.tx.550: Diabet Med 8: 402-410, 1991[ISI][Medline]. 

Phrase: "Diabet Med 8"

Phrase: ":"

Phrase: "402-410,"

Phrase: "1991"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.551: 94.  

Phrase: "94."
Processing 00000000.tx.552: The Diabetes Prevention Program. 

Phrase: "The Diabetes Prevention Program."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0679717:prevention program [Intellectual Product]
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]
   734   C1659987:diabetes prevention [Educational Activity]
Processing 00000000.tx.553: Design and methods for a clinical trial in the prevention of type 2diabetes. 

Phrase: "Design"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1707689:Design [Activity]
  1000   C2983265:DESIGN [Intellectual Product]

Phrase: "and"

Phrase: "methods for a clinical trial"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0449851:Methods [Functional Concept]
   726 E C0871511:METHOD [Intellectual Product]

Phrase: "in the prevention"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0199176:Prevention [Therapeutic or Preventive Procedure]
  1000   C1706420:PREVENTION [Research Activity]
  1000   C2700409:prevention [Qualitative Concept]

Phrase: "of type 2diabetes."
Processing 00000000.tx.554: Diabetes Care 22: 623-634, 1999[Abstract]. 

Phrase: "Diabetes Care 22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C1947933:Care [Activity]

Phrase: ":"

Phrase: "623-634,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.555: 95.  

Phrase: "95."
Processing 00000000.tx.556: The International SNP Map Working Group. 

Phrase: "The International SNP Map Working Group."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   877   C2826346:SINGLE GROUP [Research Activity]
   829   C3645577:Map group [Intellectual Product]
   818   C1883562:Working Group [Population Group]
   795   C0043227:Working [Occupational Activity]
   795   C0441833:Group [Idea or Concept]
   795   C0687744:group [Population Group]
   795   C1257890:Group [Population Group]
   795   C1552516:Group [Health Care Related Organization]
   795   C1705428:Group [Conceptual Entity]
   795   C1705429:Group [Population Group]
Processing 00000000.tx.557: A map of human genome sequence variation containing 142million single nucleotide polymorphisms. 

Phrase: "A map of human genome sequence variation containing 142million single nucleotide polymorphisms."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0024779:Map [Manufactured Object]
   736   C1706473:Map [Conceptual Entity]
Processing 00000000.tx.558: Nature 409: 928-933, 2001[ISI][Medline]. 

Phrase: "Nature 409"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "928-933,"

Phrase: "2001"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.559: 96.  

Phrase: "96."
Processing 00000000.tx.560: Thomas, H, Jaschkowitz K, Bulman M, Frayling TM, Mitchell SM, Roosen S, Lingott-Frieg A, Tack CJ, Ellard S, Ryffel GU, and Hattersley AT. 

Phrase: "Thomas,"

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Jaschkowitz K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Bulman M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Frayling TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Mitchell SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Roosen S,"

Phrase: "Lingott-Frieg A,"

Phrase: "Tack CJ,"

Phrase: "Ellard S,"

Phrase: "Ryffel GU,"

Phrase: "and"

Phrase: "Hattersley AT."
Processing 00000000.tx.561: A distant upstream promoter of the HNF4 gene connects the transcription factors involved in maturity-onset diabetes of the young. 

Phrase: "A distant upstream promoter of the HNF4 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0314621:Promoter gene [Gene or Genome]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0522505:Upstream [Spatial Concept]

Phrase: "connects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986575:Connect [Activity]

Phrase: "the transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "involved in maturity-onset diabetes of the young."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   909   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   909   C2984262:Maturity onset diabetes of the young [Functional Concept]
   800   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0332162:Onset [Qualitative Concept]
   744   C0332239:Young [Temporal Concept]
   744   C0449989:Maturity [Qualitative Concept]
   744   C0700597:Maturity [Temporal Concept]
   744   C1314939:Involved [Functional Concept]
Processing 00000000.tx.562: Hum Mol Genet 10: 2089-2097, 2001[Abstract/Free FullText]. 

Phrase: "Hum Mol Genet 10"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "2089-2097,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.563: 97.  

Phrase: "97."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]
Processing 00000000.tx.564: UK Prospective Diabetes Study Group. 

Phrase: "UK Prospective Diabetes Study Group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
Processing 00000000.tx.565: Overview of 6years' therapy of type II diabetes: a progressive disease (UKPDS 16). 

Phrase: "Overview of 6years' therapy of type II diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0814812:overview [Intellectual Product]

Phrase: ":"

Phrase: "a progressive disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0677932:progressive disease [Neoplastic Process]
  1000   C1335499:Progressive Disease [Finding]
  1000   C3539781:Progressive Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0205329:Progressive [Functional Concept]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(UKPDS 16"

Phrase: ")."
Processing 00000000.tx.566: Diabetes 44: 1249-1258, 1995[Abstract]. 

Phrase: "Diabetes 44"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "1249-1258,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.567: 98.  

Phrase: "98."
Processing 00000000.tx.568: UK Prospective Diabetes Study Group. 

Phrase: "UK Prospective Diabetes Study Group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
Processing 00000000.tx.569: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2diabetes (UKPDS 33). 

Phrase: "Intensive blood-glucose control with sulphonylureas"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0005802:Blood Glucose [Carbohydrate]
   790   C0726398:GLUCOSE CONTROL [Indicator, Reagent, or Diagnostic Aid]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0229664:Blood [Body Substance]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "compared with conventional treatment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C2945704:Conventional Treatment [Therapeutic or Preventive Procedure]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0439858:Conventional [Qualitative Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C1707455:Compared [Activity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "risk of complications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with type 2diabetes"

Phrase: "(UKPDS 33"

Phrase: ")."
Processing 00000000.tx.570: Lancet 352: 837-853, 1998[ISI][Medline]. 

Phrase: "Lancet 352"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ":"

Phrase: "837-853,"

Phrase: "1998"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.571: 99.  

Phrase: "99."
Processing 00000000.tx.572: Vaxillaire, M, Boccio V, Philippi A, Vigouroux C, Terwilliger J, Passa P, Beckmann JS, Velho G, Lathrop GM, and Froguel P. 

Phrase: "Vaxillaire,"

Phrase: "M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "Boccio V,"

Phrase: "Philippi A,"

Phrase: "Vigouroux C,"

Phrase: "Terwilliger J,"

Phrase: "Passa P,"

Phrase: "Beckmann JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Velho G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Lathrop GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "Froguel P."
Processing 00000000.tx.573: A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. 

Phrase: "A gene for maturity onset diabetes of the young"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0079429:A Gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   716   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   716   C2984262:Maturity onset diabetes of the young [Functional Concept]

Phrase: "(MODY"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
  1000   C2984262:Maturity onset diabetes of the young [Functional Concept]
   833   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C0449989:Maturity [Qualitative Concept]
   753   C0700597:Maturity [Temporal Concept]

Phrase: ")"

Phrase: "maps to chromosome 12q."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0814036:chromosome map [Intellectual Product]
   770   C0008633:Chromosome [Cell Component]
   770   C0024779:Map [Manufactured Object]
   770   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1520484:12q [Nucleotide Sequence]
   770   C1706473:Map [Conceptual Entity]
Processing 00000000.tx.574: Nat Genet 9: 418-423, 1995[ISI][Medline]. 

Phrase: "Nat Genet 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "418-423,"

Phrase: "1995"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.575: 100.  

Phrase: "100."
Processing 00000000.tx.576: Vaxillaire, M, Rouard M, Yamagata K, Oda N, Kaisaki PJ, Boriraj VV, Chvre J-C, Boccio V, Cox RD, Lathrop GM, Dussoix P, Philippe J, Timsit J, Charpentier G, Velho G, Bell GI, and Froguel P. 

Phrase: "Vaxillaire,"

Phrase: "M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "Rouard M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yamagata K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Oda N,"

Phrase: "Kaisaki PJ,"

Phrase: "Boriraj VV,"

Phrase: "Chvre J-C,"

Phrase: "Boccio V,"

Phrase: "Cox RD,"

Phrase: "Lathrop GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Dussoix P,"

Phrase: "Philippe J,"

Phrase: "Timsit J,"

Phrase: "Charpentier G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Velho G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "and"

Phrase: "Froguel P."
Processing 00000000.tx.577: Identification of nine novel mutations in the hepatocyte nuclear factor 1alpha gene associated with maturity-onset diabetes of the young (MODY3). 

Phrase: "Identification of nine novel mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "in the hepatocyte nuclear factor 1alpha gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0017337:Gene [Gene or Genome]
   771   C0209278:Hepatocyte Nuclear Factor 1-alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1420631:HEPATIC NUCLEAR FACTOR-1-ALPHA [Gene or Genome]
   717   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associated with maturity-onset diabetes of the young"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   909   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   909   C2984262:Maturity onset diabetes of the young [Functional Concept]
   800   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0332162:Onset [Qualitative Concept]
   744   C0332239:Young [Temporal Concept]
   744   C0449989:Maturity [Qualitative Concept]
   744   C0700597:Maturity [Temporal Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(MODY3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1838100:MODY3 [Disease or Syndrome]
  1000   C3273648:MODY3 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.578: Hum Mol Genet 6: 583-586, 1997[Abstract/Free FullText]. 

Phrase: "Hum Mol Genet 6"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "583-586,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.579: 101.  

Phrase: "101."
Processing 00000000.tx.580: Velho, G, Froguel Clment K P, Pueyo ME, Rakotoambinina B, Zouali H, Passa P, Cohen D, and Robert J-J. 

Phrase: "Velho,"

Phrase: "G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Froguel Clment K P,"

Phrase: "Pueyo"

Phrase: "ME,"

Phrase: "Rakotoambinina B,"

Phrase: "Zouali H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Passa P,"

Phrase: "Cohen D,"

Phrase: "and"

Phrase: "Robert J-J."
Processing 00000000.tx.581: Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. 

Phrase: "Primary pancreatic beta-cell secretory defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1457869:Defect [Functional Concept]
   799   C1861101:DEFECT [Disease or Syndrome]

Phrase: "caused by mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026882:Mutations [Genetic Function]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in glucokinase gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "in kindreds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598429:kindreds [Qualitative Concept]

Phrase: "of maturity onset diabetes of the young."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   845   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   795   C0011847:Diabetes [Disease or Syndrome]
   795   C0011849:Diabetes [Disease or Syndrome]
   795   C0332162:Onset [Qualitative Concept]
   795   C0332239:Young [Temporal Concept]
   795   C0332285:Of [Spatial Concept]
   795   C0449989:Maturity [Qualitative Concept]
   795   C0700597:Maturity [Temporal Concept]
   724 E C0205286:Mature [Temporal Concept]
Processing 00000000.tx.582: Lancet 340: 444-448, 1992[ISI][Medline]. 

Phrase: "Lancet 340"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ":"

Phrase: "444-448,"

Phrase: "1992"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.583: 102.  

Phrase: "102."
Processing 00000000.tx.584: Vidal, M. 

Phrase: "Vidal,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.585: A biological atlas of functional maps. 

Phrase: "A biological atlas of functional maps."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0004170:Atlas [Body Part, Organ, or Organ Component]
   753   C0004171:atlas [Intellectual Product,Manufactured Object]
   753   C2652343:Atla [Fungus]
Processing 00000000.tx.586: Cell 104: 333-339, 2001[ISI][Medline]. 

Phrase: "Cell 104"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "333-339,"

Phrase: "2001"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.587: 103.  

Phrase: "103."
Processing 00000000.tx.588: Vionnet, N, Hani EH, Dupont S, Gallina S, Francke S, Dotte S, De Matos F, Durand E, Leptre F, Lecouer C, Gallina P, Zekiri L, Dina C, and Froguel P. 

Phrase: "Vionnet,"

Phrase: "N,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hani EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Dupont S,"

Phrase: "Gallina S,"

Phrase: "Francke S,"

Phrase: "Dotte S,"

Phrase: "De Matos F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Durand E,"

Phrase: "Leptre F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lecouer C,"

Phrase: "Gallina P,"

Phrase: "Zekiri L,"

Phrase: "Dina C,"

Phrase: "and"

Phrase: "Froguel P."
Processing 00000000.tx.589: Genomewide search for type 2diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. 

Phrase: "Genomewide search for type 2diabetes-susceptibility genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1552603:search [Intellectual Product]
   748   C1706202:Search [Activity]

Phrase: "in French whites"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0007457:Whites [Population Group]
   861   C0043157:Whites [Population Group]
   827 E C0220938:White [Qualitative Concept]

Phrase: ":"

Phrase: "evidence for a novel susceptibility locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]

Phrase: "for early-onset diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1833334:Early-onset [Finding]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C1279919:Early [Temporal Concept]

Phrase: "on chromosome 3q27-qter"

Phrase: "and"

Phrase: "independent replication of a type 2-diabetes locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0598312:Replication [Genetic Function]
   744   C1883725:replication [Qualitative Concept]

Phrase: "on chromosome 1q21-q24."
Processing 00000000.tx.590: Am J Hum Genet 67: 1470-1480, 2000[ISI][Medline]. 

Phrase: "Am"

Phrase: "J Hum Genet 67"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "1470-1480,"

Phrase: "2000"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.591: 104.  

Phrase: "104."
Processing 00000000.tx.592: Weiss, KM, and Clark AG. 

Phrase: "Weiss,"

Phrase: "KM,"

Phrase: "and"

Phrase: "Clark AG."
Processing 00000000.tx.593: Linkage disequilibrium and the mapping of complex human traits. 

Phrase: "Linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "and"

Phrase: "the mapping of complex human traits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1283195:Mapping [Activity]
Processing 00000000.tx.594: Trends Genet 18: 19-24, 2002[ISI][Medline]. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Genet 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "19-24,"

Phrase: "2002"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.595: 105.  

Phrase: "105."
Processing 00000000.tx.596: Williams, JT, van Eerdewegh P, Almasy L, and Blangero J. 

Phrase: "Williams,"

Phrase: "JT,"

Phrase: "van Eerdewegh P,"

Phrase: "Almasy L,"

Phrase: "and"

Phrase: "Blangero J."
Processing 00000000.tx.597: Joint multipoint linkage analysis of multivariate qualitative and quantitative traits. 

Phrase: "Joint multipoint linkage analysis of multivariate qualitative"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0796345:linkage analysis [Laboratory Procedure]
   774   C0026777:Multivariate Analysis [Quantitative Concept]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0023745:linkage [Molecular Function]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "quantitative traits."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0599883:traits [Organism Attribute]
   861   C1427926:TRAITS [Gene or Genome]
Processing 00000000.tx.598: I.

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.599: Likelihood formulation and simulation results. 

Phrase: "Likelihood formulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0524527:Formulation [Research Activity]

Phrase: "and"

Phrase: "simulation results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.600: Am J Hum Genet 65: 1134-1147, 1999[ISI][Medline]. 

Phrase: "Am"

Phrase: "J Hum Genet 65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0325074:Genet [Mammal]
   812   C0450385:65 [Intellectual Product]

Phrase: ":"

Phrase: "1134-1147,"

Phrase: "1999"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.601: 106.  

Phrase: "106."
Processing 00000000.tx.602: Wiltshire, S, Hattersley AT, Hitman GA, Walker M, Levy JC, Sampson M, O'Rahilly S, Frayling TM, Bell JI, Lathrop GM, Bennett A, Dhillon R, Fletcher C, Groves CJ, Jones E, Prestwich P, Simecek N, Subba Rao PV, Wishart M, Foxon R, Howell S, Smedley D, Cardon LR, Menzel S, and McCarthy MI. 

Phrase: "Wiltshire,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454883:Wiltshire [Geographic Area]

Phrase: "S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "Hattersley AT,"

Phrase: "Hitman GA,"

Phrase: "Walker M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Levy JC,"

Phrase: "Sampson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "O'Rahilly S,"

Phrase: "Frayling TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Bell JI,"

Phrase: "Lathrop GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Bennett A,"

Phrase: "Dhillon R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Fletcher C,"

Phrase: "Groves CJ,"

Phrase: "Jones E,"

Phrase: "Prestwich P,"

Phrase: "Simecek N,"

Phrase: "Subba Rao PV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032463:PV [Neoplastic Process]

Phrase: "Wishart M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Foxon R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Howell S,"

Phrase: "Smedley D,"

Phrase: "Cardon LR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023617:LR [Geographic Area]
   861   C2986899:LR [Idea or Concept]

Phrase: "Menzel S,"

Phrase: "and"

Phrase: "McCarthy MI."
Processing 00000000.tx.603: A genome-wide scan for loci predisposing to type 2diabetes in a UK population [The Diabetes (UK) Warren 2Repository]: analysis of 573pedigrees provides independent replication of a susceptibility locus on chromosome 1q. 

Phrase: "A genome-wide scan for loci"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C1517519:Genome Scan [Molecular Biology Research Technique]
   753   C0017428:Genome [Gene or Genome]
   753   C0034606:Scan [Diagnostic Procedure]
   753   C0332464:Wide [Spatial Concept]
   753   C0441633:Scan [Diagnostic Procedure]
   753   C2338314:Genome [Conceptual Entity]
   753   C2826292:SCAN [Finding]

Phrase: "predisposing to type 2diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0231203:predisposing [Functional Concept]
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "in a UK population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "["

Phrase: "The Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(UK"

Phrase: ")"

Phrase: "Warren 2Repository"

Phrase: "]"

Phrase: ":"

Phrase: "analysis of 573pedigrees"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "independent replication of a susceptibility locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0598312:Replication [Genetic Function]
   753   C1883725:replication [Qualitative Concept]

Phrase: "on chromosome 1q."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1327882:chromosome 1q [Nucleotide Sequence]
           1q
Processing 00000000.tx.604: Am J Hum Genet 69: 553-569, 2001[Medline]. 

Phrase: "Am"

Phrase: "J Hum Genet 69"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0325074:Genet [Mammal]
   812   C0450388:69 [Intellectual Product]

Phrase: ":"

Phrase: "553-569,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.605: 107.  

Phrase: "107."
Processing 00000000.tx.606: Yamagata, K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, and Bell GI. 

Phrase: "Yamagata,"

Phrase: "K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Furuta H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Oda N,"

Phrase: "Kaisaki PJ,"

Phrase: "Menzel S,"

Phrase: "Cox NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Fajans SS,"

Phrase: "Signorini S,"

Phrase: "Stoffel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Bell GI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]
Processing 00000000.tx.607: Mutations in the hepatocyte nuclear factor-4 gene in maturity-onset diabetes of the young (MODY1). 

Phrase: "Mutations in the hepatocyte nuclear factor-4 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0596611:gene mutations [Genetic Function]
   744   C0026882:Mutations [Genetic Function]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in maturity-onset diabetes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C0449989:Maturity [Qualitative Concept]
   827   C0700597:Maturity [Temporal Concept]
   755 E C0205286:Mature [Temporal Concept]

Phrase: "of the young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "(MODY1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1852093:MODY1 [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.608: Nature 384: 458-460, 1996[ISI][Medline]. 

Phrase: "Nature 384"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "458-460,"

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.609: 108.  

Phrase: "108."
Processing 00000000.tx.610: Yamagata, K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Turner RC, Velho G, Chvre J-C, Froguel P, and Bell GI. 

Phrase: "Yamagata,"

Phrase: "K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Oda N,"

Phrase: "Kaisaki PJ,"

Phrase: "Menzel S,"

Phrase: "Furuta H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Vaxillaire M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Southam L,"

Phrase: "Cox RD,"

Phrase: "Lathrop GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Boriraj VV,"

Phrase: "Chen X,"

Phrase: "Cox NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Oda Y,"

Phrase: "Yano H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Le Beau MM,"

Phrase: "Yamada S,"

Phrase: "Nishigori H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Takeda J,"

Phrase: "Fajans SS,"

Phrase: "Hattersley AT,"

Phrase: "Iwasaki N,"

Phrase: "Hansen T,"

Phrase: "Pedersen O,"

Phrase: "Polonsky KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Turner RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Velho G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Chvre J-C,"

Phrase: "Froguel P,"

Phrase: "and"

Phrase: "Bell GI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]
Processing 00000000.tx.611: Mutations in the hepatocyte nuclear factor-1 gene in maturity-onset diabetes of the young (MODY3). 

Phrase: "Mutations in the hepatocyte nuclear factor-1 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0596611:gene mutations [Genetic Function]
   744   C0026882:Mutations [Genetic Function]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in maturity-onset diabetes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C0449989:Maturity [Qualitative Concept]
   827   C0700597:Maturity [Temporal Concept]
   755 E C0205286:Mature [Temporal Concept]

Phrase: "of the young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "(MODY3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1838100:MODY3 [Disease or Syndrome]
  1000   C3273648:MODY3 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.612: Nature 384: 455-458, 1996[ISI][Medline]. 

Phrase: "Nature 384"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "455-458,"

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.613: 109.  

Phrase: "109."
Processing 00000000.tx.614: Zimmet, P, Alberti KGMM, and Shaw J. 

Phrase: "Zimmet,"

Phrase: "P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Alberti KGMM,"

Phrase: "and"

Phrase: "Shaw J."
Processing 00000000.tx.615: Global and societal implications of the diabetes epidemic. 

Phrase: "Global"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205246:Global [Spatial Concept]
  1000   C2348867:Global [Qualitative Concept]
   928 E C0015392:globe [Body Part, Organ, or Organ Component]
   928 E C1280202:Globe [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "societal implications of the diabetes"

Phrase: "epidemic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014499:Epidemic [Phenomenon or Process]
Processing 00000000.tx.616: Nature 414: 782-787, 2001[ISI][Medline]. 

Phrase: "Nature 414"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "782-787,"

Phrase: "2001"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.617: 110.  

Phrase: "110."
Processing 00000000.tx.618: Zouali, H, Hani EH, Philippi A, Vionnet N, Beckmann JS, Demenais F, and Froguel P. 

Phrase: "Zouali,"

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hani EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Philippi A,"

Phrase: "Vionnet N,"

Phrase: "Beckmann JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Demenais F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Froguel P."
Processing 00000000.tx.619: A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. 

Phrase: "A susceptibility locus for early-onset non-insulin dependent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1708726:Locus [Gene or Genome]

Phrase: "(type 2) diabetes mellitus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
  1000   C2984301:Type II diabetes mellitus [Functional Concept]
   875   C1320657:type diabetes [Finding]
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "maps to chromosome 20q,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C0814036:chromosome map [Intellectual Product]
   819   C2599609:20q chromosome [Cell or Molecular Dysfunction]
   770   C0008633:Chromosome [Cell Component]
   770   C0024779:Map [Manufactured Object]
   770   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1521048:20q [Nucleotide Sequence]
   770   C1706473:Map [Conceptual Entity]

Phrase: "proximal to the phosphoenolpyruvate carboxykinase gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205107:Proximal [Spatial Concept]
Processing 00000000.tx.620: Hum Mol Genet 6: 1401-1408, 1997[Abstract/Free FullText]. 

Phrase: "Hum Mol Genet 6"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "1401-1408,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.621: Am J Physiol Endocrinol Metab 283(2):E217-E225 0193-1849/02 $5.00 Copyright  2002 the American Physiological Society

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 283"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ":"

Phrase: "E217-E225 0193-1849/02 $5.00 Copyright  2002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0009993:Copyright [Intellectual Product]
   791   C1552856:copyright [Idea or Concept]

Phrase: "the American Physiological Society"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0037455:society [Organization]
   827   C0205463:Physiological [Functional Concept]
   827   C0596070:American [Population Group]
   755 E C0031842:Physiology [Biomedical Occupation or Discipline]
   755 E C0031843:physiology [Physiologic Function]

